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Résumé 
Le diabète de type 2 affecte en moyenne 29% de la population adulte crie d’Eeyou 
Istchee (CEI). Afin d’identifier les plantes médicinales possédant un potentiel antidiabétique, 
des interviews ont été réalisés dans les communautés CEI de Wemindji et Oujé-Bougoumou. 
Utilisant une approche quantitative, les espèces mentionnées ont été classées et comparées à la 
pharmacopée des communautés avoisinantes. Seize et 25 plantes ont été mentionné à 
Wemindji et Oujé-Bougoumou, respectivement. Sept nouvelles espèces de plantes et une de 
champignon se sont ajoutées à la liste des espèces à potentiel antidiabétique, bien que la 
plupart de celles mentionnées pendant les interviews soit en communes à la pharmacopée CEI 
générale, démontrant ainsi leur importance culturelle. Des analyses phytochimiques sur deux 
de ces espèces, Rhododendron groenlandicum et Sarracenia purpurea, ont été réalisées à 
partir d’échantillons récoltés à différents endroits du territoire eeyouch. Bien qu’aucun patron 
n’ait été détecté dans la variation des composantes biologiquement actives chez S. purpurea, 
les composés phénoliques chez R. groenlandicum, particulièrement la (+)-catéchine, l’(-)-
epicatéchine et la quercétine-3-galactoside, varient spatialement en fonction de paramètres 
d’insolation telles la radiation solaire ou la photopériode. Les échantillons de cette dernière 
espèce, testés in vitro dans le bioessai de l’adipogenèse des cellules adipocytes murines 3T3-
L1, augmentent l’accumulation intracellulaire des triglycérides, leur conférant ainsi une 
activité diabétique semblable à la rosiglitazone. Cependant, cette activité était plus faible dans 
les échantillons à haute teneur en quercétine, cela pouvant ainsi avoir un impact sur la qualité 
d'un produit de santé naturel fabriqué à partir de cette espèce. 
Mots-clés : Diabète de type 2, Rhododendron groenlandicum, Sarracenia purpurea, 
ethnobotanique, Cri d’Eeyou Istchee, Premières Nations, phytochimie, photoinhibition, 
variations géographiques, adipogenèse, plantes médicinales, produits de santé naturels. 
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Abstract 
Type 2 diabetes has reached epidemic proportions among Canada’s aboriginal 
populations and affects on average 29% of adult Cree of Eeyou Istchee (CEI). In collaboration 
with the Cree Board of Health and Social Services of James Bay and the CIHR team in 
Traditional Antidiabetic Aboriginal Medicines, interviews were held in the CEI communities 
of Wemindji and Oujé-Bougoumou to identify potential antidiabetic plants. Using a 
quantitative approach, species mentioned were ranked and compared to the pharmacopoeia of 
other participating communities. Sixteen and 25 plants were mentioned in Wemindji and 
Oujé-Bougoumou respectively. Seven new plant and one fungal species were added to the list 
of potential antidiabetic species, although most of those mentioned were common to the 
general CEI pharmacopoeia, thus supporting the cultural importance that they hold. 
Phytochemical analyses of two of these species, Rhododendron groenlandicum and 
Sarracenia purpurea, were made from accessions harvested throughout Eeyou Istchee. While 
no pattern was detected in the variation of S. purpurea’s biologically active compounds, 
phenolic compounds from R. groenlandicum, specifically (+)-catchin, (-)-epicatechin and 
quercetin-3-galactoside, varied spatially as a function of insolation parameters such as solar 
radiation or photoperiod. Samples from the latter, tested in vitro in the 3T3-L1 murine 
adipocytes adipogenesis bioassay, increased the intracellular accumulation of triglycerides, 
thus conferring it a glitazone-like antidiabetic activity. This activity, however, was weaker in 
accessions with high quercetin content, which could have an impact on the quality of a natural 
health product made from this species. 
Keywords : Type 2 diabetes, Rhododendron groenlandicum, Sarracenia purpurea, 
ethnobotany, Eeyou Istchee Cree, First Nations, phytochemistry, photoinhibition, geographical 
variations, adipogenesis, medicinal plants, natural health products. 
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En 2003, un projet collaboratif a été mis en place avec des communautés de la Nation 
crie d'Eeyou Istchee (CEI), le Conseil Cri de la Santé et des Services Sociaux de la Baie James 
et ses professionnels de la santé (Cree Board of Health and Social Services of James Bay, 
CBHSSJB) ainsi que des chercheurs des Universités McGill, d'Ottawa et de Montréal. 
L’équipe de recherche des IRSC sur les médecines autochtones antidiabétiques (CIHR Team 
in Aboriginal Antidiabetic Medicines, CIHR-TAAM) a pour but la recherche des plantes 
médicinales ayant un potentiel antidiabétique. Abordant la problématique du diabète chez les 
Cris en respectant leur culture et leur territoire, le CIHR-TAAM travaille de façon étroite et 
éthique avec les membres des communautés CEI afin de trouver des solutions adaptées à leur 
culture. 
L’évaluation scientifique des plantes médicinales de la pharmacopée CEI comprend, 
entre autres, des analyses phytochimiques, des essais toxicologiques et des expériences 
pharmacologiques in vitro et in vivo. Plusieurs de ces plantes ont montré un potentiel 
antidiabétique et ces résultats ont suscité un intérêt soutenu de la part des Cris dans tout le 
territoire Eeyouch. Quatre des neuf communautés CEI ont déjà fait part de leur savoir 
traditionnel depuis la création du CIHR-TAAM. Mais durant l’été 2010, j’ai été invité à 
discuter avec les aînés et les Conseils de bande de Wemindji et d’Oujé-Bougoumou de leur 
participation à ce projet. Puis, j’ai été appelé à compléter les études ethnobotaniques au sein de 
ces deux communautés et à examiner davantage la phytochimie et la pharmacologie de 
certaines espèces clés. 
 
1.1 Introduction au diabète 
Le diabète est une affection chronique caractérisée par l’hyperglycémie, soit une 
concentration trop élevée du glucose dans le sang. Cela est causé par une faible sécrétion 
d’insuline généralement reliée à des problèmes chez les cellules β des tissus pancréatiques 
(Prentki and Nolan, 2006; Agence de la santé publique du Canada, 2011). 
La maladie a atteint des dimensions pandémiques. En 2011, le nombre total de 
personnes atteintes était estimé à 366 millions, un nombre représentant 8.3 % de la population 
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globale. Cette incidence risque d’augmenter jusqu’à 552 millions de personnes en 2030 
(Whiting et al., 2011). Au Canada, c'est un problème en croissance : 2,4 millions, soit 6,8 % de 
la population canadienne, vivaient avec le diabète en 2008/9, représentant ainsi une 
augmentation de 70% depuis 1998/9 (Agence de la santé publique du Canada, 2011). Les 
visites fréquentes aux cliniques et hôpitaux, l’hospitalisation liée aux complications, la 
pharmacothérapie, l’invalidité à court et à long termes, ainsi que la perte de la productivité 
constituent un fardeau économique important. En 2000, les coûts totaux associés au diabète 
étaient estimés à 2,5 milliards de dollars (Agence de la santé publique du Canada, 2011). 
Il existe trois principales formes du diabète, soit 1) le diabète gestationnel se 
manifestant durant la grossesse, 2) le diabète de type 1, d’origine génétique, qui résulte de 
l’endommagement irréversible des cellules β par une réaction auto-immunitaire, et 3) le 
diabète de type 2 (Agence de la santé publique du Canada, 2011). 
. 
1.2 Diabète de type 2 
Représentant plus de 90 % des cas, le diabète de type 2 (T2D) est la forme la plus 
courante de diabète (Tiwari and Rao, 2002; Agence de la santé publique du Canada, 2011). 
Aussi appelé diabète sucré non-insulinodépendant (DSNID), il se manifeste généralement 
suite à l’insulinorésistance des tissus cibles (Bennett et al., 1992; Agence de la santé publique 
du Canada, 2011). Dans les stades primaires de l'affection, les cellules β du pancréas sont 
portées à produire de grandes quantités d'insuline pour compenser une sensibilité réduite et 
maintenir la normoglycémie (Prentki and Nolan, 2006). Cette persistance mène 
éventuellement à la défaillance des cellules β, impliquant la diminution, voir l'interruption de 
la production d’insuline (Prentki and Nolan, 2006). 
La pathologie du T2D est bien connue. L'insulinorésistance, l’hyperinsulinémie, la 
sécrétion altérée de l’insuline ainsi que l’absorption et le transport réduits du glucose à travers 
l’action de l’insuline sont tous caractéristiques de la maladie (Tiwari and Rao, 2002). La 
fatigue et faiblesse, la soif et miction excessive, la perte de poids inexpliquée, les maladies 
parodontales, la néphropathie, la rétinopathie, l’amputation des membres, la cardiopathie 
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ischémique, les maladies cardio- et cérébro-vasculaires, les complications neuropathiques 
menant à la perte de sensation, la dysfonction sexuelle ainsi que l’augmentation des infections 
et ulcérations des pieds sont tous des symptômes et complications du T2D découlant du 
métabolisme altéré du glucose (Giugliano et al., 1996; Tiwari and Rao, 2002; Johansen et al., 
2005; Rahimi et al., 2005; Agence de la santé publique du Canada, 2011). Malgré cela, 
l’étiologie derrière plusieurs de ces problèmes confrontent toujours les chercheurs, médecins 
et patients (Tiwari and Rao, 2002; Prentki and Nolan, 2006). 
Pour ces raisons, le traitement du T2D est compliqué (Tiwari and Rao, 2002). Le 
contrôle et le maintien des mécanismes d’homéostasie dans les niveaux du glucose sanguin 
impliquent parfois des injections d’insuline, mais plus couramment l’utilisation de 
médicaments oraux tels la metformine, les composés sulfonylurés, les thiazolidinediones, les 
méglitinides et les inhibiteurs d’α-glucosidases (Agence de la santé publique du Canada, 
2011). 
 
1.3 Diabète chez les autochtones  
Le T2D était autrefois rare chez les Premières Nations du Canada (Thouez et al., 1990; 
Agence de la santé publique du Canada, 2011), mais depuis plus d’un demi-siècle, le nombre 
de cas a considérablement augmenté (Brassard and Robinson, 1995; Young et al., 2000). Le 
diabète atteint maintenant des proportions épidémiques dans certaines communautés 
autochtones (Agence de la santé publique du Canada, 2011) et ces dernières sont considérées 
parmi les groupes à haut risque mondialement (WHO and IDF, 2004; Yu and Zinman, 2007). 
Aussi, l’incidence du diabète est trois à cinq fois plus élevée que la moyenne nationale (Young 
et al., 2000; Agence de la santé publique du Canada, 2011). 
Les Cris d’Eeyou Istchee de la région de la Baie James du nord du Québec sont 
particulièrement touchés par le T2D (Robinson, 1988; Brassard et al., 1993a; Brassard et al., 
1993b; Brassard and Robinson, 1995; Dannenbaum et al., 1999). Les premiers cas rapportés 
en 1983 n’affectaient que 2,9% des CEI (Thouez et al., 1990), mais la maladie est maintenant 
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un problème de santé majeur. En 2009, l'incidence du T2D, ajusté pour l'âge, chez les CEI 
adultes était de 29 % (Kuzmina et al., 2010). 
L'inaccessibilité de certains services de santé n'aide pas à containdre ces taux élevés de 
complications chez les communautés autochtones. L'apparition est souvent précoce et la 
détection tardive. On attribut cependant i) aux changements rapides du mode de vie et de 
l’alimentation, ii) aux prédispositions génétiques et iii) à la faible adhérence aux traitements 
actuels comme étant les raisons principales expliquant cette incidence élevée. 
En premier lieu, le mode de vie traditionnel nomade n’incluait pas un historique de 
maladie chronique. Il se caractérisait par une activité physique et une alimentation saine, 
incluant poissons et plantes (Berkes and Farkas, 1978; Robinson, 1988). La transition de l’arc 
à flèche aux couteaux et fusils, ainsi que la pression commerciale associée à la traite de la 
fourrure (Robinson, 1988), aboutit à la surexploitation de la faune et facilite l’introduction de 
la diète Européenne (Berkes and Farkas, 1978). Des carences nutritives ont été associées à ces 
changements dans l’alimentation (Berkes and Farkas, 1978; Hoffer et al., 1981) allant jusqu’à 
d’importants cas de malnutrition au début du 20e siècle (Moore et al., 1946; Vivian et al., 
1948). Amplifiés par la sédentarisation (Boston et al., 1997), ces changements conduisent à 
l’obésité et celle-ci devient alors un déterminant important du T2D dans les communautés de 
la Baie James (Brassard and Robinson, 1995), comme ailleur dans le monde (Yu and Zinman, 
2007). 
Il est entendu que l’alimentation traditionnelle ne contenait pas les hydrates de carbone 
raffinés que l’on retrouve maintenant (Gittelsohn et al., 1996) dans leur diète. Les problèmes 
encourus par cette nouvelle stratégie alimentaire sembleraient être exacerbés par des 
prédispositions génétiques (Ritenbaugh and Goodby, 1989; Neel, 1999; Hegele et al., 2003; 
Chakravarthy and Booth, 2004; Yu and Zinman, 2007). L’hypothèse du génotype vigoureux, 
soit le thrifty genotype proposé par Neel (1999), stipule que les gènes associés ont été 
sélectionnés dans les sociétés chasseurs-cueilleurs afin de maintenir plus efficacement les 
réserves durant les cycles de famines et d’abondances alimentaires. Paradoxalement, la 
nourriture est de nos jours aisément accessible dans les communautés CEI et ne nécessite 
qu’un petit voyage au magasin. Associée aux changements rapides dans le mode de vie des 
populations autochtones, cette adaptation évolutive nuirait plus qu’elle ne ferait du bien en 
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menant aux désordres métaboliques tels l’obésité et le T2D (Ritenbaugh and Goodby, 1989; 
Boston et al., 1997; Chakravarthy and Booth, 2004). 
Sans s’attarder sur les détails de la théorie du génotype vigoureux et du débat sous-
jacent, Hegele et al. (2003) mettent en évidence le lien génétique au T2D dans les populations 
Oji-Cree de l’Ontario et du Manitoba. Un polymorphisme spécifique du gène HNF1A a été 
décrit dans cette population, d’où la mutation G319S encodée dans le gène. Cette mutation 
serait associée à une augmentation substantielle des risques du T2D (Hegele et al., 2003). 
Finalement, une étude parmi cette population indique qu’il existe une dichotomie entre 
le monde autochtone et non-autochtone par rapport à l’alimentation, les maladies et la 
médecine (Gittelsohn et al., 1996). Le T2D est souvent perçu comme une « maladie de 
l’homme blanc » introduite tout comme la tuberculose et la variole dans le passé (Boston et 
al., 1997; Young et al., 2000). Ainsi, 90 % des autochtones diabétiques ont consulté un 
professionnel de santé, selon une enquête auprès des peuples autochtones (EAPA) en 1991; 
cependant, une enquête de la santé régionale auprès des Premières Nations et Inuits montre 
que 80 % de ceux-ci croyaient que le système de santé a besoin d’être amélioré (Young et al., 
2000). Une autre étude, portant sur l’intervention alimentaire et l’activité physique dans les 
communautés CEI, a montré le peu d’impact de telles interventions, ce qui remet en question 
les approches jusqu'alors utilisées pour interpeler le problème du T2D (Gray-Donald et al., 
2000). Même s’ils indiquent qu’ils vont suivre les conseils des professionnels de la santé, les 
membres de la communauté crie conceptualisent toujours le traitement relié au diabète dans 
une perspective crie (Boston et al., 1997). 
C’est donc avec un succès limité que ces approches vouées à des stratégies 
alimentaires ont été mises en place parmi les populations autochtones (Boston et al., 1997; 
Gray-Donald et al., 2000). Il s’ensuit que le défi du T2D devra être résolu avec une 
compréhension approfondie de la perception autochtone vis-à-vis de la médecine 
contemporaine (Gray-Donald et al., 2000). 
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1.4 Approches alternatives 
La prise en compte de la culture et du langage sont des recommandations qui doivent 
être adoptées au sein des cliniques visant à combattre la maladie parmi les peuples autochtones 
(Meltzer et al., 1998). Cela aura pour effet d’augmenter la participation des membres des 
communautés autochtones quant à la médecine allochtone (Robinson, 1988; Boston et al., 
1997; Meltzer et al., 1998; Bisset et al., 2004; Yu and Zinman, 2007). 
Une étude menée dans un centre de santé autochtone urbain de Milwaukee, Wisconsin, 
montre qu’une grande portion (38 %) des patients fréquentait un guérisseur (Marbella et al., 
1998). Bien qu’un tiers de ces patients recevait cependant des conseils différents de la part des 
médcins et des guérisseurs, 61 % avaient une meilleure opinion des conseils de ces derniers et 
15 % en informaient le médecin de ces visites (Marbella et al., 1998). Pareillement, la 
perspective CEI considère la médecine occidentale séparée des concepts et des approches cries 
sur la santé et ne rapporte pas régulièrement ces pratiques alternatives (Boston et al., 1997). 
Les chercheurs donnent donc raison à l’intégration des médecines traditionnelles aux 
approches modernes courantes (Niezen, 1997; Young et al., 2000). Bien que l’utilisation de la 
médecine traditionnelle et conventionnelle en tandem soit fréquemment employée dans les 
pays en développement (Bodeker, 2001), au Canada, c’est une approche originale qui doit 
débuter par l’intermédiaire de la recherche en ethnobotanique (Young et al., 2000). 
 
1.5 Ethnobotanique 
L’origine végétale de la galégine, précurseur de l’une des drogues antidiabétiques les 
plus prescrites mondialement, la metformine, met en lumière l’importance d’une approche 
ethnobotanique dans le domaine de la santé. En effet, plus de 42 millions de prescriptions ont 
été faites en 2009 aux États-Unis, le classant au 10e rang des drogues les plus distribuées du 
pays (SDI/Verispan and VONA, 2010). Cette drogue hypoglycémiante (Marles and 
Farnsworth, 1995) est dérivée de la guanidine isolée du Galega officinalis L. (Fabaceae) à la 
fin du 19e siècle. Les parties aériennes de cette plante étaient utilisées médicalement en 
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Europe médiévale pour traiter une panoplie de symptômes et malaises, dont certains sont liés 
au T2D (Bailey and Day, 2004). 
Il va de soi que la médecine traditionnelle CEI contient un savoir approfondi des 
plantes médicinales (Marshall et al., 2003; Fraser, 2006; Leduc et al., 2006; Marshall, 2006; 
Cosset and Mansion, 2009; Downing, 2010). Ces espèces boréales sont utilisées 
communément par les diverses Nations cries à travers la forêt boréale canadienne (Holmes, 
1884; Strath, 1903; Beardsley, 1941; Arnason et al., 1981; Zieba, 1990; Siegfried, 1994; 
Marles et al., 2008; Moerman, 2009; Uprety et al., 2012). Plusieurs de ces espèces sont 
utilisées pour traiter des complications et des symptômes pouvant être associés au T2D. Il 
existe désormais une compréhension limitée, notamment chez les aînés, par rapport à 
l’association entre ces problèmes et le T2D (Boston et al., 1997). Afin de prioriser l’évaluation 
des plantes à potentiel antidiabétique, Leduc et al. (2006) ont développé un indice permettant 
de mesurer l’importance d’une plante par rapport à une maladie. La valeur de l’importance 
syndromique (syndromic importance value, SIV), tenant compte i) du consensus, ii) du 
nombre de symptômes pour lesquels une plante est citée et iii) de l’importance de ces 
symptômes pour le diabète, a été utilisée au sein du CIHR-TAAM dans les communautés CEI 
de Mistissini (Leduc et al., 2006), Whapmagoostui (Fraser, 2006; Fraser et al., 2007), 
Nemaska et Waskaganish (Downing, 2010). 
Grâce à cette approche ethnobotanique quantitative, une multitude de plantes ont été 
identifiées pour des évaluations antidiabétiques poussées. Une grande portion de ces espèces 
proviennent de la famille des Ericaceae et des Pinaceae, mais aussi des Cupressaceae, 
Betulaceae, Lycopodiaceae, Salicaceae, Sarraceniaceae, Rosaceae, Typhaceae, Poaceae, 
Empetraceae et Apiaceae (Fraser, 2006; Leduc et al., 2006; Downing, 2010). Quoique la 
phytochimie et la pharmacologie de la majorité de ces espèces aient été peu étudiées, certains 
représentants de ces familles, tels les Vaccinium spp. des Ericaceae et les Salix spp. des 
Salicaceae, sont tout de même bien connus pour leurs bienfaits sur la santé. 
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1.6 Pharmacologie 
Les plantes médicinales CEI, résultant de ces études ethnobotaniques, ont fait l’objet 
de plusieurs bioessais pour évaluer leur potentiel antidiabétique (Spoor et al., 2006; Fraser et 
al., 2007; Harbilas et al., 2009; Harris et al., 2011). Ainsi, le thé du Labrador, Rhododendron 
groenlandicum (Oeder) Kron & Judd (fig 1.1a) stimule l’adipogenèse des cellules 
adipocytaires murines 3T3-L1 possiblement par l’activation du récepteur de type gamma 
activé par les proliférateurs de peroxysomes (peroxisome proliferator-activated receptor 
gamma, PPARγ) (Spoor et al., 2006; Ouchfoun, 2011). La sarracénie pourpre, Sarracenia 
purpurea L. (fig 1.1b), quant à elle, stimule l’absorption du glucose par les cellules 
musculaires C2C12 (Spoor et al., 2006; Muhammad et al., 2012) et protège les pré-neurones 
sympathiques PC12-AC de la toxicité glycémique (Spoor et al., 2006; Harris et al., 2012). 
Figure 1.1 Image de Rhododendron groenlandicum, thé du Labrador, en fleurs (A) et 
Sarracenia purpurea, sarracénie pourpre (B). 
Dans le premier cas, le mécanisme d’action améliore l’insulinorésistance conférant au 
R. groenlandicum l’activité antidiabétique imputée aux thiazolidinediones comme la 
rosiglitazone (Grimaldi, 2001; MacDougald and Mandrup, 2002; Hansen and Kristiansen, 
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2006; Rosen and MacDougald, 2006; Ouchfoun, 2011). Dans le deuxième, le mécanisme 
d’action, analogue à la metformine, passerait par la protéine kinase activée par l’AMP (AMP-
activated protein kinase, AMPK) en réponse aux désordres mitochondriaux (Martineau, 
Adeyiwola-Spoor, et al., 2010). 
Le fractionnement guidé par bioessais des extraits bruts de ces plantes dévoile que les 
composés phénoliques sont en partie responsables de leur activité antidiabétique. La (+)-
catéchine et l’(-)-épicatéchine, stimulant l’adipogenèse, a été isolée du R. groenlandicum 
(Ouchfoun, 2011), alors que la quercétine-3-O-galactoside, stimulant l’absorption du glucose, 
a été isolée chez S. purpurea (Muhammad et al., 2012). Le fractionnement des extraits bruts 
de cette plante par le test de toxicité glycémique a également démontré l’activité 
cytoprotectrice de la quercétine-3-O-galactoside sur les cellules PC12-AC (Harris et al., 2012). 
Il semblerait que ces espèces posséderaient une activité antidiabétique primaire, soit une 
activité hypoglycémiante, et secondaire, soit la protection contre les complications indirectes. 
 
1.7 Phytochimie 
Il devient de plus en plus évident que plusieurs des symptômes et des complications 
associés au T2D sont causés par les stress oxydatifs liés à l’hyperglycémie sur les systèmes 
micro- et macro-vasculaires (Giugliano et al., 1996; Tiwari and Rao, 2002; Johansen et al., 
2005; Rahimi et al., 2005). L’auto-oxydation du glucose, entre autres, mènerait à la production 
de radicaux libres et le déséquilibre ainsi créé dans les réactions d’oxydo-réductions cellulaire 
contribuerait à augmenter la production d’espèces réactives d’oxygène (reactive oxygen 
species, ROS) (Tiwari and Rao, 2002; Johansen et al., 2005; Rahimi et al., 2005). 
Bien que l’activité antidiabétique soit connue pour plusieurs composés phénoliques 
(Marles and Farnsworth, 1995), leurs propriétés antioxydantes le sont davantage, tout 
particulièrement chez les flavones, flavonoles et flavonoïdes (Harborne et al., 1999). Les 
recherches scientifiques montrent de plus en plus le bienfait des antioxydants dans la gestion 
des complications associées au diabète (Marles and Farnsworth, 1995; Rahimi et al., 2005; 
Harris et al., 2011). La production élevée de produits terminaux de glycation avancée 
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(advanced glycation end-products, AGE) chez les diabétiques, par exemple, contribue au 
développement des complications micro- et macro-vasculaires (Hegab et al., 2012; Yamagishi 
et al., 2012). Harris et al. (2011) montrent cependant une corrélation entre le contenu 
phénolique d’une plante et sa capacité à réduire la production d’AGE. Ils montrent de plus que 
ce dernier est corrélé à l’activité antioxydante de la plante. 
Les composés phénoliques possèdent des structures chimiques qui leur permettent 
d’inactiver les ROS et d’agir comme antioxydant (Haslam, 1996; Habtemariam, 1997; Rice-
Evans et al., 1997; Takahama and Oniki, 1997; Pietta et al., 1998; Plumb et al., 1998; 
Kähkönen et al., 1999). Cette activité pharmacologique tient de leur fonction physiologique 
chez la plante qui est elle-même susceptible au dommage oxydatif. Malgré la nécessité de 
recevoir de l’énergie lumineuse, les plantes peuvent souffrir de la photoinhibition lorsque la 
densité du flux de photons photosynthétiquement actifs surpasse ce qui est nécessaire à 
l’assimilation du CO2 (Carvalho and Amâncio, 2002). L’augmentation des ROS, produits par 
cet excès d’énergie, est de plus susceptible à d’autres facteurs environnementaux, telles les 
températures extrêmes, qui réduisent la capacité photosynthétique des photosystèmes (Dixon 
and Paiva, 1995; Carvalho and Amâncio, 2002; Close et al., 2003; Carvalho et al., 2006; 
Solovchenko and Merzlyak, 2008; Bhattacharjee, 2011). Récemment, maintes études ont 
élucidé les fonctions antioxydantes des composés phénoliques dans la protection contre les 
stress oxydatifs induits par ces facteurs environnementaux (Dixon and Paiva, 1995; Takahama 
and Oniki, 1997; Pietta et al., 1998; Close et al., 2003; Solovchenko and Merzlyak, 2008; 
Faisal and Anis, 2009; Bhattacharjee, 2011). Il a été également montré que la lumière induit 
l’expression des gènes responsables aux voies biosynthétiques des flavonoïdes (Hartmann et 
al., 2005; Matus et al., 2009) et que cette expression est modulée, d’autre part, par la 
température et l’azote (Lillo et al., 2008; Usadel et al., 2008). 
Plusieurs des plantes médicinales cries, tels R. groenlandicum et S. purpurea, sont 
abondantes et largement distribuées sur le territoire Eeyouch et la zone boréale du Canada. Le 
vaste territoire dans lequel les CEI puisent leurs ressources médicinales, s’étend du 49e au 55e 
parallèle nord. Ainsi, des différences marquées dans la durée du jour (fig. 1.2) ainsi que dans 
les conditions climatiques peuvent être observées entre ces extrémités nord-sud. Étant donné 
les relations étroites entre le rôle physiologique des composés phénoliques dans la plante et les 
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conditions climatiques, nous nous attendons à ce que cela joue sur la normalisation et le 
contrôle de qualité des produits de santé naturels provenant de ce territoire et a fortiori de la 
forêt boréale. Jusqu’à présent, il existe peu d’études concernant la variation phytochimique, 
particulièrement dans la composition de composantes pharmacologiquement actives, sur de 
grands gradients géographiques. Des corrélations positives entre la concentration phénolique 
et la latitude ont été montrées chez les Cupressaceae, les Ericaceae et les Betulaceae, soit 
Juniperus communis (Martz et al., 2009a), Vaccinium myrtillus (Martz et al., 2010) et Betula 
pubescens (Stark et al., 2008), respectivement. Bien que le rôle des facteurs 
environnementaux, tels la luminosité, la température et la qualité du sol, ait été mentionné 
(Stark et al., 2008; Martz et al., 2010), aucune étude à notre connaissance ne s’attarde sur le 
rôle et l’impact de ces facteurs, autant abiotiques que biotiques. 
 
1.8 Objectifs du mémoire  
Les neuf communautés CEI sont dispersées sur un vaste territoire dans le nord du 
Québec entre les 49e et 55e parallèles nord. Caractéristique de la forêt boréale, la diversité 
végétale varie néanmoins sur ce vaste territoire qui chevauche la toundra au nord et la forêt 
mixte au sud (Farrar, 2005). Cependant, les études ethnobotaniques réalisées au sein du CIHR-
TAAM représentent le savoir traditionnel de moins de la moitié des communautés, ce qui ne 
peut pas être interprété comme une représentation complète du savoir CEI. De plus, à l’instar 
du savoir qui change selon différents environnements, l’arsenal de défense des plantes est 
également apte à répondre aux mêmes changements. Les aînés rapportent que le potentiel 
médicinal des plantes n’est pas identique sur la totalité du territoire. Cependant, de telles 
variations dans le profil phytochimique et leur activité biologique peuvent avoir un impact sur 
la normalisation et le contrôle de qualité des produits de santé naturels. 
Afin de fournir de meilleures recommandations pour le développement de traitements 
antidiabétiques culturellement adaptés aux CEI, trois objectifs principaux divisés en quatre 
articles sont présentés dans ce mémoire. 
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Objectif 1 : Identifier les plantes à potentiels antidiabétiques provenant de la pharmacopée 
traditionnelle de Wemindji et d’Oujé-Bougoumou et les comparer à la pharmacopée des autres 
communautés CEI. 
Objectif 2 : Déterminer si des variations spatiales (latitudinales) peuvent être observées parmi 
les composantes biologiquement actives de deux plantes médicinales CEI: 
i) le thé du Labrador, Rhododendron groenlandicum; 
ii) la sarracénie pourpre, Sarracenia purpurea. 
Objectif 3 : Déterminer si ces variations phytochimiques sont pharmacologiquement 
significatives. 
Considérant les différences dans la durée du jour sur le territoire Eeyouch (fig 1.2) et 
l’intensification des conditions climatiques extrêmes dans le nord, l’hypothèse suivante est 
postulée : 
Hypothèse : Le contenu phénolique de ces deux plantes sera plus élevé dans les 
populations exposées à de plus hauts niveaux de stress associés à l’ensoleillement, comme la 
radiation solaire ou la photopériode. 
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Figure 1.2. Variation spatiale de la durée du jour, mesurée lors du solstice d'été, dans la région 
de la Baie James et dans le sud du Canada. Figure adaptée de l'Atlas National du Canada, 5e 
édition (National Research Council, 1995). 
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2.1 Abstract 
Type 2 diabetes (T2D) has reached epidemic proportions in aboriginal communities 
across Canada with an average age-adjusted incidence of 29% of the population in some 
nations. In collaboration with the Cree Board of Health and Social Services of James Bay 
(CBHSSJB) and the CIHR Team in Traditional Antidiabetic Aboriginal Medicines (CIHR-
TAAM), surveys were conducted in two Eeyou Istchee Cree communities to identify potential 
antidiabetic plants used within the traditional Cree pharmacopoeia. 52 Elders were interviewed 
using a list of 15 symptoms in association with T2D. Altogether, one fungal species and 28 
plant species were identified by community members. Species were ranked based on their 
Syndromic Importance Value calculated using the frequency of citation by informants, the 
number of symptoms they were mentioned for and the importance of that symptom to T2D. 
Results concur with those obtained from past ethnobotanical studies conducted in other 
communities of the Eeyou nation. Although many of the same species were cited in these 
studies and have since been tested and shown to possess antidiabetic potential, 7 new species 
were identified. This study not only contributes to the edification of the general 
pharmacopoeia of the Eeyouch, but also demonstrates once again the importance of valuable 
quantitative tools in ethnobotany for bridging traditional and modern medicinal knowledge in 
the preliminary development of culturally sound therapeutic approaches. 
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Le diabète de type 2 (T2D) a atteint un niveau épidémique chez les communautés 
autochtones à travers le Canada et il affecte en moyenne 29% de la population dans certaines 
régions. En collaboration avec le Conseil Cri de la santé et des services sociaux de la Baie 
James et l'Équipe de recherche sur les médecines autochtones antidiabétiques des IRSC, des 
interviews ont été réalisés chez deux communautés cries de la Nation d'Eeyou Istchee. De ces 
deux communautés, 52 ainés ont été interviewés au sujet de l’usage traditionnel des plantes 
médicinales en utilisant une liste de 15 symptômes associés au T2D. Un champignon et 28 
espèces végétales ont été identifiés par les membres de la communauté. Les espèces ont été 
classées selon la Valeur de leur Importance Syndromique calculée selon la fréquence des 
mentions, le nombre de symptômes pour lesquels les espèces ont été nommées ainsi que 
l’importance des symptômes au T2D. Les résultats concordent avec ceux d'études antérieures 
menées dans les autres communautés d'Eeyou Istchee. Plusieurs des espèces citées ont depuis 
été testées et montrent un potentiel antidiabétique. Nous avons tout de même identifié sept 
nouvelles espèces provenant de la pharmacopée crie. Cette étude souligne la nécessité 
d’utiliser des outils quantitatifs en ethnobotanique pour faire le pont entre les connaissances 
médicinales traditionnelles et modernes pour le développement préliminaire d'approches 
thérapeutiques culturellement adaptées. 
 
Mots-clés: Ethnobotanique, Cri d'Eeyou Istchee, diabète de type 2, plantes médicinales 
 
2.2 Introduction 
Diabetes is a chronic disease that has reached pandemic proportions. In 2011, the 
number of people affected by diabetes was estimated at 366 million and this number is 
expected to rise to 522 million people in 2030 (Whiting et al., 2011). Many ethnic groups are 
at risk, especially the indigenous peoples of the Americas (WHO and IDF, 2004), where 
transition from a traditional diet and lifestyle to a modern high glycemic diet and sedentary 
lifestyle are contributing risk factors to diabetes. 
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In Canada, diabetes is a growing concern with health care cost projected at $8.14 
billions by 2016 (Ohinmaa et al., 2004). While it affected 6.8% of the total Canadian 
population in 2008/09, the incidence among First-Nations' population on reserves, is three 
times higher than the national average, and is considered by Health Canada to have reached 
epidemic proportions (Public Health Agency of Canada, 2011). With an age-adjusted 
prevalence of 29% (Kuzmina et al., 2010) the Cree of Eeyou Istchee (CEI) of Northern 
Québec are severely affected. Moreover, in northern regions of the country, where 
communities are often isolated, access to health care services and medical resources are often 
limited. 
Because of long standing traditions in local medicinal practices and overall traditional 
knowledge, it has been suggested that traditional medicines, such as the Cree traditional 
medicine (CTM), may be used in the prevention and complementary treatment of diabetes 
(Marles and Farnsworth, 1995; Ryan et al., 2000; Young et al., 2000). This is particularly 
relevant since studies have revealed that current approaches to treating diabetes are culturally 
inappropriate in Cree communities (Boston et al., 1997; Johnston, 2002). Low compliance has 
led to higher levels of type 2 diabetes (T2D) complications and a resulting diminution in the 
quality of life. Since 2003, the CIHR Team in Aboriginal Antidiabetic Medicine (CIHR-
TAAM) has been working in a multidisciplinary fashion with researchers, health care 
professionals, the Cree Board of Health and Social Services of James Bay (CBHSSJB) and 
CEI community members with the goal of identifying traditional medicinal plants and 
assessing their safety and mode of action. 
An ethnobotanical approach to developing culturally appropriate therapies is thus 
warranted. Knowledgeable Healers from the communities of Mistissini (Leduc et al., 2006), 
Whapmagoostui (Fraser, 2006; Fraser et al., 2007), Nemaska and Waskaganish (Downing, 
2010) participated in studies identifying traditional medicinal plants for T2D. The CIHR-
TAAM has attempted to translate traditional knowledge into scientific knowledge through 
continuous discourse and cultural dialogue (Cuerrier et al., 2012). This collaboration has 
allowed the ethnobotanical prioritization and ranking of species for the pharmacological 
screening of their antidiabetic potential (Haddad et al., 2012). However, these studies 
represent less than half the CEI communities and cannot be considered a complete 
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representation of the CEI pharmacopoeia. The collaboration of all or most communities is thus 
essential in obtaining a better understanding of the CEI pharmacopoeia not only in providing 
appropriate recommendations for the research in antidiabetic plants but also ensuring that 
these are culturally relevant to all the CEI. 
Prior to 1940, diabetes was rare amongst the Aboriginal population in North America 
(Thouez et al., 1990; Public Health Agency of Canada, 2011). Because the high occurrence of 
diabetes in CEI communities is relatively recent (first cases reported in 1983 with a 2.87 % 
prevalence (Thouez et al., 1990)), in-depth knowledge and understanding of T2D is poor. A 
novel approach, developed by Leduc et al. (2006), consisted of breaking down the disease into 
easily discernible and significant symptoms is employed in our study to a) rank traditional 
medicinal plants for research, b) identify plant species with strong associations to specific 
symptoms, and c) quantitatively compare communities. CEI resides primarily in the boreal 
forest region and we therefore expected major medicinal plants commonly used amongst Cree 
communities to be cultural keystone species, abundant and widely distributed within that 
region. However, the territory is vast, extending from the 49th to the 55th parallel, thus 
witnessing the overlap in niches of a variety of northern and southern plant species, as well as 
neighbouring cultural influences at the edge of the Cree territory. Hence, we reasonably expect 
specific uses and ranking to vary amongst communities. 
Therefore the objectives of this study were to identify traditional medicinal plants from 
the CEI communities of Wemindji and Oujé-Bougoumou that have potential antidabetic 
properties. In continuing the CIHR-TAAM collaborative research in antidiabetic plants, we 
present not only the first ethnobotanical study of Oujé-Bougoumou, but also, the first 
ethnobotanical reports of the latest communities to have joined the team. We compared our 
results to those from four other communities and report important medicinal plants commonly 
used by the CEI. In doing so, we report new boreal plant species that are added to the general 
CEI pharmacopoeia. 
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2.3 Materials and Methods 
2.3.1 Study Site 
The Eeyou Istchee is a large region in northern Québec also known as the James Bay 
region. It borders Nunavik in the north at the 55th parallel, and extends south to Abitibi-
Témiscamingue and la Mauricie at the 49th parallel. From the James Bay coast in the west, it 
ranges to its eastern border, the Saguenay-Lac-Saint-Jean region. In the nine Eeyou Istchee 
communities, two dialects are spoken. These can be roughly categorized as the northern (or 
coastal) and the southern (or inland) dialects. Wemindji, at the 53rd parallel, is a coastal 
community speaking the northern dialect. Situated at the mouth of the Maquatua river where it 
flows into James Bay, it is a small community of 1,267 inhabitants relocated in the late 50's 
from Old Factory, a small island 30km to the south (Scott et al., 2009). Inland, Oujé-
Bougoumou sits on the shores of Lake Opemisca, not too far from Chibougamau and Chapais 
at the 50th parallel. Designed by the Métis architect Douglas Cardinal and built in 1992, it is 
one of the youngest and smallest communities, with a population of 725 people (Statistique 
Canada, 2012). It is also one of the most progressive, gaining international recognition by 
winning a UNESCO award for its construction based on criterion of sustainable development. 
2.3.2 Interviews 
Participants were identified by community members as possessing a great deal of 
knowledge in traditional herbal medicine. Interviews took place in each community for a 
period of one month. They began in June 2011, starting with Wemindji, and July for Oujé-
Bougoumou. The average age of participants was 72 (n=27) years in Wemindji and 66 (n=22) 
in Oujé-Bougoumou. While the average age in Oujé-Bougoumou might be slightly lowered by 
two participants in their mid to late 40's, this, nonetheless, reflects the relatively young age of 
the community’s members. Couples were interviewed in pair and in one case, two siblings 
preferred to be interviewed together. These were consequently counted as n=1. One Métis and 
one Inuit, who now live in Wemindji, were also known for their knowledge in herbal 
remedies. While these two were interviewed, they were not included in the calculation of SIVs 
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in order to keep strictly to the Cree pharmacopoeia and, consequently, the information they 
shared will simply be mentioned in the discussion. 
The survey used the same semi-structured questionnaire previously used by Leduc et 
al. (2006), Fraser et al. (2007) and Downing (2010) in the aforementioned communities. The 
survey is structured around 15 symptoms and complications in association with T2D (table 
2.1). Survey and methods were approved by the Université de Montréal ethics committee, 
« Commité d'éthique de la recherche de la faculté des arts et de sciences (CÉRFAS) » 
(appendix I). Informed consent was obtained prior to the interview and participants were 
informed that they were not obligated to answer all questions and that they could stop the 
interview at any time. Four voucher specimens were collected for each plant cited and used to 
confirm their identity. Specimens will be donated to the Cree Cultural Institute and the local 
school for educational purposes, while the others will remain in the Marie-Victorin (MT) and 
University of Ottawa (OTT) herbaria (appendix II). 
2.3.3 Ranking 
Each plant was ranked based on their frequency of citation (FC; Ladio and Lozada, 
2004) which reveals their relative importance and their syndromic importance value (SIV; 
Leduc et al., 2006). Due to the inclusion of personalized disease symptoms into the equation, 
the SIV ranking enables the comparison of the plants' potential importance to the treatment of 
a specific illness, such as T2D in this case. It is this measure of importance that is used to 
compare pharmacopoeias amongst communities and rank all these as one overall population. 
The SIV is calculated using the following equation, 
where “F” is the total number of interviews, “f” is the frequency of citations and “S” is the 
number of symptoms in the survey (i.e. 15) for which each contributes a value “s” of 0 or 1 
and has a specific degree of association to T2D, “w”  ((0 < w < 1, ∑w = 1), table 2.1). Thus 
“∑ws” is the sum of all weighted symptoms for which the plant was mentioned, whereas ∑ws 
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= 1 if a plant was mentioned for all 15 symptoms, and “∑wf” is the sum of the symptom 
weight multiplied by the amount of times it was mentioned for that use (Leduc et al., 2006). 
2.3.4 Data Analysis 
Results were analyzed using both univariate and multivariate statistical analysis. 
Spearman rank correlations and matrix comparisons such as Mantel tests and data level 
comparison tests as per Leduc et al. (2006) and Downing (2010) to compare ethnobotanical 
results from one community to the next. Wemindji and Oujé-Bougoumou are thus compared 
against one another as well as against Whapmagoostui, Waskaganish, Nemaska and Mistissini. 
In order to determine the degree of association between plant species and specific symptoms 
within the survey list, correspondence analysis was performed (Leduc et al., 2006). 
Non-parametric Spearman rank correlations were used to evaluate the similarity 
amongst species ranking (i.e., importance) in each community. These analyses were 
performed on SIV results in order to keep with the methodology first employed by Leduc et al. 
(2006). This measure of importance also proved more informative than FC rankings as the 
latter ranked many plant species equally (see also the comparison of different methods in 
Araújo et al., 2008). Only species in common to both communities being compared were 
included in the analysis so that they would be ranked 1 to n, whereas n = the number of 
species in common. 
Matrices were produced with symptoms as objects and species as descriptors for each 
community and then compared using multivariate statistical tests. Mantel tests enabled us to 
compare distance matrices from two communities based on the null hypotheses that these were 
no more similar that two randomly generated matrices. For these, raw data were transformed 
into presence/absence of species mentions (1 or 0). Euclidean distances were calculated 
amongst symptoms prior to obtaining the Mantel statistic and significance was obtained by 
permutation tests (100,000 permutations). For data level comparison tests, raw data, 
corresponding to the number of mentions for each plant species at any given symptom, were 
employed. These tests use Manhattan differences via 10,000 permutations of rows, columns or 
both (developed by Podani, see Leduc et al., 2006). This enabled us to further explore how 
communities resembled one another without relying on prior modification of the data into 
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distance or similarity matrices. Matrices were constructed by including solely the plant species 
which appeared in both communities being compared. 
Correspondence analyses were performed on two-dimensional contingency tables 
constructed similarly to those employed in data level comparison tests. All species mentioned 
more than once in the survey were included and the data in each cell correspond to the number 
of mentions. Those which appeared once were considered outliers and removed from the table. 
Results were visualized by three-dimensional scatter diagrams representing both species and 
symptoms. Species are said to be closely associated to a symptom if both points lie in 
proximity of one another. This holds true if a) the species had the highest frequency of citation 
for the symptom and b) the symptom had the highest frequency of citation for the particular 
species (Leduc et al., 2006). 
In order to compare plant uses of the CEI with neighbouring First Nations from the 
same linguistic family, all the species compiled since the beginning of these surveys were 
traced back into the scientific literature (Arnason et al., 1981; Marles et al., 2008; Moerman, 
2009; Uprety et al., 2012). Plant uses from Wemindji, Oujé-Bougoumou and the compiled 
results of all 6 communities were compared against uses by the Algonquin, Atikamekw, Innu 
and Ojibway. A generalized matrix for the Algonquian linguistic family was also constructed 
by summing up the uses from all those First Nations. CEI plant uses were also compared to 
those of the Nunavik Inuit based on the literature (Cuerrier and Elders of Kangiqsualujjuaq, 
2011; Cuerrier and Elders of Kangiqsujuaq, 2011; Cuerrier et al., 2011). Because a reliable 
measure of consensus and frequency based on the literature could not be made, data were 
summarized as presence/absence of species mention and analyzed using Mantel tests. 
Spearman rank correlations, Mantel tests and correspondence analysis were all 
performed using R (R Development Core Team, 2012). Data level comparison tests were 
performed using the algorithm programmed by Podani (see Leduc et al., 2006). 
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2.4 Results 
2.4.1 Ranking 
In Wemindji, 22 interviews were completed with 28 Elders. Because two of the 
informants were not Cree, they where excluded from the ranking calculations thus providing n 
= 20 interviews. Sixteen plants were listed, one of which, Populus tremuloides (table 2.2 and 
2.3), is new to the project (species names and family are presented in appendix IV). While 
most of the plants cited by both non-Cree participants belong to the Wemindji Cree 
pharmacopoeia, Empetrum nigrum, Rhododendron tomentosum Harmaja, Chamerion 
angustifolium subsp. angustifolium, and Salix spp. were unique to them. Furthermore, Sorbus 
decora was cited by the Métis Elder, while Andromeda polifolia, Honckenia peploides and 
Fucus spp. were cited by the Inuit Elder. Kalmia angustifolia, Abies balsamea, Rhododendron 
groenlandicum, Picea mariana and Sphagnum fuscum were the top 5 species according to SIV 
ranking (Table 2.2). With the exception of K. angustifolia, which is replaced by Larix 
laricina, these species also hold the top 5 spots with the FC ranking (table 2.3, figure 2.1a).  
As for Oujé-Bougoumou, 18 interviews were completed with 24 Elders mentioning 25 
plants (table 2.4 and 2.5). Prunus pensylvanica, Cornus stolonifera, Rubus pubescens, Ribes 
lacustre, Salix humilis var. humilis and an unknown plant by the Cree name 
achikaashwaashkw are new to the project. Interestingly, their rankings are low. A fungus 
which could not be identified to species level, Boletus spp., was also new to the project and is 
the only mention of a fungal species in all 6 communities. The fruits of R. pubescens and R. 
lacustre were given by one of the youngest participants in response to the symptom of general 
weakness, whereas C. stolonifera was given by the second youngest participant who learned 
the practice from his mother, an Elder of the nearby community of Waswanipi. For both 
Boletus spp. and C. stolonifera, traditional Cree names could not be given. Populus 
tremuloides was also cited and bears the same Cree name as Populus balsamifera, as is the 
case in Wemindji. Plantago major was also cited by a few participants and is new to the 
project. Because it is an introduced plant in the region, it was omitted from the analysis. Larix 
laricina, R. groenlandicum, Sorbus spp., Alnus incana subsp. rugosa and A. balsamea were 
the top 5 species according to SIV ranking (table 2.4). With the exception of Sorbus spp., 
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which is replaced by Sarracenia purpurea, these species also hold the top 5 spots with the FC 
ranking (table 2.5, figure 2.1b). 
In both communities, informants claimed certain species could be used specifically for 
general diabetes. In Wemindji, these were R. groenlandicum, Vaccinium vitis-idaea, 
Vaccinium angustifolium and Gaultheria hispidula. Rhododendron groenlandicum was 
mentioned in Oujé-bougoumou as well as R. tomentosum. Elders from that community also 
stressed the general health benefits associated with the consumption V. angustifolium and G. 
hispidula berries.  
Other plant-based medicinal preparations made from store bought foods and materials 
were frequently mentioned in both communities. These involve various preparations made 
from flour, rice, oats, tea, bread, peanut butter or even pipe tobacco. Although they were 
frequently cited and are worth mentioning as part of the Cree pharmacopoeia, these were not 
included in our analyses as they are not native, nor do they grow readily in the boreal forest 
region. 
Species of the animal kingdom are also an important faction of the Cree 
pharmacopoeia. Preparations made with the grease of beaver, Castor canadensis, black bear, 
Ursus americanus, Canada goose, Branta canadensis, either alone or as adjuvants to plant 
medicinal preparations, were also mentioned. Beaver castoreum, wishna, regarded as a 
particularly strong medicine, is frequently employed and mentioned. Other animal species 
appearing in the surveys are mink, seal, otter, mice and fish such as walleye, pike and 
whitefish. 
When the data from all communities are combined together, there are a total of 32 
plant species, excluding mosses, cited for the 15 diabetes associated symptoms. Rhododendron 
groenlandicum, L. laricina, R. tomentosum, P. mariana and Picea glauca remained among the 
top 5 plants (table 2.6), as reported in Downing (2010), and differed from that study only in P. 
glauca and P. mariana switching ranks. 
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2.4.2 Community Comparison 
Results of Spearman rank correlations, Mantel tests and data level comparison tests are 
presented in table 2.7. Oujé-Bougoumou possessed significant similarities in plant SIV 
ranking to Whapmagoostui (r = 0.78, p = 0.017) and Mistissini (r = 0.60, p = 0.02). Although 
Wemindji and Oujé-Bougoumou possessed a relatively high Spearman's r, it was not 
statistically significant (r = 0.53, p =0.079). 
Mantel tests using presence-absence matrices of plant uses enable us to compare how 
similar they are between communities. Contrary to results from the Spearman's rank 
correlation, Wemindji and Oujé-Bougoumou were significantly similar regardless of a small 
correlation factor (r =0.21, p = 0.036), as were Wemindji and Nemaska (r = 0.19, p = 0.041). 
As with the Spearman's rank correlation, the similarity between Oujé-Bougoumou and 
Mistissini was stronger, as well as highly significant (r = 0.43, p = 0.0019). 
Results from data level comparison tests were considerably more liberal, with 
Wemindji and Nemaska being the only pair of communities not showing significant 
similarities based upon low Manhattan differences. These results conflict with those from the 
Mantel test between Wemindji and Nemaska. Although the Mantel test suggests that plant 
uses are similar between these two communities, raw counts are used in the data level 
comparison test. It may be that where uses are similar in the former test, the consensus factor, 
represented by high counts of specific species to specific symptoms, may not be strong enough 
to warrant similarities in the latter. The opposite appears to apply as well. Whereas general 
plant uses between two communities may differ based on Mantel results, the consensus factor, 
where similarities exist for specific uses, may be high enough to appear significant in data 
level comparison tests. 
With regards to all three tests, only Oujé-Bougoumou and Mistissini seemed to be truly 
similar to one another. 
2.4.3 Symptom-Species Associations 
Symptom-species associations for each community are summarized in table 2.8. In 
Wemindji (figure 2.2a) four plant species were strongly associated with symptoms in three 
 27 
distinct groupings. Both poplar species, P. balsamifera and P. tremuloides, were strongly 
associated with the treatment of abscesses and boils, the latter being mentioned more 
frequently than the former. Juniperus communis was strongly associated to the symptom of 
frequent urination and V. vitis-idaea was the only species that could be associated with two 
symptoms: blurry vision and increased thirst. 
In Oujé-Bougoumou, species-symptom associations did not appear as evident as those 
in Wemindji. Nonetheless, seven species closely linked to symptoms formed three distinct 
groupings (figure 2.2b). Vaccinium angustifolium was associated to general weakness 
whereas S. purpurea, L. laricina and A. balsamea were associated with infections. For back 
and kidney pains, three plants came out, namely, K. angustifolia, R. groenlandicum and P. 
pensylvanica, the latter being mentioned only once for that symptom. Although this grouping 
is visually discernible, the species that can be associated with back and kidney pains had 
higher frequency of mentions for other symptoms that were popularly treated by a variety of 
plant species as well. These were not highlighted by the correspondence analysis as both 
species and symptoms play a role in the algorithm. The association of a frequently cited plant 
to a symptom will inherently be weighted by other species which are just as frequently cited. 
When all six communities are analyzed together, J. communis, V. vitis-idaea, P. 
balsamifera and P. tremuloides remained strongly associated with frequent urination, blurry 
vision and abscesses and boils, just as they were when analyzing the community of Wemindji 
separately. Sarracenia purpurea was associated with symptoms of infections as in Oujé-
Bougoumou and A. incana subsp. rugosa was the only species that could be associated with 
two symptoms intricately related: abscesses, boils and infections (table 2.9, figure 2.3). 
 
2.5 Discussion 
During the interview process, Cree Elders often referred to morphologically similar 
plants interchangeably by giving them the same name and usage. Taxa in which this has been 
noted include Sorbus spp. (S. americana and S. decora), blueberries, herein referred to as V. 
angustifolium, but encompassing also V. myrtilloides and V. boreale, and clubmosses, herein 
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referred to as Lycopodium clavatum, but also encompassing L. annotinum Leduc et al. (2006) 
reported the same for Alnus spp. (A. incana subsp. rugosa and A. viridis subsp. crispa) among 
the Mistissini Cree, although it has since been rectified to include only A. incana subsp. 
rugosa (Cuerrier, verbatim). Indeed, Elders from Wemindji and Oujé-Bougoumou clearly 
specified as utuuspii the species whose branches and inner bark turns red upon bruising and 
cutting, which is consistent with A. incana subsp. rugosa. Although no distinction was made 
in the identity and uses of the aforementioned species, Populus tremuloides and P. 
balsamifera were distinguished as separate plants even though they have identical names 
(mitus) and similar uses (table 2.2 and 2.4). In fact, a few Elders from Mistissini distinguish 
P. balsamifera by the name mash-mitus as opposed to mitus (Cuerrier, verbatim). 
Surprisingly, this name did not receive any mention in Oujé-Bougoumou, a neighbouring 
community sharing the same dialect. Given their lack of popularity within the community's 
pharmacopoeia, it may be that the name has simply not been retained in the community or that 
it is simply vernacularly distinct to Mistissini. 
The frequency of citation, as a basic measure of informant consensus, reveals the 
relative importance of species (Ladio and Lozada, 2004). High FC values reflect top SIV 
ranking order between species and these consensuses support the idea that these species are 
culturally important to the CEI. However, similar ranking orders between these two methods 
(figure 2.1) is expected as consensus is also implied in the SIV calculation. Yet differences in 
the order of certain species point to differences that exist between the FC and SIV 
calculations. First, it assumes, like the SIV method, that the more biologically effective a plant 
is, the more agreement there will be concerning its use, but it also assumes that specialized 
knowledge is not present (Araújo et al., 2008). In spite of a relatively low FC ranking in 
Wemindji, K. angustifolia was the top ranking species when using the SIV method. It is used 
in the community much like R. groenlandicum but is believed to be stronger. Nonetheless, the 
fact that the plant is toxic (Hill, 1986) is known to the community members who constantly 
advise that its use be undertaken with great caution. Risk versus benefit assessment may lead 
to informants preferring the use of a safer plant and perhaps being more selective in sharing 
this knowledge. Furthermore, the FC method is less informative than the SIV and does not 
distinguish as many ranks amongst species. When comparing different quantitative methods of 
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ranking medicinal plants, it was shown that the SIV approach allowed the identification of 
plant species with high levels of biologically active compounds (Araújo et al., 2008). 
Combining symptoms, and their relevance, to the consensus factor not only narrows the search 
through specialized knowledge, but provides a seemingly more informative index to 
identifying biologically active plants and compounds. 
Although these are the first mentions of P. tremuloides, Betula papyrifera, R. lacustre, 
P. pensylvanica, Typha latifolia and Boletus spp. in interviews conducted within the scope of 
the CIHR-TAAM project, B. papyrifera and T. latifolia had been mentioned in Mistissini at a 
meeting held during the cultural gathering (2008) and at another meeting in Chibougamau in 
2009. Furthermore, B. papyrifera has already been reported in the CEI pharmacopoeia for 
treating symptoms employed in this study. It is reported in both the communities of Chisasibi 
(Marshall, 2006) and Waskaganish (Marshall et al., 2003) for treating abscesses, boils, 
wounds and skin infections such as impetigo and scabies. This highlights the unique 
contributions in knowledge that each community can bring as well as the importance of 
including as many communities as possible in completing the Cree pharmacopoeia. 
Interestingly, B. papyrifera did not arise in Downing's (2010) ethnobotany of Waskaganish, 
nor did cattails (T. latifolia), which are also reported in Waskaganish for skin infections 
(Marshall et al., 2003). Moreover, Jacques Rousseau noted the use of P. pensylvanica and P. 
tremuloides for medicinal purposes by the Mistissini Cree (Cosset and Mansion, 2009). 
Although these are not being specified for uses related to T2D, it does provide evidence 
nonetheless of their presence in the CEI pharmacopoeia. 
Differences in the usage of plant species are the result of many factors. The distribution 
of plant species, for one, explains why some species are employed in certain communities, and 
not in others. Thuja occidentalis reaches its northern limits around Waskaganish and Oujé-
Bougoumou (Chambers, 1993), while S. purpurea is absent from the area of Whapmagoostui 
(Forest and Legault, 1977). Where distribution is not a factor, unique local histories and 
inherent subcultures may play an important role. It may also simply be that plant species are 
not used in the same way (Johns et al., 1990) by different groups. Nonetheless, these 
differences do not undermine the cultural relevance and value of these plants towards the CEI 
as it is evidenced by intercommunity comparisons. 
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When compiling the data from all the communities, the highest ranked species are 
commonly used in most communities and often ranking high in each of them. Among the top 
10, only two species were absent from more than two communities. Rhododendron 
tomentosum, a close relative of the popular R. groenlandicum, was mentioned solely in 
Whapmagoostui, yet ranked 3rd overall and J. communis ranked 10th (table 2.6). Even if 
mentioned for many symptoms, some of these highly ranked species seemed strongly 
associated to specific ones (table 2.8 and 2.9). Alnus incana subsp. rugosa is acknowledged 
by at least half the participating communities to be effective against skin infections, abscesses 
and boils, while Juniperus communis was strongly associated with the symptom of frequent 
urination in the community of Wemindji. Similarities in uses between this community and 
Whapmagoostui means that this remained true when combining the knowledge from all 
participating communities. Although contrary to the idea that Juniper cones act as a diuretic 
(Stanić et al., 1998; DiPasquale, 2008), CEI traditional uses suggest a general application of 
this species to ailments associated with voiding of urine. 
Alternatively, species with low SIV values need not be regarded as being less 
important, particularly if they are strongly associated with certain symptoms. Such is the case 
of V. vitis-idaea for blurry vision. This symptom was generally associated with the culturally 
relevant problem of snow blindness or photokeratitis, overexposure by UV irradiation to the 
cornea and conjunctiva (Cullen, 2002) causing damage, even destruction, of epithelial cells 
and significant stromal swelling (Bergmanson, 1990; Cullen, 2002). Vaccinium vitis-idaea, 
however, is known to possess anti-inflammatory activity (Tunón et al., 1995; Markov et al., 
2011), which may play a role in attenuating the damaging effect of extensive ultra-violet 
exposure to the eyes. Also, blurry vision, like general weakness, may also be caused by the 
hypoglycemic state found in diabetics, as a side effect to therapy, such as insulin or 
sulphonylurea, seeking to restablish normoglycemia (Hepburn et al., 1993; Henderson et al., 
2003). Consequently, spikes in blood sugar, caused by the absorption of those naturally found 
in the fruit, might give temporary relief of this symptom. In brief, even if certain species may 
eventually show low antidiabetic potential, strong bioactivity to certain symptoms and 
complications can nonetheless increase the quality of life of diabetics if taken appropriately. 
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Similarly, species mentioned in selected communities should not be regarded as less 
important. The absence of R. tomentosum from other communities is due to its natural 
distribution, but knowledge of its medicinal uses exists outside of Whapmagoostui. One 
community member from Oujé-Bougoumou kept in the freezer a container filled with the 
aerial parts of R. tomentosum which had been obtained from Whapmagoostui and used it for 
medicinal purposes. On the other hand, community members from Wemindji had a name for 
the species with claims that it grew on the islands within James Bay. Indeed, a study of the 
flora of Wemindji and its surroundings (Blondeau, 2009) does not report R. tomentosum. Nor 
does it report K. angustifolia, which is commonly used in Wemindji (table 2.2 and 2.3). 
Although we could not confirm this species in the immediate surroundings of the community, 
we managed to find it in the greater region (MTR-2011-086; MT and OTT herbarium), an area 
which was not included in Blondeau's (2009) study. Naturally, community members may 
travel long distances to have access to hunting territories not only inland, but also into James 
Bay. Many of the islands are characterised by the similar arctic and boreal ecological elements 
(Bussières et al., 2008). The Manitounuk Islands, in Hudson Bay, is where R. tomentosum is 
found (Deshaye and Cayouete, 1988). In venturing out on islands further off the coast, it may 
in fact be possible to find populations of this species in the Wemindji region. If that is the 
case, evaluating these populations' susceptibility to potential harvesting, as it has been done 
for R. groenlandicum (Tendland et al., 2012), will be indispensable. 
The above situation provides evidence of the transfer of knowledge that exists within 
the CEI nation. But not only are knowledgeable Elders from certain communities known by 
others, there is also a certain openness to knowledge coming from outside. In Wemindji, 
where an Inuit and Métis Elder became fixtures, they were known for their mastery of 
medicinal plants and consulted by Cree community members. Although many of the plants 
cited by these two are common to the CEI pharmacopoeia, many others such as C. 
angustifolium and Honckenya peploides seem to reflect knowledge unique to these Elders' 
cultural background (Cuerrier and Hermanutz, 2012). 
In Oujé-Bougoumou, there were frequent mentions of the current cultural influences 
from the Ojibway as well as from the neighbouring Innu of Mashteuiatsh, consequently 
highlighting the differences in the naming and usage of plants. Interactions between the Innu 
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from Lac Saint-Jean and the Oujé-Bougoumou Crees are well documented. Whereas many 
families have hunting territories in proximity to rivers leading into the lake, many had 
historically adopted the habit of reprovisioning at the Mashteuiatsh trading post instead of 
Mistissini, thus creating close relationships between certain families (Frenette, 1985). This 
interaction with members of neighbouring First Nations may explain the presence of a 
considerable number of outliers: species with infrequent mentions, low SIV values and/or 
specific to certain communities. This is particularly supported by strong similarities, from 
Mantel test results, in plant uses between Oujé-Bougoumou and the Innu-Naskapi (r = 0.42, p 
= 0.013) and the Ojibway (r = 0.49, p = 0.0067, table 2.10). 
Medicinal plant uses by the community of Wemindji were also statistically similar to 
uses by the Innu-Naskapi (r = 0.36, p = 0.0048). Based upon the literature, of the 33 plant 
species mentioned in the Cree pharmacopoeia, all but A. polifolia, E. nigrum, Leymus mollis, 
R. pubescens and Vaccinium uliginosum possessed medicinal uses by First Nations of the 
Algonquian linguistic family for key T2D associated symptoms identified in this study. As an 
Algonquian nation, it is not surprising that CEI uses were statistically similar to those of 
culturally and linguistically related nations (table 2.10). 
Cultural influence is a basic assumption, which can certainly be made about certain 
plant uses in Whapmagoostui, the northernmost CEI community, which is often mistaken for 
Kuujjuarapik, the adjacent Inuit community. Although no significant similarity was 
statistically detected between Cree and Inuit uses (table 2.10), P. mariana, P. glauca, L. 
laricina, J. communis, E. nigrum, V. uliginosum, V. vitis-idaea, Salix planifolia, R. 
tomentosum and R. groenlandicum were common to both pharmacopoeia. Furthermore, plant 
species unique to Whapmagoostui and mentioned by Wemindji's Inuit Elder are all present in 
the ethnobotany of Kuujjuarapik and other Inuit communities (Cuerrier and Elders of 
Kangiqsualujjuaq, 2011; Cuerrier and Elders of Kangiqsujuaq, 2011; Cuerrier et al., 2011). 
While some knowledge is specific to certain families and contribute to local 
specificities in plant uses, the loss of knowledge resulting from traumatic experiences felt by 
some communities may also be a contributing factor to these differences. These include 
residential schools, relocations and other collateral implications from the major hydro projects 
of the 1970's (Berkes, 1981; Kirmayer et al., 2000). Whereas uses and traditional knowledge 
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of certain plant species may have been borrowed, some communities may also act as a refuge 
for knowledge from a once larger and extentsive CEI pharmacopoeia. 
Plant uses by the aboriginal people of Canada's boreal forest for diabetes are not very 
common. Aside from a few documented cases, this appears to be a reflection of the modern 
day rise in T2D affecting the CEI and other aboriginal people. Of the species appearing in our 
study, P. balsamifera, P. tremuloides and Ribes americanum, a close relative of R. lacustre 
cited here, are mentioned specifically for diabetes (Marles et al., 2008; Uprety et al., 2012). 
Using quantitative methods and breaking down an illness into basic symptoms is an effective 
approach in bridging the gap between traditional knowledge and modern ailments, as our 
study has shown.  However, it cannot be used solely by itself. Even in plants where SIV values 
are low, it is argued that the lack of direct information does not imply biological inactivity 
(Moerman, 2007). Although this measure is appropriate for assessing the cultural relevance of 
a medicinal plant, one must also consider the complex nature of relationships existing with 
plant species. Berries, such as those of V. angustifolium, V. vitis-idaea, V. uliginosum and E. 
nigrum, are primarily considered as food by the CEI and are consequently ranked poorly. Yet 
the scientific literature abunds with studies supporting the health benefits and antidiabetic 
potential of many of these berries (table 2.11) due in part to an abundance of phenolic 
compounds (Martineau et al., 2006; McIntyre et al., 2008; Grace et al., 2009; Graf et al., 2010; 
Hohtola, 2010; Sancho and Pastore, 2012). 
Many of these berries are abundant and were once an important part of the Cree diet 
(Anonymous, 1971; Berkes and Farkas, 1978). Blueberries are still culturally important and 
celebrated in certain communities, such as Oujé-Bougoumou, with yearly festivals. 
Nonetheless, the CEI would greatly benefit from a significant reintroduction of these berries 
into their diet. Just as the Cree Trapper's Association manages programs established to support 
the Cree Hunters in their activities, similar programs should be created for the gathering of 
wild berries, which, in the case of abundant species, could potentially open the door to an 
economically viable commerce (Määttä-Riihinen et al., 2005). One needs only consider the 
case of V. vitis-idaea, strongly associated with blurry vision (table 2.8 and 2.9), which is 
harvested commercially in Scandinavian countries (Ihalainen et al., 2003), as well as in 
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Newfoundland and Labrador, and can be harvested from unmanaged natural stands (Penney et 
al., 1997). 
While studies show there is a consumer interest in boreal forest products of aboriginal 
origin (Boxall et al., 2003; Murray et al., 2005), there already exists a line of successful 
products marketed by aboriginal and non-aboriginal groups alike (BMC - Boreal Medicinal 
Canada, 2011; Avataq Cultural Institute, 2012; Lise Watier Cosmétiques, 2012; Produits es 
Bois Inc., 2012). This raises questions about the concept of commercialization of non-timber 
forest products, which is not always well accepted amongst aboriginal people. Without 
exception, CEI Elders consider themselves custodians of the land where knowledge provided 
by the creator is to be used for human health and wellbeing (Cuerrier et al., 2012), hence, a 
responsibility of stewardship (Sioui, 2012). However, this may locally render accessible 
medicinal products to those whose lifestyle or physical and health limitations may not allow 
the personal collection of these materials and in periods and times when they cannot be 
collected. Elders should thus be concerned with and consulted on potential strategies towards 
making CEI medicine more accessible. 
Many of the plants mentioned in the ethnobotany of Wemindji and Oujé-Bougoumou, 
particularly amongst the high ranking ones, have undergone more in depth studies since the 
creation of the project in 2003 (Haddad et al., 2012). The screening process has revealed that 
many of these plants are active in vitro in various antidiabetic bioassays (Spoor et al., 2006; 
Fraser et al., 2007; Harbilas et al., 2009). The highest ranking plant of the CEI, R. 
groenlandicum, has been shown in multiple in vitro assays to possess antioxidant activity 
(Dufour et al., 2007; Fraser et al., 2007) a strong adipogenic activity and slight activity in 
glucose uptake (Spoor et al., 2006), all of which play an important role in the pathology of 
T2D. In a diet-induced obese mouse model, it has also been shown to possess hypoglycemic 
and anti-obesity properties in vivo (Ouchfoun, 2011). In the same model, L. laricina 
effectively decrease glycemia levels, improve insulin resistance, and decrease abdominal fat 
pad and body weight (Harbilas et al., 2012a), while P. balsamifera was also shown to reduce 
glycemia, weight gain, retroperitoneal fat pad and liver as well as improve insulin sensitivity 
(Harbilas et al., 2012b). 
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In keeping with providing recommendations for the application of these traditional 
medicines for the treatment of T2D, multiple studies have been realized on the impact of 
harvest as well as the seasonal and geographical variations in biologically active compounds. 
It was shown that harvesting of R. groenlandicum was sustainable if leaves from the previous 
growing season were collected (Tendland et al., 2012) and that concentrations in active 
compounds varied geographically in response to environmental variables (Rapinski et al., in 
preparation(a)). Concentrations in the active compounds of R. tomentosum and V. 
angustifolium leaves and stem varied throughout the growing season to reach optimum 
concentration at the end of summer or beginning of fall, in turn affecting these plants’ 
bioactivity (McIntyre et al., 2008; Black et al., 2011). These studies show the need for 
knowledge of harvesting time and place in the production of reliable standardized and 
sustainable products. Surely, strong consideration should be taken of the impact of harvesting 
these plants, especially when heavy impact harvesting methods, such as removing the bark, are 
used. 
Evidently, treatment of T2D with drugs does not cure the disease, but does indeed 
increase the quality of life of those affected. That is true even among a demographic group 
which is compliant and is used to the current health care approach. Thus, careful attention to 
the diet of diabetics is necessary and in agreement with the opinions of Elders and other 
community members. While this study focuses on exploring medicinal plants and their 
antidiabetic potential, Elders are quick to stress that food and medicine go hand in hand, and 
when one talks about food, one talks about plants and animals alike. During the interview 
process, animals were often cited for the treatment of many symptoms (data not shown). More 
importantly, however, is the report by community members affected by T2D, and disciplined 
in checking their blood glucose levels, that extended periods of feeding oneself with 
traditional meats effectively has a hypoglycemic effect. While this important observation has 
yet to be verified in a controlled study, they certainly cannot be ignored. 
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2.6 Conclusion 
We clearly show in this study that many of the plants in the CEI pharmacopoeia are 
generally and culturally important to Wemindji, Oujé-Bougoumou and its neighboring 
communities. Many of these top ranking species identified within the CTM have shown 
pharmacological activity and potential benefit to treat TD2. While our results demonstrate the 
potential benefit of using multidisciplinary approaches in medicinal plant research, they also 
support the ongoing research on these plants, especially pertaining to high ranking species. 
Furthermore, special attention should be given to Vaccinium spp., which, although scoring low 
in the SIV ranks, are readily available in the CEI territory and are known for their health 
benefits. Continuing work on selected species identified here may help provide better 
recommendations for the development of sustainable and alternative therapies, but much 
thought and discussion must be devoted to ensuring that these are culturally and ethically 
appropriate. 
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2.8 Tables and Results 
Table 2.1 List of 15 symptoms and complications 
used in semi-structured questionnaires. The weight 
(w) represents their degree of association to type 2 
diabetes and is used in the SIV calculation. 
Symptom w 
  
1. Abcesses/boils 0.0838 
2. Increased appetite 0.0681 
3. Back/kidney pain 0.0419 
4. Diarrhea 0.0419 
5. Foot numbness/sores 0.0942 
6. Headache 0.0366 
7. Heart/chest pain 0.0733 
8. Skin infections; slow healing 0.0942 
9. Inflammation/swelling 0.0471 
10. Rheumatism/arthritis 0.0366 
11. Sore/swollen limbs 0.0681 
12. Increased thirst 0.0785 
13. Increased urination 0.0890 
14. Blurred vision 0.0838 
15. General weakness 0.0628 
∑w 1 
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Table 2.2 Species mentioned by informants in Wemindji in decreasing order of SIV ranking. Latin and Cree names are provided 
as well as the number of symptoms (S) each species was mentioned for, the number of informants (I) who have mentioned that 
species and the plant organs (O) that were utilized.  
SIV Rank Latin Cri S I O 
0,0265 1 Kalmia angustifolia ᐅᔅᒋᔅᒋᐱᒄᐦ  uschischipikw-h 11 9 L 
0,0232 2 Abies balsamea. ᐃᔮᔑᐦᑦ  iyaashiht 8 201 Ca, L, S 
0,0212 3 Rhododendron groenlandicum  ᑳᒋᒑᐱᒄ  kaachichaapikw 121,1,2 131,2 L 
0,0169 4 Picea mariana  ᐄᔮᐦᑎᒄ  iiyaahtikw 71 161 Ca, W, S, L, C 
0,0168 5 Sphagnum fuscum ᐊᐙᔑᔥᒌᔥ  awaashishchiish 7 15 A 
0,0157 6 Larix laricina  ᐙᒋᓈᑭᓐ  waachinaakin 91,1,2 191,2 Ca, S, B, L, Br 
0,0128 7 Betula papyrifera  ᐧᐃᔥᑯᐃ  wishkui 6 1 S 
0,0120 8 Picea glauca  ᒥᓂᐦᐄᒄ  minihiikw 61 81 S, L, Ca, C 
0,0114 9 Populus tremuloides ᒦᑐᔅ  miitus 61,1 111 Ca, B, CaA, L 
0,0099 10 Vaccinium vitis-idaea ᐐᓯᒋᒥᓐ  wiisichimin 42 111,2 F 
0,0065 11 Populus balsamifera  ᒦᑐᔅ  miitus 2 4 Ca, CaA 
0,0055 12 Juniperus communis. ᑳᐦᑳᒌᒥᓈᐦᑎᒄ  kaahkaachiiminaahtikw 31 81 C 
0,0044 13 Alnus incana subsp. rugosa  ᐅᑐᔅᐲ  utuspii 1 8 B, Ca, Br 
0,0029 14 Typha latifolia  ᐅᒋᔥᒀᔫᔥᑯᔑᐤᐦ uchishkwaayuushkushiuh 1 1 R 
0,0027 15 Vaccinium angustifolium  ᐄᔨᒥᓐ  iiyimin 22 22 F 
0,0027 15 Vaccinium uliginosum ᓂᒋᑯᒥᓐ  nichikumin 22 22 F 
L = leaf/needles, Br = branch, S = sap/gum, W = wood, B = bark, C = cone, Ca = cambium, A = aerial part, CaA= cambium ash, F = fruit, R 
= root 
1 = (S) Symptom mentioned by the Métis informant and not the Cree; (I) Métis informant included 
   2 = (S) Symptom mentioned by the Inuit informant and not the Cree; (I) Inuit informant included 
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Table 2.3 Species mentioned by informants in Wemindji in 
decreasing order of rank based on the FC method. 
Consensus is represented by the frequency of citations 
calculated over the total number of interviews. 
Species % Frequency Rank 
Abies balsamea 95 1 
Larix laricina 85 2 
Picea mariana 75 3 
Sphagnum fuscum 75 3 
Rhododendron groenlandicum 55 4 
Populus tremuloides 50 5 
Vaccinium vitis-idaea 45 6 
Kalmia angustifolia 45 6 
Alnus incana subsp. rugosa 40 7 
Juniperus communis 35 8 
Picea glauca 35 8 
Populus balsamifera 20 9 
Vaccinium angustifolium 5 10 
Vaccinium uliginosum 5 10 
Betula papyrifera 5 10 
Typha latifolia 5 10 
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Table 2.4 Species mentioned by informants in Ouje-Bougoumou in decreasing order of SIV ranking. Common, Latin and 
Cree names are provided as well as the number of symptoms (S) each species was mentioned for, the number of 
informants (I) who have mentioned that species and the plant organs (O) that were utilized.  
SIV Rank Latin Cree S I O 
0.0214 1 Larix laricina ᐧᐋᒋᓈᑲᓐ  waachinaakan 8 13 Ca, Br, C, L 
0.0210 2 Rhododendron groenlandicum   ᑳᒋᒉᐸᒄ  kaachichepakw 9 11 L, Br 
0.0187 3 Sorbus spp. ᒪᔅᑯᒥᓈᓈᐦᑎᒄ  maskuminaanaahtikw 9 5 B, Ca, F, Br 
0.0171 4 Alnus incana subsp. rugosa ᐅᑑᔅᐲ  utuuspii 7 7 B, Ca, L 
0.0144 5 Abies balsamea  ᐄᓈᔥᑦ  iinaasht 5 14 Ca, S, C, L 
0.0131 6 Kalmia angustifolia ᐅᔅᒋᔅᒋᐸᒄ  uschischipakw 6 3 L 
0.0103 7 Prunus pensylvanica  ᑰᐦᐄᒥᓈᓐᐦ  kuuhiiminaanh 4 2 Ca, B 
0.0098 8 Betula papyrifera ᐅᔥᑯᐃ  ushkui 4 3 Ca, S 
0.0095 9 Sarracenia purpurea ᐊᔨᑲᑖᔥ  ayikataash 3 11 L, R 
0.0079 10 Gaultheria hispidula  ᐱᔦᐅᒥᓈᓐᐦ  piyeuminaanh 3 2 F, L 
0.0079 11 Picea glauca ᒥᓇᐦᐄᒄ  minahiikw 3 5 L, S, C, R 
0.0078 12 Picea mariana ᐄᓈᐦᑎᒄ  iinaahtikw 3 5 W, C 
0.0060 13 Pinus banksiana ᐅᔅᒋᔅᒃ  uschisk 2 3 C, L 
0.0049 14 Thuja occidentalis ᒫᔅᒌᔅᒃ  maaschiisk 2 2 C 
0.0048 15 Salix humilis var. humilis ᓃᐲᔑᐋᐦᑎᒃ  niipiishiaahtik 1 1 B 
0.0048 16 Vaccinium vitis-idaea ᐧᐄᓴᒋᒥᓈᓐᐦ  wiisachiminaanh 2 2 F, L 
0.0048 16 ? ᐊᒋᑳᔣᔥᒄ achikaashwaashkw 2 2 L 
0.0041 16 Cornus stolonifera ? 2 1 Ca 
0.0036 17 Vaccinium angustifolium  ᐄᓂᒥᓈᓐᐦ  iiniminaanh 2 3 F, L 
0.0033 18 Lycopodium clavatum ᐹᔅᒋᓈᐦᐧᑳᓐ  paaschinaahkwaan 1 1 L 
0.0033 18 Boletus spp. ? 1 1 A 
0.0030 19 Populus tremuloides ᒦᑐᔅ  miitus 1 1 Ca 
0.0026 20 Populus balsamifera ᒦᑐᔅ  miitus 1 1 L 
0.0022 21 Rubus pubescens ᐊᔫᔅᑲᓐ  ayuuskan 1 1 F 
0.0022 21 Ribes lacustre ᔖᐳᒥᓇᒡ  shaapuminach 1 1 F 
0.0013 22 Andromeda polifolia ᐧᐄᓴᒋᐸᒄ  wiisachipakw 1 1 L 
L = leaf/needle, Br = branch, S = sap/gum, W = wood, B = bark, C = cone, Ca = cambium, A = aerial part, F = fruit, R = root 
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Table 2.5 Species mentioned by informants in Oujé-
Bougoumou in decreasing order of rank based on the FC 
method. Consensus is represented by the frequency of 
citations calculated over the total number of interviews.  
Species % Frequency Rank 
Abies balsamea 77.78 1 
Larix laricina 72.22 2 
Rhododendron groenlandicum 61.11 3 
Sarracenia purpurea 61.11 3 
Alnus incana subsp. rugosa 38.89 4 
Picea glauca 27.78 5 
Picea mariana 27.78 5 
Sorbus spp. 27.78 5 
Betula papyrifera 16.67 6 
Kalmia angustifolia 16.67 6 
Pinus banksiana 16.67 6 
Vaccinium angustifolium 16.67 6 
Gaultheria hispidula 11.11 7 
Prunus pensylvanica 11.11 7 
Thuja occidentalis 11.11 7 
Vaccinium vitis-idaea 11.11 7 
Achikaashwaashkw 11.11 7 
Andromeda polifolia 5.56 8 
Cornus stolonifera 5.56 8 
Lycopodium clavatum 5.56 8 
Populus tremuloides 5.56 8 
Populus balsamifera 5.56 8 
Salix humilis var. humilis 5.56 8 
Rubus pubescens 5.56 8 
Ribes lacustre 5.56 8 
Boletus spp.  5.56 8 
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Table 2.6 List of 32 plant species and one fungal species mentioned by informants from six 
Eeyou Istchee Cree communities in decreasing order of their global SIV ranks. The ranking 
of species in each community is compared. Zero indicates that a species was not mentioned 
in that community. Communities are numbered (1) Whapmagoostu, (2) Waskaganish, (3) 
Mistissini, (4) Nemaska, (5) Wemidnji and (6) Oujé-Bougoumou. 
Rank SIV Species Community rank 1 2 3 4 5 6 
1 0.0377 Rhododendron groenlandicum 1 5 1 6 3 2 
2 0.0370 Larix laricina 2 3 2 3 6 1 
3 0.0359 Rhododendron tomentosum 3 0 0 0 0 0 
4 0.0352 Picea mariana 5 4 4 1 4 12 
5 0.0347 Picea glauca 4 1 14 10 8 11 
6 0.0321 Kalmia angustifolia 6 0 12 9 1 6 
7 0.0312 Sorbus spp. 8 12 5 8 0 3 
8 0.0245 Abies balsamea 0 2 3 4 2 5 
9 0.0240 Alnus incana subsp. rugosa 0 9 6 2 13 4 
10 0.0203 Juniperus communis 7 0 0 0 12 0 
11 0.0180 Pinus banksiana 13 6 9 7 0 13 
12 0.0178 Salix spp. 10 0 7 0 0 15 
13 0.0167 Betula papyrifera 0 0 0 0 7 8 
14 0.0165 Vaccinium vitis - idaea 11 0 13 0 10 16 
15 0.0132 Sarracenia purpurea 0 11 8 0 0 9 
16 0.0117 Populus balsamifera 0 10 0 5 11 20 
17 0.0100 Gaultheria hispidula 0 0 15 0 0 10 
18 0.0099 Populus tremuloides 0 0 0 0 9 19 
19 0.0099 Prunus pensylvanica 0 0 0 0 0 7 
20 0.0087 Lycopodium clavatum 0 0 10 0 0 18 
21 0.0083 Vaccinium angustifolium 0 0 11 0 15 17 
22 0.0073 Thuja occidentalis 0 7 0 0 0 14 
23 0.0072 Leymus mollis 12 0 0 0 0 0 
24 0.0046 Heracleum maximum 0 8 0 0 0 0 
25 0.0046 Achikaashwaashkw 0 0 0 0 0 16 
26 0.0039 Cornus stolonifera 0 0 0 0 0 16 
27 0.0032 Boletus spp.  0 0 0 0 0 18 
28 0.0030 Empetrum nigrum 14 0 0 0 0 0 
29 0.0028 Typha latifolia 0 0 0 0 14 0 
30 0.0026 Vaccinium uliginosum 0 0 0 0 15 0 
31 0.0021 Rubus pubescens 0 0 0 0 0 21 
31 0.0021 Ribes lacustre 0 0 0 0 0 21 
32 0.0012 Andromeda polifolia 0 0 0 0 0 22 
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Table 2.7 Community pharmacopoeia comparisons as evaluated by three statistical methods, Spearman rank correlation test, Mantel 
analysis and data level comparisons. Spearman rank correlation test was a measurement of how similarly plants were ranked 
between communities (p < 0.5 considered similar). The Mantel analysis evaluated whether the same plants were used for the same 
symptoms (p < 0.05 were considered similar) while data level comparison tests compared the number of times each plants was 
mentioned (p< 0.05, were considered similar). Significant results are shown shaded. 
 Comparison Spearman Mantel Data level comparisons 
r p r p Row Column Both 
Wemindji/Whapmagoostui 0.5000 0.2667 0.1068 0.1252 0.0001 0.0051 0.0000 
Wemindji/Waskaganish 0.4643 0.3024 0.0455 0.2956 0.0439 0.0413 0.0092 
Wemindji/Nemaska -0.2619 0.5364 0.1857 0.0408 0.1057 0.3520 0.1288 
Wemindji/Mistissini 0.3500 0.3586 0.1694 0.0547 0.0254 0.0098 0.0013 
Wemindji/Oujé-Bougoumou 0.5315 0.0793 0.2061 0.0357 0.0000 0.0000 0.0000 
Oujé-Bougoumou/Whapmagoostui 0.7833 0.0172 -0.0402 0.5831 0.0260 0.0122 0.0002 
Oujé-Bougoumou/Waskaganish 0.1273 0.7138 0.1091 0.2318 0.0042 0.0512 0.0026 
Oujé-Bougoumou/Nemaska 0.1152 0.7588 0.1377 0.1800 0.0309 0.0874 0.0263 
Oujé-Bougoumou/Mistissini 0.6000 0.0204 0.4342 0.0019 0.0001 0.0000 0.0000 
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Table 2.8 Species-symptom associations obtained by comparing 
three-dimensional perceptual maps resulting from 
correspondence analysis of the species-use contingency table for 
Wemindji (fig 2.2a) and Oujé-Bougoumou (fig 2.2b). 
Group Symptom Species # mentions 
 
1 Abscesses/Boils P. balsamifera 3 
P. tremuloides 9 
2 Frequent urination J. communis 7 
3 Blurry vision V. vitis-idaea 8 
4 Increased thirst V. vitis-idaea 1 
Oujé-Bougoumou 
1 General weakness V. angustifolium 2 
2 Back/kidney pains 
R. groenlandicum 4 
P. pensylvanica 1 
K. angustifolia 3 
3 Infections 
S. purpurea 8 
L. laricina 10 
A. balsamea 14 
Table 2.9 Species-symptom associations obtained by comparing three-dimensional 
perceptual maps (fig 2.3) resulting from correspondence analysis of the species-use 
contingency table for six Eeyou Istchee Cree communities. 
Group Symptom Species Communities (# mentions) 
1 Increased urination J. communis Whap(34), Wem(7) 
2 Blurred vision V. vitis-idaea Whap(15), Wem(8) 
3 Infections 
S. purpurea Mist(6), OJ(8) 
A. incana subsp. rugosa Mist(5), Nem(1), Wem(8), OJ (6) 
4 Abscesses/boils 
A. incana subsp. rugosa Wask(13), Nem(13), OJ(1) 
P. balsamifera Wask(7), Nem(3), Wem(3) 
P. tremuloides Wem(9), OJ(1) 
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Table 2.10 Community pharmacopoeia comparisons against litterature 
based surveys for surrounding First Nations of the Algonquian 
linguistic familly and Inuit. Results from Mantel analysis evaluated 
whether the same plants were used for the same symptoms (p < 0.05 
were considered similar and are shaded). 
Comparison r p 
CEI/Algonquin 0.185 0.148 
CEI/Attikkamek 0.006 0.461 
CEI/Innu 0.193 0.098 
CEI/Ojibway 0.224 0.082 
CEI/Algonquian 0.299 0.002 
CEI/Inuit (Nunavik) -0.132 0.899 
    
Oujé-Bougoumou/Algonquin 0.268 0.097 
Oujé-Bougoumou/Attikkamek -0.008 0.483 
Oujé-Bougoumou/Innu 0.420 0.013 
Oujé-Bougoumou/Ojibway 0.439 0.007 
Oujé-Bougoumou/Algonquian 0.214 0.032 
Oujé-Bougoumou/Inuit (Nunavik) 0.195 0.086 
    
Wemindji/Algonquin 0.150 0.107 
Wemindji/Attikkamek 0.173 0.108 
Wemindji/Innu 0.358 0.005 
Wemindji/Ojibway 0.064 0.267 
Wemindji/Algonquian 0.329 0.006 
Wemindji/Inuit (Nunavik) 0.059 0.272 
 46 
Table 2.11 Literature review of the known pharmacological activity of berries used by the Cree of Eeyou Istchee pertaining to the pathology 
of type 2 diabetes 
Species Pharmacological activity Reference 
Empetrum nigrum Antioxidant activity Fraser et al., 2007; Ogawa et al., 2008 
   
Gaultheria hispidula Antioxidant activity Fraser et al., 2007; Harbilas et al., 2009 
 Hypoglycemic activity Harbilas et al., 2009; Nistor Baldea et al., 2010 
 Anti-glycation activity Harris et al., 2011 
 Cytoprotection against glucose toxicity 
and deprivation 
Harbilas et al., 2009 
   
Vaccinium angustifolium Antioxidant activity Boivin et al., 2007; Mizuno and Rimando, 2009; Papandreou et al., 
2009; Del Bo’ et al., 2010; Joseph et al., 2010 
 Anti-glycation activity McIntyre et al., 2008 
 Hypoglycemic activity Martineau et al., 2006; Grace et al., 2009; Graf et al., 2010; 
Hohtola, 2010  
 Adipogenic, insulinotropic and 
proliferative (pancreatic β cells) activity 
Martineau et al., 2006 
 Cytoprotection against glucose toxicity Martineau et al., 2006; Hohtola, 2010 
 Insulinosensitizing and anti-obesogenic 
activity 
Hohtola, 2010 
   
Vaccinium vitis-idaea Antioxidant activity Kahkonen et al., 2001; Korotkova et al., 2003; Määttä-Riihinen et 
al., 2005; Wang et al., 2005; Fraser et al., 2007; Yang et al., 2011 
 Anti-glycation activity Beaulieu et al., 2010; Harris et al., 2011  
 Hypoglycemic activity Harbilas et al., 2009; Eid et al., 2010; Nistor Baldea et al., 2010  
 Adipogenic activity Harbilas et al., 2009 
 Anti-inflammatory activity Markov et al., 2011 
   
Vaccinium uliginosum Antioxidant activity Fraser et al., 2007 
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Figure 2.1 Ranking comparison between SIV (black) and FC (white) for the 16 plants 
mentioned in Wemindji (A) and the 26 species mentioned in Oujé-Bougoumou (B). 
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Figure 2.2 Three-dimensional scatterplots from correspondence analysis of plant species (●) 
and symptoms (¢) for Wemindji (A) and Oujé-Bougoumou (B). Symptoms and species 
located in proximity to one another are deemed to be highly associated. Interpretations of 
scatterplots are summarized in table 2.8. 
 
 
Figure 2.3 Three-dimensional scatterplots from correspondence analysis of plant species (●) 
and symptoms (¢) for all six communities combined. Symptoms and species located in 
proximity to one another are deemed to be highly associated. Interpretations of scatterplots are 
summarized in table 2.9. 
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3.1 Abstract  
The impact of several environmental factors was studied on the production of phenolic 
compounds in a North American medicinal plant, Labrador tea (Rhododendron 
groenlandicum). Leaves were harvested in 2006 and 2010 over a latitudinal gradient in 
Northern Quebec, and known phenolic markers were quantified by HPLC-DAD. The 
concentration of selected compounds expressed a quadratic relationship with latitude where 
they were higher between the 51-53rd parallel of Northern Quebec and lower in the peripheral 
northern and southern. Major variations were observed in the following marker compounds: 
(+)-catechin, (-)-epicatechin, quercetin-3-galactoside and an undetermined quercetin-
glycoside. The variation in phenolic compounds was best explained by insolation parameters 
such as solar radiation and photoperiod in the month of June. 
 
Key words: Phenolic compounds, traditional medicine, insolation, photoinhibition, Cree 
Nation of Eeyou Istchee. 
 
3.2 Introduction 
Rhododendron groenlandicum (Oeder) Kron & Judd, Labrador tea, from the Ericaceae, 
is a common plant growing in Canada's boreal forests with a long history of traditional uses 
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among indigenous populations. Its recorded and/or current uses are reported for the Inuit 
(Cuerrier and Hermanutz, 2012) and First Nations of the Algonquian, Salish, Waskashane and 
Tsimshianic linguistic families (Arnason et al., 1981; Zieba, 1990; Siegfried, 1994; Marles et 
al., 2008; Moerman, 2009; Uprety et al., 2012). Its widespread use is perhaps due to its 
abundance, wide distribution, medicinal properties and aromatic flavour. 
A high incidence of type 2 diabetes (T2D), reaching an average of 29%, has been 
reported in the Cree Nation of Eeyou Istchee (CEI) communities (Kuzmina et al., 2010), and 
the CIHR Team on antidiabetic aboriginal medicines (TAAM) was formed to undertake 
collaborative research with Cree Healers to study traditional medicinal plants for their 
antidiabetic potential. Within the pharmacopoeia of the CEI, Labrador tea was mentioned for 
the treatment of a wide range of symptoms related to diabetes (Marshall et al., 2003; Fraser, 
2006; Leduc et al., 2006; Marshall, 2006; Downing, 2010). In pharmacological studies, R. 
groenlandicum was shown also to posses in vitro glitazone-like activity comparable to 
rosiglitazone in the lipid accumulation of the 3T3-L1 preadipocytes (Spoor et al., 2006). 
Flavonoids, catechins and triterpenes are biologically active components that play a 
key role in the protection of plants from the oxidative stress induced by environmental factors 
(Dixon and Paiva, 1995; Close et al., 2003; Solovchenko and Merzlyak, 2008). Stressors such 
as solar irradiation, cold temperatures and low soil nutrients vary considerably over the large 
CEI territory, which extends midway through Quebec from the James Bay coast, and these 
have been shown to induce the expression of flavonoid pathway genes (Hartmann et al., 2005; 
Lillo et al., 2008; Usadel et al., 2008; Matus et al., 2009). Variation in medicinal efficacy has 
been observed by CEI Elders who report northern populations to be “stronger medicine” 
(Cuerrier, verbatim). 
Indeed, studies have shown the important role that phenolic compounds play in 
reducing solar-induced damage to plants. High quantities of UV-absorbing polyphenols in 
epidermal and hypodermal layers of leaves and branches (Li et al., 1993; Dixon and Paiva, 
1995) screen the sun's damaging rays before they reach the photosystems. Li et al. (1993) were 
the first to demonstrate a direct link between flavonoids and UV protection in Arabidopsis 
mutants. Although solar radiation is essential for photosynthesis, plants may suffer from 
photoinhibition when photosynthetically active photon flux density is in excess of what is 
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necessary for CO2 assimilation (Carvalho and Amâncio, 2002). Such excess in energy due to 
high light can generate an increase in reactive oxygen species (ROS) such as H202 as shown in 
various acclimatization studies (Carvalho and Amâncio, 2002; Carvalho et al., 2006). UV 
radiation has also been shown to increase ROS production (Bhattacharjee, 2011). Oxidative 
damage due to ROS and photodamage due to high levels of UV-A and UV-B radiation include 
dimerization of lipids, enzymes, proteins, pigments, nucleic acids, DNA and RNA (Dixon and 
Paiva, 1995; Pietta et al., 1998; Solovchenko and Merzlyak, 2008; Faisal and Anis, 2009; 
Bhattacharjee, 2011). Plants are thus equipped with antioxidant systems, scavenging ROS 
through enzymatic and non-enzymatic mechanisms whose activity has been shown to increase 
with insolation parameters (Carvalho and Amâncio, 2002; Carvalho et al., 2006; Faisal and 
Anis, 2009). Of the non-enzymatic mechanisms, phenolic compounds are well-known 
antioxidants repeatedly demonstrated to play a key protective role against ROS. 
Phenolic compounds are free or cell wall-bound compounds (Nara et al., 2006) whose 
chemical structure allows them to efficiently inactivate ROS (Takahama and Oniki, 1997) and 
act as antioxidants (Haslam, 1996; Habtemariam, 1997; Rice-Evans et al., 1997; Pietta et al., 
1998; Plumb et al., 1998; Kähkönen et al., 1999). Due to absorption in the ultraviolet range of 
the electromagnetic spectrum, some compounds, such as kaempferol glycosides, may act as 
UV filters, while others are radical scavengers or chelators of metals that prevent the Fenton 
reaction (Takahama and Oniki, 1997). 
The antioxidant capacity of phenolic compounds to UV-induced ROS in plant tissues 
has proven to be transferable to animal tissues as well. Compounds isolated from Dalbergia 
odorifera T. Chen (Fabaceae) showed antioxidant activities and helped mediate oxidative 
damage in rat lenses exposed to UV irradiation (Yu et al., 2007). Such antioxidant activities 
from exogenous plant-based compounds in humans have a favourable impact on chronic 
diseases such as T2D (McCune and Johns, 2007; Sancho and Pastore, 2012) and total 
phenolics generally tend to correlate positively with antioxidant activity in in vitro studies 
(Pietta et al., 1998; Fraser et al., 2007; Harris et al., 2011). 
The biological activity of many plants, including Labrador tea, identified in the CEI 
pharmacopoeia for the treatment of symptoms related to T2D (Spoor et al., 2006; Harbilas et 
al., 2009; Saleem et al., 2010), has been attributed to phenolic compounds (Eid et al., 2010; 
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Guerrero-Analco et al., 2010; Harris et al., 2012; Muhammad et al., 2012; Shang et al., 2012). 
Yet the abundance and wide distribution of these plants across Eeyou Istchee and the boreal 
zone of Canada pose potential problems for quality control both for current traditional use and 
in the event that they may be transformed into natural health products (NHPs) for future use in 
communities. The territory occupied by the CEI lies between the 50th and 55th parallel North, 
and a marked difference can be observed in the increase of day length between the extremities 
of the territory (National Research Council, 1995). Cree Elders and Healers have noted 
variations in the medicinal potential of plants within this territory. We hypothesize that such 
observations in R. groenlandicum reflect changes in its phenolic content, which increases as a 
function of latitude, and that these are positively related to insolation parameters such as solar 
radiation and photoperiod. 
To date, there have been few studies addressing the question of geographical variations 
in the phytochemistry of plants, especially biologically active compounds. Positive 
correlations between phenolic concentration and latitude have been shown in the 
Cupressaceae, Ericaceae and Betulaceae, or Juniperus communis (Martz et al., 2009a), 
Vaccinium myrtillus (Martz et al., 2010) and Betula pubescens (Stark et al., 2008), 
respectively. But fewer studies address the question of the environmental factors responsible 
for these changes. In the present study, we report variations in the phenolic content of 
compounds quantified from R. groenlandicum, as well as a link between environmental factors 
and phytochemical concentrations over a large latitudinal gradient. 
 
3.3 Materials and Methods 
3.3.1 Sampling 
Mature leaves of R. groenlandicum were sampled during the summers of 2006 and 
2010 around the communities of Mistissini, Nemaska, Waskaganish, Eastmain, Wemindji and 
Whapmagoostui, thus covering the entire north-south gradient in Eeyou Istchee. Waskaganish 
was the only CEI community that was not sampled in 2006. Samples from the Ottawa region, 
south of the CEI territory, were also collected in 2010. This effectively doubles the latitudinal 
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gradient, extending it into the Great Lakes St-Lawrence forest region characterized by a 
greater diversity of deciduous hardwood trees (Farrar, 2005). Ten accessions, each containing 
leaves from multiple (~ 5) individual plants, were collected within a 50 km radius around each 
community. In 2010, additional samples, collected along the James Bay Highway and in the 
Ottawa region, were included in the statistical analyses involving geographic coordinates. 
Samples were air dried and preserved in paper bags at room temperature. Representative 
voucher specimens from each community are deposited at the Marie-Victorin Herbarium of 
the University of Montréal (MT) and the University of Ottawa Herbarium (OTT) (Appendix 
III). 
3.3.2 Extraction 
Plant material was thoroughly dried at 35°C over night in a commercial food 
dehydrator (Nesco® Professional Food and Jerky Dehydrator). Samples were milled through a 
Wiley Mill with at 40 mesh and extracted overnight in at 25 mL/g of 80 % EtOH by orbital 
shaking at room temperature at 250 RPM. The pellet was extracted overnight in 15 mL 80 % 
EtOH. The pooled supernatants (adjusted to 50.0 mL in a volumetric flask) were centrifuged 
for 15 min at 1828 x g at room temperature. An aliquot (1 mL) of the centrifuged extract was 
prepared for High Performance Liquid Chromatography hyphenated with Diode Array 
Detector (HPLC-DAD) by filtering through a 20 µm PTFE filter. Extracts were kept at -20°C 
and sonicated before analysis. Unfiltered crude extracts were dried using a speedVac. Trace 
water was removed by lyophilization using a SuperModuylo freeze dryer and stored at -80°C 
for future use. 
3.3.3 Chemicals and standards 
(+)-Catechin (1), chlorogenic acid (2), (-)-epicatechin (3), p-coumaric acid (4), rutin 
(5), quercetin-3-galactoside (6), quercetin-3-glucoside (7), quercetin-3-rhamnoside (12), 
myricetin (13) and quercetin (14) were purchased from Sigma-Aldrich (Oakville, Ontario, 
Canada) and Extrasynthese (Genay, France). HPLC grade water, acetonitrile, and formic acid 
(99% purity) were purchased from Sigma-Aldrich. 
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3.3.4 Identification and Quantification 
The identification and quantification of phenolic compounds listed in table 3.1 in the 
crude extracts were based on a validated method (Saleem et al., 2010). Briefly, a 10 µl of each 
extract was injected through an autosampler and detected by DAD at 290 nm, band width 4, 
reference off. The separations were performed on a Luna C18 column (250 x 4.6 mm, 5 µM 
particle size). Peak identification was undertaken by co-chromatographic comparison of the 
spectral data adopted in our in-house metabolomics spectral library (Saleem et al., 2010). A 
standard curve was constructed by injection of serially diluted marker compounds in 
methanol. The quantification was based on peak height and area. The quantitation of 
putatively identified quercetin-glycosides was done based on the calibration curve of 
quercetin-galactoside. Each sample was analyzed in triplicate and averaged to account for 
instrumental variation. 
3.3.5 Environmental data 
Estimates for over 190 environmental and climatic variables were provided by the 
Canadian Forest Services of Natural Resources Canada. Values were generated by spatially 
continuous climatic models adjusted by ANUSPLIN, a non-parametric multivariate technique 
for the noise-reduction of multiple variable data. Interpolation of surfaces is calculated by 
smoothing algorithms and taking into consideration the effect of altitude. For the most part, 
these surfaces are generated from a 30 years data span collected by meteorological stations 
across the country. Using each sample's geographical coordinates at a resolution of 4 decimal-
degrees, environmental and climatic estimates were obtained for each collection site. Monthly 
estimates for solar radiation (Mjoules) and photoperiod (h) were obtained from data of the 
1961-1990 period. Other variables including evapotranspiration and climatic moisture index 
(CMI) were available for the 1971-2000 period while monthly and annual estimates for such 
variables as temperature and precipitation were also available for the first collection year of 
2006. Details of the protocols generating these estimates are described by McKenney et al. 
(2007a,b). 
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3.3.6 Statistical analysis  
Univariate and multivariate statistical analyses were performed using R statistical 
language (R Development Core Team, 2012). Because sampling sites are concentrated around 
specific communities, these were considered as a grouping factor in analysing how phenolic 
content varied from region to region. Specific compounds were analyzed separately by 
parametric analysis of variance (ANOVA) and post-hoc Tukey multiple comparisons to 
elucidate how each varied. To elucidate potential chemotypes and important markers, phenolic 
profiles of R. groenlandicum were analyzed by performing a multivariate analysis of variance 
(MANOVA) using a partial-RDA approach (Anderson and Legendre, 1999). Following the 
significant results in the interaction between communities and harvest years in a 2-way 
factorial analysis, 1-way analyses were performed for each year thus including supplementary 
samples for the analysis of 2010. Post-hoc pairwise comparisons were realized by performing 
an RDA for each pair of community and adjusting the α value using Holm’s correction. In 
order to facilitate the visualization of relationships among communities, we opted for 
dendrograms using complete linkage analysis to ensure that the fusion of each community is 
based on their most distant pairs.  
The spatial pattern in the variation of phenolic compounds was further examined by 
using the geographic coordinates as a continuous variable. Polynomial regressions were used 
to analyze the spatial variation in the sum of quantified phenolic markers in order to assess the 
general trend of phenolic compounds. Determination of polynomial equations for fitted values 
were realized based on Legendre and Legendre (1998). Regression models for both years were 
subsequently compared by analysis of covariance (ANCOVA), specifying latitude and year as 
a continuous and grouping variable respectively. 
Furthermore, the phytochemical profile of R. groenlandicum was spatially analyzed by 
canonical redundancy analysis (RDA) in order to identify the important varying markers. 
Spatial representations of the multivariate data were obtained by interpolating the first 
canonical axis over the constricting geographical area of the sampling sites. Interpolation was 
performed by ordinary kriging using v.krige.py, a command from the GRASS environment 
(GRASS Development Team, 2012), using R software functions in the background. 
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Intermediate values were estimated by adjusting the best-fit theoretical model, automatically 
detected in the command script, to empirical variograms generated for each spatial analysis. 
Simple and multiple linear regressions were used to determine which climatic and 
environmental variables best explained the spatial variation observed in the sum of quantified 
phenolic markers. In a similar fashion, the phytochemical profile of R. groenlandicum was 
analyzed by RDA with these variables to determine which of these best explained the 
variations of important phenolic markers. Because of the large quantity of variables available, 
they were selected for a most parsimonious model explaining the maximum variation in the 
phenolic profile. Selection was performed using both information-theoretics and hypothesis-
testing approaches. Automated routines for forward, backward and stepwise selection were 
realized using Akaike’s information criterion (AIC) (Akaike, 1973) as the selection criteria. 
Forward selection was also performed using adjusted R2 and α level as selection criteria in a 
hypothesis-testing approach (Blanchet et al., 2008). Results from all four methods were taken 
into consideration in the selection of final variables to be modelled and the variance inflation 
factor (VIF) calculated for each of these to evaluate the severity of multicolinearity. 
Statistical significance of multivariate analyses was determined by non-parametric tests 
using 100,000 permutations and α = 0.05, while the statistical significance of univariate 
analyses was determined using the normal distribution after verifying that the data met the 
required assumptions. 
 
3.4 Results and discussion  
3.4.1 Phenolic content and profile 
Representative HPLC-DAD chromatographs of R. groenlandicum leaf extracts (fig. 
3.1) show that of 10 known and identified phenolic compounds, all but p-coumaric acid, rutin 
and myricetin, which were detected in trace amounts, were quantified and subsequently 
analyzed. Three of these compounds, (+)-catechin, (-)-epicatechin and quercetin, have been 
found responsible for the adipogenic activity of R. groenlandicum in bioassay-guided 
fractionation (Ouchfoun, 2011). Four unknown, yet significantly present, quercetin-glycosides 
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were detected through chromatographs (fig. 3.1) and also quantified. These compounds, 
including quercetin-glycosides, have been found in a multitude of boreal plants, most notably 
members of the Ericaceae such as Gaultheria hispidula, Kalmia angustifolia, Rhododendron 
tomentosum, Vaccinium vitis-idaea and V. angustifolium (Harris et al., 2007; McIntyre et al., 
2008; Saleem et al., 2010; Black et al., 2011; Ferrier et al., 2012). These species also appear in 
CEI pharmacopoeia and, like R. groenlandicum, have been screened by the CIHR-TAAM and 
shown to possess antioxidant activity and antidiabetic potential (Spoor et al., 2006; McIntyre 
et al., 2008; Harbilas et al., 2009; Black et al., 2011; Ferrier et al., 2012). 
The sum of quantified compounds varied between 21.3 – 33.9 mg/g DW in 2006 (fig. 
3.2a), averaging 28.8 mg/g DW. In 2010, concentrations were lower, averaging 21.1 mg/g 
DW and varying between 12.6 – 29.2 mg/g DW (fig. 3.2b). Figure 3.2 clearly shows that 
roughly two thirds of accessions were within the mid-range: 64 % and 71.4 % in 2006 and 
2010, respectively, and a lower number of accessions was observed at the high and low 
concentration ranges. This is useful for considering the plant as an NHP, since the 
pharmacological activity of these compounds are well documented and are known to possess 
antidiabetic, antioxidant, anti-inflammatory and even antibiotic properties (Gray and Flatt, 
1997; Harborne et al., 1999). 
The most abundant compound was quercetin-3-galactoside, followed by quercetin-
glycoside 4, (+)-catechin, chlorogenic acid and (-)-epicatechin (fig. 3.3). Although means 
differed between sampling years, the ranking of concentrations were relatively similar. In 
2006, all but quercetin-3-galactoside varied geographically between communities while in 
contrast, only (+)-catechin, (-)-epicatechin, quercetin, quercetin-3-galactoside and quercetin-
glycoside 1 varied significantly in 2010 (results are presented in table 3.2). Of the most 
abundant compounds, only (+)-catechin and (-)-epicatechin remained significantly variable 
during both harvest years (fig. 3.4). Although not as clear in 2010, variations in metabolite 
concentrations, in both cases, follow a bell-shaped pattern where concentration means are 
higher towards the centre of the sampling gradient. 
The relationship between the phytochemical profiles of plants collected in the different 
communities are further elucidated in figure 3.5c and 3.6c. How these differed from one 
community to the others were not identical between harvest years (p=5.1 x 10-4). Nonetheless, 
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canonical relationships were significant in 2006 (p =1 x 10-5, R2adj = 0.32, fig. 3.5a and b) and 
2010 (p = 1 x 10-5, R2adj = 0.17, fig. 3.6a and b), and show in both cases that the phenolic 
profiles of R. groenlandicum from Eastmain, Wemindji and Nemaska were similar. Regardless 
of statistical differences, the clustering of samples resulting from canonical analyses (fig. 3.5a 
and 3.6a) do not appear distinct enough to propose various chemotypes, but rather a 
differentiation towards chemoraces. This is particularly true for the northern plant accessions 
of Whapmagoostui, which lies in the transitional taïga forest region. Located between two 
distinct ecosystems, the boreal forest and the tundra, changes in environment, climate and 
species composition may play an important role in driving this differentiation. The same can 
be said about R. groenlandicum populations in Ottawa as they grow in isolated remnants of a 
once more extensive boreal forest interspersed within the mixed Laurentian forest region. 
However, a supplementary harvest for that area is necessary to verify this assertion. 
When considering the theory that the impact of abiotic parameters, leading to the 
ecological distinctiveness of these forest regions, acts in the differentiation of chemotypes, this 
may explain why accessions from the boreal forest were generally not statistically different as 
their environment might be too similar. Even so, Mistissini's relationship to other communities 
differs between harvest years (fig. 3.5c and 3.6c). This may simply be caused by yearly 
fluctuations of local climatic and environmental variables, for which the effect is suppressed in 
the calculations of estimates. Regardless, important markers explaining the spatial variations 
in the phenolic profile of R. groenlandicum were (+)-catechin, (-)-epicatechin, quercetin-3-
galactoside and quercetin-glycoside 4 (fig. 3.5b and 3.6b), all of which rank amongst the most 
abundant compounds (fig. 3.3). Quercetin-3-rhamnoside was ranked as a less-important 
marker, yet its relationship to geographical variations was inversely proportional to the general 
trend (fig. 3.4) and only chlorogenic acid showed some discrepancy by acting as a major 
compound in 2006. Of these compounds, (+)-catechin and (-)-epicatechin seem like the most 
important in supporting the claim of a chemotype differentiation in the Whapmagoostui 
populations where concentrations are lower. This may have important implications in the 
antidiabetic potential of R. groenlandicum as these two compounds have been shown in vitro 
to promote adipogenesis (Ouchfoun, 2011). From an NHP perspective, this suggests that 
harvesting should take place within the boreal forest. 
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3.4.2 Spatial patterns and variation 
A geographic variation was observed for the sum of quantified phenolics that, although 
not varying linearly in 2006 (p = 0.802) or 2010 (p = 0.101), showed a significant quadratic 
relationship with latitude. Concentrations peaked at midlatitudes but were lower at highest and 
lowest latitudes  (fig. 3.7). The regression equations of fitted values for 2006 and 2010 were 
 
ŷ = -2253.86 + 86.30x – 0.81x2 (p =1.48 x 10-6, R2adj = 0.425) 
 
and 
 
ŷ = -353.18 + 14.78x – 0.15x2 (p = 0.000715, R2adj = 0.158) 
 
respectively. The quantitative scales in concentrations were statistically different (p <  2.2x10-
16) as observed in figure 3.2, but for both years, the sum of quantified phenolics reached a 
maximum concentration at mid range of the sampling area. 
When the RDA results of all phenolic compounds were interpolated (fig. 3.8), the 
spatial variation in the phytochemical profile of R. groenlandicum continued to reflect 
quadratic relationships with latitude. These canonical relationships were globally very highly 
significant in 2006 (p =1 x 10-5, R2adj = 0.33) and 2010 (p = 3 x 10-5, R2adj = 0.13). 
Redundancy analysis produced two canonical axes in 2006 (λ1 = 0.952, λ2 = 0.640) of which 
the first was very highly significant (p =1 x 10-5) and explained 21.7% of the variance in the 
phytochemical profile. As for 2010, two canonical axes were also produced (λ1 = 0.641, λ2 = 
0.088) of which the first was again very highly significant (p =1 x 10-5) and explained 13.4 % 
of the variance in the phytochemical profile. Interpolation of the first canonical axis (fig. 3.8) 
illustrates the general variation of phenolic compounds across the sampling gradient, whereas 
concentrations are highest between the 51st and 53rd parallel. This corresponds to the region 
where lie the communities of Wemindji, Nemaska and Waskaganish as discussed in the 
previous section. 
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Our results differ from those obtained by Martz (2009a; 2010) and Stark et al. (2008). 
Although, positive relationships between phenolic concentrations and latitude were observed 
in V. myrtillus (Martz et al., 2010), this is the only other report of this kind for a species of 
Ericaceae. Other studies have shown various geographical trends in the variations of phenolic 
compounds from other species. Both positive and negative correlations with latitude were 
observed for specifc phenols in B. pubescens (Stark et al., 2008). Positive relationships with 
altitude were observed in species of Dennstaedtiaceae, Pteridium caudatum and Pteridium 
arachnoideum (Alonso-Amelot et al., 2004, 2007), as well as a species of Jungermanniaceae, 
Jungermannia exsertifolia subsp. cordifolia (Arróniz-Crespo et al., 2006), while a negative 
one was observed in the Asteraceae Scorzoneroides helvetica (Zidorn, 2009). Spatial 
correlations of different natures have also been observed in alkane, alkaloid and terpene 
concentrations from various other species (Camp, 1949; Lincoln and Langenheim, 1976, 1979, 
1981; Nicholls and Bohm, 1982, 1983; Dodd and Poveda, 2003). 
 The discovery of quinine and related alkaloids in the bark of Cinchona spp. 
(Rubiaceae) is one of the major ethnobotanical contributions to modern medicine in the 
treatment of malaria. The quest for high-yielding trees has led to Camp's (1949) study in the 
latitudinal and altitudinal variations of Cinchona alkaloid concentrations. His study showed 
geographic variations whereas concentrations related positively with altitude rather than 
latitude, an effect attributed to cooler temperatures in the high mountains of the Andes. 
Alternatively, a negative relationship was observed between the flavone, orientin and latitude 
in Lupinus sericeus (Fabaceae) collected along a 1500 km north-south transect (Nicholls and 
Bohm, 1982, 1983). Studies for both plants suffered, however, from taxonomic difficulties in 
species identification. This is illustrated by the number of debated taxa amongst the L. sericeus 
complex at the time of the study (Fleak, 1971), by speciation into subspecies (Nicholls and 
Bohm, 1982, 1983) and by hybridization among Cinchona spp. (Camp, 1949). 
One of the better documented studies in the geographical variations of secondary 
metabolites in a given species is that of Satureja douglasii (Lincoln and Langenheim, 1976, 
1979, 1981) of the Lamiaceae. Sampled between latitudes 34ºN and 50ºN in western North-
America, the pattern of monoterpene variations in mature leaves supports geographically 
distinct chemotypes in S. douglasii (Lincoln and Langenheim, 1976). Discontinuities in the 
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linear gradients with regards to latitude suggest the presence of significant differences, as we 
observed in our own results. Although diverse, spatial patterns can clearly be distinguished in 
the variation of plant phytochemicals. This diversity may be attributed to the fact that latitude 
acts as a marker for underlying abiotic factors, as Camp's (1949) study and our results further 
suggest. 
3.4.3 Environmental and climatic relationships 
Of over 190 climatic and environmental variables, selection of the most parsimonious 
models explaining variations in the phenolic profile of R. groenlandicum included factors 
related to insolation as most important and significant (fig. 3.9). For 2006, the best-fit model 
included solar radiation for the months of March and June (p =1 x 10-5, R2adj = 0.33, fig. 3.9a) 
for which partial p values were all statistically significant (p < 0.05). Redundancy analysis 
produced two canonical axes explaining cumulatively 36.1% of the variation of the 
phytochemical profile. The canonical axes were statistically significant (λ1 = 1.034, p1 = 1 x 
10-5 and λ2 = 0.552, p2 = 8 x 10-5) and individually explained 23.5% and 12.6% of the 
variation respectively. Important markers correlated well with climatic variables. For instance, 
along the main canonical axis, (+)-catechin, (-)-epicatechin and chlorogenic acid were best 
associated to March solar radiation.  Along the secondary canonical axis, quercetin-3-
galactoside and quercetin-glycoside 4 related better to June solar radiation. 
For 2010, the best-fit model included monthly photoperiod averages for the months of 
June and September (p = 0.001, R2adj = 0.09, fig. 3.9b) for which partial p values were all 
statistically significant (p < 0.05). Redundancy analysis produced two canonical axes (λ1 = 
0.316, λ2 = 0.167), explaining cumulatively 12.3% of the variation in the phytochemical 
profile, of which the first was significant (p = 0.00265) in explaining 8.4% of the variance. 
Important markers, such as  (+)-catechin and (-)-epicatechin, correlated well with climatic 
variables, notably associating with the June photoperiod, while quercetin-3-galactoside related 
best to the September photoperiod. Quercetin-3-rhamnoside, for its part, related negatively to 
June photoperiod. Unlike the results for 2006, the unidentified quercetin-glycoside 4 and 
chlorogenic acid did not present themselves as important markers. 
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In a similar fashion to the RDA results, the sum of quantified compounds in 2006 (fig. 
3.10a) is related to the solar radiation in June (p = 0.00388, R2adj = 0.149). When removing 
compounds which did not vary significantly with environmental variables, the sum of 
quantified compounds in 2010 (fig. 3.10b) was related to the monthly photoperiod averages 
for the month of June (p = 0.00467, R2adj = 0.11), thus corroborating multivariate results 
shown in figure 3.9. Similarly, the variation could be better explained in both cases when the 
same explanatory variables (R2adj = 0.414; see fig. 3.9) are analysed with March solar radiation 
in 2006 (p = 2.25x10-6) and September monthly photoperiod in 2010 (R2adj = 0.146; p = 
0.00324). 
Solar radiation and photoperiod during the month of June were the most significant and 
important environmental variables explaining the variation in the phenolic profile of R. 
groenlandicum for 2006 and 2010 samples, respectively. Coinciding with the summer solstice, 
June photoperiod is at its longest, giving higher levels of solar radiation than any other month 
of the year. Although preliminary, March solar radiation and September photoperiod results 
suggest, however, that the concentration of certain phenolic compounds reflect stresses during 
other periods of the year. This may represent a long-term adaptation to predictable and 
cyclical events such as the melting of snow and ice in late winter and at the beginning of 
spring, as it is suggested by the analysis of the 2006 accessions, or the sudden drops in 
temperature at the beginning of fall, as suggested by the 2010 analysis. In both cases, these 
represent periods where photosystem activity is either inhibited or reduced by factors such as 
temperature, all while still being exposed to potentially harming levels of solar energy. 
In S. douglasii, based upon environmental factors such as insolation and herbivory, 
high-yielding chemotypes tended to occur under low light-high herbivore pressure, while low-
yielding chemotypes tended to occur under high light-low herbivore pressure (Lincoln and 
Langenheim, 1979). While this relationship with light intensity contradicts the results obtained 
in our study, this may be attributed to the quantification of a different phytochemical class, 
since terpenes are known to act as a deterrent to herbivory (Harborne, 2001), thus, also 
highlighting the role biotic factors may also play. 
Furthermore, Nicholls and Bohm (1983) have shown that variations in flavonoid 
concentrations in L. sericeus disappeared when plants from geographically distinct 
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populations were grown under controlled and uniform conditions of day length and 
temperature. The Lincoln and Langenheim's (1979, 1981) studies suggest otherwise however, 
as they argue that constant exposure to certain ecological variables specific to the habitat may 
lead to the genetic selection of monoterpenoid chemotypes; this may not be the case amongst 
phenolic compounds as evidenced by Nicholls and Bohm (1983). Rhododendron 
groenlandicum can be found growing indiscriminately in open bogs and in the forest 
understory. Delayed production and accumulation of phenolics have been shown in V. 
myrtillus growing in forest compared to high light sites (Martz et al., 2010). Although 
habitat/abiotic parameters were not taken into account in this study, such consideration may 
eliminate some of the statistical variation obtained and does not rule out possible genetic 
adaptations towards phenolic concentrations and insolation. 
Indeed, a high variance in the data is expected as biological mechanisms are naturally 
affected by complex interactions between multiple biotic and abiotic factors. Seasonal 
variation in phenolic concentrations has been detected in other members of the Ericaceae such 
as Vaccinium angustifolium (McIntyre et al., 2008) and Rhododendron tomentosum (Black et 
al., 2011). Circunmcribing the sampling time to a larger window of operation, as was the case 
for the 2010 harvest, may result in a larger variance thus explaining smaller R2 values. 
Another possible bias lays in the accuracy of the environmental data and the means by which 
they were obtained (McKenney et al., 2007a,b), as these factors can change considerably from 
year to year. Utilizing estimates obtained from observations over long periods of time is useful 
in pulling out underlying trends, but does not explain yearly variation properly. Regardless of 
these sources of variation, observed trends were supported by two years of harvest suggesting 
a cyclical and long-term adaptation by plants to conditions of insolation. 
The role of measuring instruments must also be considered in interpreting these results. 
Photoperiod was measured using a Campbell-Stokes heliograph, a ground recording 
instrument which does not measure visible sunshine, but bright sunshine as determined by the 
intensity of focused sun rays reaching the instrument (Environment Canada, 2011). 
Consequently, bright sunshine, and inherently, solar radiation, is reduced by diffusion through 
atmospheric turbidity and cloud factors. It has thus been suggested that enhanced 
evapotranspiration rates over large bodies of water may result in bright sunshine decline in 
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coastal regions as they increase cloud formation (Pallé and Butler, 2001). This may explain 
why Whapmagoostui, which lies on the banks of Hudson Bay and experiences frequent fogs, 
possesses the lowest bright sunshine period while it should be highest. This supports the 
quadratic relationship observed between phenolic concentrations and latitude because bright 
sunshine does vary with latitude as visible sunshine does. 
Similar trends in the variation of phenolic profile and the lack of distinct chemotypes 
from one year to the next in boreal regions seem to downplay the genotypic involvement in 
predetermining the phenolic profile of R. groenlandicum. It seems more probable that these 
variations depend simply on annual changes in environmental factors. Low phenolic 
concentrations in Whapmagoostui accessions may alternatively be constrained by increasingly 
stressful conditions. Since the species distribution reaches into its northern limits (Hébert and 
Thiffault, 2011), it may be investing more into the production of primary metabolites rather 
than secondary metabolites to ensure basic survival. Furthermore, plants collected around the 
Ottawa region were ecological outliers; the surrounding natural habitat in the Ottawa region is 
characterized by the Great Lakes St-Lawrence forest region, whereas R. groenlandicum grows 
in isolated vestiges of a formely more extensive boreal forest, such as the Mer Bleu and Alfred 
bogs. Phytochemically, phenolic concentrations were low yet solar radiation during the 
summer months was considerably higher than those in Eeyou Istchee. Similarly, temperature 
was also higher, a factor that is known to increase photosynthetic capacity and productivity as 
long as it does not converge to the extreme (Chabot and Chabot, 1977; Pastenes and Horton, 
1996; Solovchenko and Merzlyak, 2008). Due to unique climatic conditions, their cumulative 
stress may not be important enough in enhancing photoinhibition of photosystems, thus 
suppressing the need to produce greater quantities of phenolic compounds for the purpose of 
photoprotection. Unfortunately, the lack of samples filling the gap between Ottawa and the 
southernmost boreal communities does not allow us to adequately assess this hypothesis and 
draw firm conclusions on this observed phenomenon. It is also possible that isolation in 
environmentally distinct regions may also have contributed to distinct genotypes. Needless to 
say, genetic or common garden studies on all plant populations may further elucidate the 
mechanisms behind the phytochemical variations of R. groenlandicum. 
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Although specific climatic variables explaining the variation in the phytochemical 
profile of R. groenlandicum differ between harvest years, variation partitioning of these best-
fit models with spatial variables, i.e. the quadratic model, produced similar results (fig. 3.11). 
For both years, the unique contribution of each group of variables (fraction [a+b] and [b+c]) to 
variation in the phytochemical profiles is statistically significant, yet, when the effect of one 
over the other is taken into consideration, they no longer are ([a] and [c]). Because most of the 
variation is explained by spatial and climatic variables together ([b]), this confirms that the 
variation explained by the latitudinal relationship is the same as that which is explained by 
climatic variables, notably, factors of insolation. 
Because the phenolic compounds quantified here were identified by bioassay-guided 
isolation, variations in their concentration should have an impact on the pharmacological 
activity of R. groenlandicum. Ferrier et al. (2012) showed relationships between total 
phenolics and anti-glycation end products inhibition within the Vaccinium genus, which varied 
with latitude. As well, McIntyre et al. (2008) and Black et al. (2011) reported variations in 
pharmacological activities associated with seasonal variations in the phenolic concentrations 
of plants from the Ericaceae, V. angustifolium and R. tomentosum, respectively. Although 
biologically active constituents in R. groenlandicum were found to vary geographically, 
pharmacological bioassays need to be performed in order to properly assess the 
pharmacological significance of these observations. 
 
3.5 Conclusion 
Our study demonstrates a relationship between phenolic compound quantities and 
latitude, which is an indirect marker for environmental parameters that directly affect plant 
physiology. The quantitative variations in the biologically active phytochemicals of R. 
groenlandicum relate best to insolation parameters such as solar radiation and photoperiod, 
notably during the month of June. The reason for such observations may be explained by the 
role that phenolic compounds play as protective agents against photoinhibition and 
photodamage. In short, latitude acts as a geographical marker translating the effect of 
environmental variables affecting R. groenlandicum's photosynthesis needs. Major markers to 
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which these trends may be attributed are (+)-catechin, (-)-epicatechin, quercetin-3-galactoside 
and quercetin-glycoside 4, whereas concentrations were highest between the 51-53rd parallel 
and lowest in the peripheral distribution area of this species. In providing appropriate 
recommendations for the harvest of R. groenlandicum in quality controlled NHPs, our results 
show that medicinal quality is similar over most of the Cree communities except the most 
northerly area Whapmagoostui where a differentiation to a distinct chemorace seems to 
occurs. 
 
3.6 Acknowledgements 
This work was supported by the Canadian Institutes of Health Research (CIHR) Team 
Grant (CTP-79855) to Pierre S. Haddad, J.T. Arnason and Alain Cuerrier, discovery grant to 
J.T. Arnason as well as funding from the Natural Sciences and Engineering Research Council 
(NSERC), Canada’s Northern Internship program, and Network Environments for Aboriginal 
Health Research (NEAHR) to M. Rapinski. Special thanks to the Eeyou Istchee Cree Nations 
of Mistissini, Nemaska, Waskaganish, Eastmain, Wemindji and Whapmagoostui for sharing 
their traditional knowledge and allowing us to collect medicinal plants from their lands with 
the purpose of bridging indigenous knowledge and contemporary science. We also thank the 
Cree Board of Health and Social Services of James Bay for their constant support, as well as 
A. Léger, N. Roy, A. Downing, Y. Tendland, B. Walsh-Roussell, C.H Ta for helping out with 
field and lab work. Special recognition to Jonathan Ferrier who also provided comments, ideas 
and support. Finally, thank you to S. Daigle and P. Legendre for statistical advice and G. 
Larocque for advice in GRASS and QGIS. 
 
 
 
 
 
 68 
3.7 Tables and Figures 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 List of compounds identified and quantified from the leaves of Rhododendron 
groenlandicum. Concentration means ± SD for all samples collected in 2006 and 2010 and 
references for studies corroborating its presence in R. groenlandicum 
Peak # Compound 
Concentration (mg/g 
DW) Reference 
2006 2010 
1 (+)-Catechin 4.98 (1.04) 2.16 (0.64) Ouchfoun, 2011; Saleem et al., 2010 
2 Chlorogenic acid 3.17 (0.77) 1.53 (0.55) Ouchfoun, 2011; Saleem et al., 2010; Spoor et al., 2006 
3 (-)-Epicatechin 2.73 (0.78) 1.78 (0.68) Ouchfoun, 2011; Saleem et al., 2010 
4 p-Coumaric acid T T  
5 Rutin T T  
6 Quercetin-3-galactoside 6.49 (0.97) 5.50 (1.26) Ouchfoun, 2011; Saleem et al., 2010 
7 Quercetin-3-glucoside 1.81 (0.27) 1.42 (0.36) Ouchfoun, 2011; Saleem et al., 2010 
8 Quercetin-glycoside 1 0.68 (0.19) 0.51 (0.22)  
9 Quercetin-glycoside 2 1.52 (0.25) 0.89 (0.30)  
10 Quercetin-glycoside 3 1.36 (0.20) 1.02 (0.24)  
11 Quercetin-glycoside 4 5.53 (0.88) 4.67 (1.02)  
12 Quercetin-3-rhamnoside 0.38 (0.36) 1.41 (0.82) Saleem et al., 2010; Scott et al., 2006 
13 Myricetin T T Saleem et al., 2010 
14 Quercetin 0.12 (0.03) 0.09 (0.05) Chartier, Staub, & Goetz, 2005; Ouchfoun, 2011 
 Total 28.76 (3.09) 21.08 (3.77)  
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Table 3.2 ANOVA results analyzing concentration variations of phenolic 
compounds in Rhododendron groenlandicum collected around various 
communities in 2006 and 2010. Significant results are determined at α = 0.05 
and are shaded. 
Compound 
2006 2010 
p-value R2adj p-value R2adj 
(+)-Catechin 2.17x10-06 0.454 2.72x10-11 0.562 
Chlorogenic acid 0.00761 0.195 0.131 0.0572 
(-)-Epicatechin 1.94x10-06 0.457 7.2x10-12 0.580 
Quercetin-3-galactoside 0.147 0.0607 0.0406  0.102 
Quercetin-3-glucoside 0.0151 0.167 0.0933 0.0710 
Quercetin-glycoside 1 0.0147 0.168 0.0367 0.106 
Quercetin-glycoside 2 0.0361 0.129 0.113 0.0632 
Quercetin-glycoside 3 0.000114 0.343 0.575 -0.0173 
Quercetin-glycoside 4 1.63x10-06 0.461 0.1228 0.0599 
Quercetin-3-rhamnoside 0.00939 0.274 0.217 0.0350 
Quercetin 0.00865 0.190  3.25x10-10 0.526 
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Figure 3.1 Sample HPLC chromatogram with DAD at 325 and 280 nm of R. groenlandicum 
leaves. Numbers represent compounds as follows : (+)-catechin (1), chlorogenic acid (2), (-)-
epicatechin (3), p-coumaric acid (4), rutin (5), quercetin-3-galactoside (6), quercetin-3-
glucoside (7), quercetin-glycoside 1 (8), quercetin-glycoside 2 (9), quercetin-glycoside 3 (10), 
quercetin-glycoside 4 (11), quercetin-3-rhamnoside (12), myricetin (13) and quercetin (14). 
Figure 3.2 Frequency (%) of accessions found within various ranges of phenolics 
concentrations (% calculated from the lowest to highest concentration ) expressed as the sum 
of all quantified compounds for A) 2006 (n = 50) and B) 2010 (n = 77). 
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Figure 3.3 Concentration means ± SD (mg/g DW) for each quantified marker from 2006 (n = 50) and 2010 (n = 77) harvests. 
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Figure 3.4 Phytochemical variation of two of the most abundant compounds ((+)-catechin and 
(-)-epicatechin). Mean concentration ± SD (n = 10) in R. groenlandicum leaf extracts collected 
from Northern Quebec and Eastern Ontario is shown. A) 2006 (5 locations) and B) 2010 (7 
locations). Different letters indicate significant differences amongst communities for each 
compound at α = 0.05. 
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Figure 3.5 RDA ordination biplots, in type 2 scaling, of concentration variations in the 
phenolic profile of R. groenlandicum leaves as a function of community of origin for the 2006 
harvest. A) Symbols represent sampling sites from the communities of Mistissini (▲), 
Nemaska (●), Eastmain (■), Wemindji (®) and Whapmagoostui (▼). Centroids for these sites 
are drawn out by ellipses. B) Phenolic markers are represented by arrows. C) Similarities 
between community based on phenolic profile is elucidated by complete linkage cluster 
analysis. Communities which do not share a common letter represent significant differences in 
profile concentrations as determined by post-hoc pairwise comparisons with Holm's 
correction. Numbers represent compounds as follows : (+)-catechin (1), chlorogenic acid (2), 
(-)-epicatechin (3), quercetin-3-galactoside (6), quercetin-3-glucoside (7), quercetin-glycoside 
1 (8), quercetin-glycoside 2 (9), quercetin-glycoside 3 (10), quercetin-glycoside 4 (11), 
quercetin-3-rhamnoside (12) and quercetin (14). 
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Figure 3.6 RDA ordination biplots, in type 2 scaling, of concentration variations in the 
phenolic profile of R. groenlandicum leaves as a function of community of origin for the 2010 
harvest. A) Symbols represent sampling sites from the communities of Ottawa (○), Mistissini 
(▲), Nemaska (●), Waskaganish (□), Eastmain (■), Wemindji (®) and Whapmagoostui (▼). 
Centroids for these sites are drawn out by ellipses. B) Phenolic markers are represented by 
arrows. C) Similarities between community based on phenolic profile is elucidated by 
complete linkage cluster analysis. Communities which do not share a common letter represent 
significant differences in profile concentrations as determined by post-hoc pairwise 
comparisons with Holm's correction. Numbers represent compounds as follows : (+)-catechin 
(1), chlorogenic acid (2), (-)-epicatechin (3), quercetin-3-galactoside (6), quercetin-3-
glucoside (7), quercetin-glycoside 1 (8), quercetin-glycoside 2 (9), quercetin-glycoside 3 (10), 
quercetin-glycoside 4 (11), quercetin-3-rhamnoside (12) and quercetin (14). 
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Figure 3.7 Concentration of the sum of quantified phenolics in R. groenlandicum leaves as a 
function of latitude for A) 2006 (n = 48) and B) 2010 (n = 77) samples. Total phenolics were 
determined as the sum of all quantified phenolic compounds. Curves reprensent the significant 
quadratic relationships in the spatial distribution of total phenolic concentrations determined 
by parametric polynomial regressions (α = 0.05). 
 
Figure 3.8 Maps showing high (black background) and low (white background) 
concentrations of phenolic compounds for the two harvest years A) 2006 and B) 2010. 
Shading data are based on the assessment of the first canonical axis (RDA1) resulting from the 
RDA of the phytochemical profile in R. groenlandicum constrained by the spatial polynomial 
(i.e. the quadratic relationship with latitude). Interpolation by kriging was performed with 
fitted site scores and circles represent sampling sites. The north-south direction is parallel to 
the vertical axis of the maps and covers a larger area in (B). 
A B 
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Figure 3.9 RDA ordination biplots in type 2 scaling representing the variation in the 
phytochemical profile of  R. groenlandicum leaves as a function of solar radiation (Mjoules) 
for the 2006 harvest (a) and monthly bright sunshine photoperiod averages (h) for the 2010 
harvest (b). Samples from Ottawa were not included in the analysis for 2010. Full lines 
represent explanatory variables and dashed lines represent quantified phenolic compounds. 
 
 
 
 
Figure 3.10 Variation of the sum of quantified compounds in relation to averages of A) June 
solar radiation in 2006 and B) June monthly bright sunshine photoperiod in 2010. Samples 
from Ottawa were excluded from the analysis for 2010 and only significantly varying 
compounds were including in calculating the sum of phenolics. 
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Figure 3.11 Variation partitionning between spatial and environmental variable groups for 
2006 (a) and 2010 (b) harvests. Fraction a = spatial variables (latitude), b = spatial variables + 
environmental variables, c = environmental variables (insolation). 
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4.1 Abstract 
A survey of the phytochemistry of biologically active compounds in a North American 
medicinal plant, Sarracenia purpurea L., was conducted for two harvest years. Leaves were 
harvested from wild populations in 2006 and 2010 over a latitudinal gradient in Northern 
Québec, and known biologically active compounds were quantified by UPLC-MS. Major 
quantified compounds were the terpenes, morronoside, ursolic acid and betulinic acid, as well 
as the phenolics quercetin-3-O-galactoside, quercetin-3-O-glucoside, taxifolin-3-O-glucoside 
and (-)-epicatechin. Morronoside was the most abundant marker and the only one to vary 
geographically during both harvest years. Variations in the content of these compounds did not 
reflect a distinct spatial pattern nor could the underlying effect of environmental and climatic 
factors be discerned. Despite the patchy nature of the distribution of populations, no 
chemotypes could be distinguished. Baseline data on the content level of pharmacologically 
active compounds in S. purpurea reported here provide reference values for possible quality 
assurance programs in the implementation of locally and culturally appropriate approaches to 
treating type 2 diabetes. 
 
Key words: Sarracenia purpurea, phenolics, terpenes, phytochemical variations, traditional 
medicine, type 2 diabetes, Cree Nation of Eeyou Istchee. 
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4.2 Introduction 
Sarracenia purpurea L. (Sarraceniaceae), pitcher plant or Aygadash in Cree, is a 
common plant growing in the sphagnum bogs and peaty barrens of Canada's boreal forests 
(Scoggan, 1978). It has a long history of traditional uses among indigenous populations. Its 
recorded and/or current uses are primarily reported for First Nations groups of the Algonquian 
linguistic family and the Iroquois (Arnason et al., 1981; Zieba, 1990; Siegfried, 1994; Marles 
et al., 2008; Moerman, 2009). 
A high incidence (29%) of type 2 diabetes (T2D) has been reported in communities of 
the Cree Nations of Eeyou Istchee (CEI) (Kuzmina et al., 2010), and the CIHR Team on 
Antidiabetic Aboriginal Medicines (CIHR-TAAM) was formed to undertake collaborative 
research with Cree Healers to study traditional medicinal plants for their anti-diabetic 
potential. Within the pharmacopoeia of the CEI, S. purpurea is used to treat a range of 
symptoms related to diabetes (Marshall et al., 2003; Leduc et al., 2006; Marshall, 2006; 
Downing, 2010). In laboratory studies, it was shown to possess in vitro pharmacological 
activity comparable to metformin in the glucose uptake of C2C12 myotubes and significantly 
protected against glucose toxicity and deprivation of PC12-AC neurones (Spoor et al., 2006; 
Harris et al., 2012; Muhammad et al., 2012). 
The CEI, however, occupy a very large territory lying between the 50th and 55th 
parallel. Although sphagnum bogs and peaty barrens are widely distributed within the region, 
they are highly fragmented with a patchy distribution (Schwaegerle and Schaal, 1979). This 
creates challenges to gene flow that may lead to substantial levels of genetic differentiation 
between populations (Schwaegerle and Schaal, 1979) and inbreeding depression due to self-
pollination (Ne’eman et al., 2006). In keeping with CIHR-TAAM goals of developing 
culturally adapted therapies for the treatment of T2D in the communities, this situation is not 
without problems in ensuring the quality control of natural health products (NHPs). 
Little is known about the phytochemical composition of S. purpurea, particularly 
concerning its biologically active constituents. Yet its antidiabetic potential promises possible 
alternative approaches to treating diabetes in the CEI. Establishing the nature of 
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phytochemical variation in the plant is of interest in assessing the practicability of employing 
this resource in a controlled and standardized manner. 
The objective of this study was to determine the phytochemical variation in S. 
purpurea populations. Because of the wide territory within which pitcher plant occurs, we 
hypothesized that such variation might be attributed to environmental variables and may be 
reflected in distinct chemotypes. We report spatial and temporal variations of important 
pharmacologically active markers. 
 
4.3 Materials and Methods 
4.3.1 Sampling  
Mature leaves of S. purpurea were sampled during the summers of 2006 and 2010 
around the communities of Mistissini, Nemaska, Waskaganish, Eastmain and Wemindji, thus 
covering most of the entire north-south gradient in Eeyou Istchee. Waskaganish was the only 
CEI community that was not sampled in 2006. Samples from the Ottawa region, south of the 
CEI territory, were also collected in 2010. This collection effectively doubles the latitudinal 
gradient, extending it into the Great Lakes St-Lawrence forest region characterized by a 
greater diversity of deciduous hard wood trees (Farrar, 2005). Ten accessions, each containing 
leaves from multiple (~5) individual plants, were collected within a 50 km radius around each 
community. Representative voucher specimens from each community are deposited at the 
Marie-Victorin Herbarium of the Université de Montréal (MT) and the University of Ottawa 
Herbarium (OTT) (Appendix III). 
4.3.2 Extraction 
Plant material was thoroughly dried at 35°C overnight in a commercial food 
dehydrator (Nesco® Professional Food and Jerky Dehydrator). Samples were milled through a 
Wiley Mill with at 40 mesh and extracted overnight in 25 mL/g of 80 % EtOH by orbital 
shaking at room temperature at 250 RPM. The pellet was extracted overnight in 15 mL of 80 
% EtOH. The pooled supernatants (adjusted to 50 mL in a volumetric flask) were centrifuged 
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for 15 min at 1828 x g at room temperature. An aliquot (1 mL) of the centrifuged extract was 
prepared for chromatographic analysis by filtering through a 20 µm PTFE filter. Extracts were 
kept at -20°C and sonicated before analysis. Unfiltered crude extracts were dried using a 
speedVac. Trace water was removed by lyophilization using a SuperModulo freeze dryer and 
stored at -80°C for future use. 
4.3.3 Chemicals and standards 
(+)-Catechin (1), morronoside (2), (-)-epicatechin (3), taxifolin-3-glucoside (4), 
quercetin-3-galactoside (5), quercetin-3-glucoside (6), kaempferol-3-rutinoside (7), betulinic 
acid (8), ursolic acid (9) and rutin (10) were purchased from Sigma-Aldrich (Oakville, 
Ontario, Canada) and Extrasynthese (Genay, France). LC-MS grade water, acetonitrile, and 
formic acid (99.9% purity) were purchased from Fisher (Fisher Scientific, Ottawa, Ontario). 
4.3.4 Identification and Quantification 
The identification of compounds listed in table 4.1 was carried out on a Shimadzu 
Ultra-High Performance Liquid Chromatography hyphenated with Mass Spectrometer (UPLC-
MS) system (Mandel scientific company Inc, Guelph, Ontario), which consisted of LC30AD 
pumps, a CTO20A column oven, a SIL-30AC autosampler and a LCMS-2020 mass 
spectrometer. Briefly, the separation of the phenolic compounds was carried out on a 
phenomenex Kinetex™ C18 column (100 x 2.1mm, 2.6µm particle size, phenomenex, 
Mississauga, Ontario) with a gradient elution method (Method A). The initial solvent was 86% 
solvent A (0.1% formic acid) and 14% solvent B (70%ACN+ 30%MeOH), the ratio remained 
at 86:14 for 5.5 min and then changed to 65:35 in 2 min. The column was then washed with 
100% B for 2 min and change back to the initial condition. The flow was set at 0.4 ml/min 
with a column temperature at 55 °C. The separation of terpenes was carried out on the same 
column with an isocratic elution method (Method B). Marker compounds were eluted with a 
0.4 ml/min flow of 62.5% ACN for 5 min. The column temperature was set at 55 °C. 
Peak identifications were undertaken by co-chromatographic comparison of the 
retention time and mass data with commercially available purified compounds. Appropriate 
and corresponding standard curves were built by injecting dilutions of standard compounds 
 83 
stock solutions. These curves were then used to quantify the amount of each marker 
compound. Each sample was analyzed in triplicate and averaged to account for instrumental 
variation. 
4.3.5 Environmental data 
Estimates for over 190 environmental and climatic variables were provided by the 
Canadian Forest Services of Natural Resources Canada. Values were generated by spatially 
continuous climatic models adjusted by ANUSPLIN, a non-parametric multivariate technique 
for the noise-reduction of multiple variable data. Interpolation of surfaces is calculated by 
smoothing algorithms and taking into consideration the effect of altitude. For the most part, 
these surfaces are generated from a 30 years data span collected by meteorological stations 
across the country. Using each sample's geographical coordinates at a resolution of 4 decimal-
degrees, environmental and climatic estimates were obtained for each collection site. Monthly 
estimates for solar radiation (Mjoules) and photoperiod (h) were obtained from data of the 
1961-1990 period. Other variables including evapotranspiration and climatic moisture index 
(CMI) were available for the 1971-2000 period while monthly and annual estimates for such 
variables as temperature and precipitation were also available for the first collection year of 
2006. Details of the protocols generating these estimates are described by McKenney et al. 
(2007a,b). 
4.3.6 Statistical analysis 
The statistical analyses performed on the obtained data were based on the procedure 
described in Rapinski et al. (in preparation(a)). 
One-way or two-way analysis of variance (ANOVA) were carried out to determine 
differences in the concentrations of different compounds and how each of those differed from 
one community to the next. Tukey's multiple-comparison tests were performed post-hoc when 
initial ANOVA's were statistically significant.  All results were expressed as mean ± SD and 
considered to be statistically significant using α = 0.05. 
To elucidate potential chemotypes and important markers, the phytochemical profiles 
of S. purpurea were analyzed by performing a multivariate analysis of variance (MANOVA) 
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using a partial-RDA approach (Anderson and Legendre, 1999) if more than one compound 
varied significantly among communities. Ellipses around the centroid for each community 
facilitate the visualization of relationships amongst these. These relationships were determined 
by post-hoc pairwise comparisons done by performing a canonical redundancy analysis 
(RDA) for each pair of community and adjusting the α value using Holm’s correction. 
Simple and multiple linear regressions were used to determine which climatic and 
environmental variable best explained the variation observed in quantified compounds from S. 
purpurea. Because of the large quantity of variables available, they were selected for a most 
parsimonious model explaining the maximum variation in the phenolic profile. Selection was 
performed using both an information-theoretics and hypothesis-testing approach. Automated 
routines for forward, backward and stepwise selection were generated using Akaike’s 
information criterion (AIC) (Akaike, 1973) as the selection criteria. Forward selection was 
also performed using adjusted R2 and α level as selection criterion in a hypothesis-testing 
approach (Blanchet et al., 2008). Results from all four methods were taken into consideration 
in the selection of final variables to be modelled and the variance inflation factor (VIF) 
calculated for each of these to evaluate the severity of multicolinearity. 
Statistical significance of multivariate analyses was determined by non-parametric tests 
using 100,000 permutations and α = 0.05 while statistical significance of univariate analyses 
was determined using the normal distribution after verifying that the data met, or was 
transformed to meet, the assumptions required. Univariate and multivariate statistical analyses 
were performed using R statistical language (R Development Core Team, 2012). 
 
4.4 Results and Discussion 
Representative UPLC-MS-ESI chromatographs of S. purpurea leaf extracts are shown 
in figure 4.1. Of all 10 compounds, only the terpenes morronoside, ursolic acid and betulinic 
acid, as well as the phenolic compounds (-)-epicatechin, quercetin-3-O-galactoside, taxifolin-
3-O-glucoside and quercetin-3-O-glucoside were found in sufficient quantifiable quantities for 
both sampling years (table 4.2). Rutin was not detected in the 2006 harvest but was found in 
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trace amounts in 2010. Kaempferol-3-O-rutinoside was found in trace amounts both years, 
while (+)-catechin could only be quantified in 2010. The remainder of compounds were either 
found in low concentrations one year, or in trace amount the other year. 
Taxifolin-3-O-glucoside, rutin, kaempferol-3-O-rutinoside, morronoside and quercetin-
3-O-galactoside were active compounds isolated from S. purpurea by bioassay-guided 
fractionation on glucose uptake in C2C12 mouse muscle cells (Muhammad et al., 2012). All 
of these, with the exception of taxifolin-3-O-glucoside, significantly potentiated glucose 
uptake whereas quercetin-3-O-galactoside exhibited the highest maximal efficacy 
(Muhammad et al., 2012). Morronoside and quercetin-3-O-galactoside were also the active 
compounds in protecting against glucose toxicity (Harris et al., 2012). Phenolic compounds 
are some of the most common bioactive compounds detected in the boreal forest plant species 
of the CEI pharmacopoeia (Spoor et al., 2006; Saleem et al., 2010), particularly in genera, 
such as Vaccinium (McIntyre et al., 2008; Beaulieu et al., 2010; Ferrier et al., 2012) and 
Rhododendron (Rapinski et al., in preparation(a); Black et al., 2011), of the Ericaceae. The 
terpene betulinic acid is one of the major bioactive compounds reported in Betula papyrifera 
(Pisha et al., 1995; Takada and Aggarwal, 2003; Tan et al., 2003; Cichewicz and Kouzi, 2004; 
Ehrhardt et al., 2004; Jeremias et al., 2004; Krasutsky, 2006; Lavoie and Stevanovic, 2007; 
Thibeault et al., 2007; Gauthier et al., 2010) and has been extensively studied for anti-
inflammatory, antiviral, antibiotic and anticancer properties (see Krasutky (2006) for an 
extensive review). Ursolic acid is known for similar properties (Harborne et al., 1999) and has 
been identified in Rhododendron tomentosum (Wollenweber and Kohorst, 1984), R. 
groenlandicum (Hooper and Chandler, 1984; Wollenweber and Kohorst, 1984; Dufour et al., 
2007; Ikeda et al., 2008; Jangra et al., 2010) and V. vitis-idaea (Fokina et al., 1988; Kondo et 
al., 2011). 
The most abundant compound was morronoside, followed closely by quercetin-3-O-
galactoside, then betulinic acid, taxifolin-3-O-glucoside, ursolic acid, quercetin-3-O-glucoside 
and (-)-epicatechin (fig. 4.2), where concentrations were considerably higher for the first two. 
With the exception of quercetin-3-O-glucoside, mean concentration for each compound was 
higher in 2010 than in 2006 and maintained a similar ranking order. Furthermore, the sum of 
quantified compounds, calculated from those which were common to both sampling years 
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(table 4.2), be it phenolics, terpenes or both, ranged over greater concentrations in 2010 than 
in 2006 (fig. 4.3). Nonetheless, figure 4.3 clearly shows that the content of bioactive 
compounds are normally distributed with most accessions containing average quantities. 
These distributions were similar for both sampling years and also show that fewer accessions 
possessed a phenolic content in the upper range than in the lower. 
An ANOVA of the concentration of compounds by locality is presented in table 3 with 
each year analysed separately. Morronoside was the only compound to vary among localities 
for both sampling years (fig. 4.4), but relationships between communities were completely 
different each year. Whereas Mistissini was the region with the lowest concentrations in 2006, 
it was amongst the highest in 2010 and vice-versa for Nemaska and Eastmain. Waskaganish 
had the lowest concentrations of all the regions sampled. In 2010, (+)-catechin, (-)-
epicatechin, quercetin-3-O-galactoside and ursolic acid also varied among localities (fig. 4.5). 
How concentrations of (-)-epicatechin varied from one community to the next reflect the 
relationships observed in morronoside. On the other hand, those observed for the other two 
compounds were similar to morronoside's pattern in 2006 with a distinct spike in 
concentrations in Eastmain. 
The contribution of large concentrations of morronoside appears to weigh importantly 
in determining how terpene content, and total compound content, vary from one community to 
the next as patterns mirror one another in both years (fig. 4.4 and 4.6). This is evident in the 
2006 collection as it was the only compound varying significantly. An RDA (p = 1x10-5, R2adj 
= 0.462) of quantified compounds from 2010 samples support this idea further (fig. 4.7). 
Morronoside appeared in the analysis as the most important marker, strongly associated with 
the first canonical axis (λ = 81.861) which was highly significant (p = 1x10-5) and explained 
45.36 % of the variance in the phytochemical profile. Quercetin-3-O-galactoside was the only 
other important marker that could explain some of the variance in the phytochemical profile 
but associations to any of the canonical axes were weak. Consequently, the geographical 
trends shown for quercetin-3-O-galactoside did not appear to be great enough to affect the 
general quantified phenolic content as they remained statistically similar in each community 
(fig. 4.6).  
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Our results do not show temporally distinct geographical pattern in the phytochemistry 
of S. purpurea. Coupled with the inconsistent nature of certain compounds varying one year 
but not the other, there is no support for the presence of distinguished chemotypes. Although 
this is the first study of this type for this species, a study on the phytochemistry of isolated 
wild populations of North American ginseng, Panax quinquefolius (Araliaceae), also failed to 
show distinguishing chemotypes in its northern range (Assinewe et al., 2003), though there is 
evidence of a chemotype in the far south of its range. Bees and flies are known floral visitors 
and pollinators to S. purpurea (Ne’eman et al., 2006) and their contribution to gene flow may 
be enough in attenuating the distinction towards chemoraces. The reduction of migrating 
genotypes on a glacial front and time since colonization of the region by the species may as 
well play a role (Soltis et al., 1997). Alternatively, variations in the phytochemical profile of S. 
purpurea may be primarily dependant on other factors than genetics. 
Although we found some relationships between bioactive compounds with 
environmental and climatic factors, no distinct pattern was conspicuous. For example, step-
wise regression showed that morronoside, the most abundant and important marker in 
explaining the phytochemical variation in S. purpurea, correlated best with minimum 
December temperature in 2006 (p = 0.001, R2adj = 0.273), in contrast to mean diurnal ranges 
and April mean monthly sunshine hours together in 2010 (p = 0.001, R2adj = 0.6387). The lack 
of consistent trends with climatic factors does not enable us to make significant biological 
interpretations of content based on these factors. Furthermore, the considerable change in the 
geographical pattern of morronoside from one year to the other suggests that its concentration 
is simply not dependent on long-term climatic patterns. These patterns are in contrast to 
latitudinal and climatic parameters that correlate with phenolic content in Rhododendron 
groenlandicum (Ericaceae) as found in a separate chapter in this thesis. In comparing the 
preferred environment of the two species, the effect of the pitcher plant’s aquatic habitat may 
affect its response to climatic influences as opposed to the terrestrially inclined R. 
groenlandicum. 
Although the role of morronoside in the plant is not well studied, it is known that 
iridoid glycosides are important in defense reactions against insects and mammals (Martz et 
al., 2009b) but have also been shown to vary in response to abiotic factors. Concentrations 
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have been shown to increase in the flower buds of Lonicera japonica, of the Caprifoliaceae 
(Ning et al., 2012), and decrease in Menyanthes trifoliate, of the Menyanthaceae (Martz et al., 
2009b), in relation to UV radiation, a relationship which our results have failed to suggest in 
one form or another. Wang et al. (2010) showed, on the other hand, that drought stress 
increased iridoid glycoside content in the root of Scrophularia ningpoensis 
(Scrophulariaceae). It was observed during ongoing fieldwork that a considerable number of S. 
purpurea plants from study sites around Mistissini had died. Drought may explain the 
considerable increase in morronoside contents in the Mistissini samples; however, 2010 
environmental and climatic data are not yet available to confirm this suspicion. 
Alternatively, the emulsion (or acid) hydrolysis of morronoside is also known to derive 
sarracenin (Miles et al., 1976; Baldwin and Crimmins, 1982), a key compound of S. purpurea 
(Newman et al., 2000). The role of the volatile monoterpene sarracenin was initially thought 
as an intermediate in the biosynthesis of certain monoterpenes and indole alkaloids (Miles et 
al., 1976), though more recently, it has been suggested to play a role in carnivorous plants in 
attracting insect prey (Jaffé et al., 1995). As a product of sarracenin's biosynthetic pathway, 
morronoside may in fact be largely dependent on biotic factors for which underlying climatic 
trends do not act as proper markers of this variation. 
In a similar study of the phytochemistry of bioactive compounds in R. groenlandicum, 
we found quercetin-3-O-galactoside, the second most abundant compounds in S. purpurea, to 
be a major marker in explaining geographical trends in the species phenolic profile (Rapinski 
et al., in preparation(a)). Latitudinal trends were found to act as markers for translating the 
effect of environmental variables, notably, insolation parameters. However, the absence of 
such trends in the phenolic compounds from S. purpurea quantified here fail to support such a 
conclusion. This may be attributed to the presence of anthocyanins responsible for the red 
pigmentation of S. purpurea (Sheridan and Mills, 1998a; b; Sheridan and Griesbach, 2001). It 
is presumed that the presence of these compounds in carnivorous plants play a role in 
increasing insect capture rates, yet studies both support (Schaefer and Ruxton, 2008) and 
refute (Rodenas, 2012) this hypothesis. Needless to say, ample studies show that anthocyanins 
play an important protective role in reducing photoinhibition and photobleaching of 
chlorophyll under light-induced stress conditions (see Steyn et al. (2002), for a comprehensive 
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review of the subject). They were shown to increase in the carnivorous plant Pinguicula 
vulgaris (Lentibulariaceae) under high UV-B radiation, which was subsequently found to be 
less susceptible to photoinhibition (Mendez et al., 1999). This suggests that S. purpurea may 
not need to produce the phenolic compounds, quantified here, in response to light-induced 
stress, as it was shown in R. groenlandicum (Rapinski et al. in preparation(a)), since there 
already is an elevated presence of anthocyanins. 
Nonetheless, anthocyanin deficient individuals exist (Sheridan and Mills, 1998a) and a 
range in the intensity of leaf pigmentation can be clearly observed. Individuals with little or no 
pigmentation may be more reliant on the production of phenolics compounds, such as those 
identified here, to fill the photoprotective role that anthocyanins would normally play in 
Sarracenia purpurea. Although this has not been taken into account in our study, it may 
explain why concentrations in the species’ phenolic compounds do not follow a consistent 
pattern from one sampling year to the other. For the purpose of producing standardized NHPs 
from wildcrafted S. pupurea plants, the role and influence which anthocyanins play, if any, in 
the production of targeted phenolic compounds should be evaluated. 
Our study shows morronoside to be a major compound in the phytochemical profile of 
biologically active constituents in S. pupurea. It is a promising pharmacologically active 
compound, not only for its antidiabetic activity, but also for its anti-osteoporosis activity 
(Dinda et al., 2011). However, the content variability observed in wild populations may 
represent challenges for ensuring standardized NHPs. Nonetheless, concentrations reported 
here (table 4.2) are higher than those reported in other pharmacologically active plants, such 
as the antioxidant Cornelian cherry fruits, Cornus officinalis (Cornaceae), reported to contain 
between 9.94 – 17.07 mg/g DW of morronoside (West et al., 2012). 
 
4.5 Conclusion 
Our study underlines morronoside as a major component in the phytochemistry of 
bioactive compounds in S. purpurea. Although other major compounds were found to vary 
within samples of the second harvest year, morronoside remains the most important marker in 
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explaining geographical variations. No distinct chemotypes were apparent despite the patchy 
nature of S. purpurea's distribution and the content of pharmacologically active compounds in 
random collections appear to have a normal distribution around the median of their expected 
range. Nonetheless, the lack of predictive patterns, geographical, environmental or climatic, in 
the content of these compounds has important implications in ensuring a standard use for the 
treatment of T2D in Cree communities, particularly because wildcrafting is, so far, the only 
harvest method used by CEI Elders and Healers. Cultivation of S. pupurea under controlled 
growing conditions might produce more constant levels of bioactive compounds. 
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4.7 Tables and Figures 
Table 4.1 Identification of marker compounds from the leaves of Sarracenia purpurea by 
UPLC-MS. 
Peak # Compound Separation 
Method 
Retention 
time (min) 
Detected 
Mass 
Ionization 
Method 
1 (+)-Catechin A 1.61 291 (M+H+) ESI-(+) 
2 Morroniside A 1.77 429 (M+Na+) ESI-(+) 
3 (+)-Epicatechin A 2.10 291 (M+H+) ESI-(+) 
4 Taxifolin-3-glucoside A 2.47 465 (M-H+) ESI-(-) 
5 Quercetin 3-galactoside A 4.81 487 (M+H+) ESI-(+) 
6 Quercetin 3 -glucoside A 5.30 487 (M+H+) ESI-(+) 
7 Kaempferol-3-rutinoside A 7.28 593 (M-H+) ESI-(-) 
8 Betulinic acid B 3.24 455 (M-H+) ESI-(-) 
9 Ursolic acid B 3.48 455 (M-H+) ESI-(-) 
10 Rutin A 5.09 609 (M-H+) ESI-(-) 
 
 
 
 
Table 4.2 List of compounds identified and quantified from the leaves of Sarracenia 
purpurea, geographical concentration means ± SEM and references for studies corroborating 
its presence in S. purpurea. 
Peak # Compound Concentration (mg/g DW) Reference 
  2006 2010  
1 (+)-Catechin T 0.11 (0.08)  
2 Morronoside 21.22 (8.98) 22.83 (11.38) Jensen et al., 1975; Harris et al., 2012; Muhammad et al., 2012 
3 (-)-Epicatechin 0.54 (0.13) 0.94 (0.40) Harris et al., 2012 
4 Taxifolin-3-O-glucoside 3.20 (1.75) 5.80 (3.23) Muhammad et al., 2012 
5 Quercetin-3-O-galactoside 11.87 (3.40) 21.92 (6.15) Romeo et al., 1977; Harris et al., 2012; Muhammad et al., 2012 
6 Quercetin-3-O-glucoside 0.72 (0.25) 0.42 (0.24) 
 
 
7 Kaempferol-3-O-rutinoside 0.13 (0.04) T Romeo et al., 1977 
8 Betulinic acid 5.18 (1.19) 6.47 (1.35)  
9 Ursolic acid 2.53 (0.51) 4.13 (0.73)  
10 Rutin ND T Muhammad et al., 2012 
 Total 28.76 (3.09) 21.08 (3.77)  
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Table 4.3 ANOVA of concentration of phenolic compounds in Sarracenia purpurea by 
collection site near 5 Eeyou Istchee communities in 2006 and 2010. Significant results are 
determined at α = 0.05 and are shaded. 
Compound 
2006 2010 
p-value R2adj p-value R2adj 
(+)-Catechin NA NA 0.0033┼ 0.207┼ 
Morronoside 0.00314 0.259 2.86x10-10 0.583 
(-)-Epicatechin 0.744 -0.0472 7.30x10-6 0.382 
Taxifolin-3-O-glucoside 0.913 -0.0678 0.523 -0.0134 
Quercetin-3-O-galactoside 0.950 -0.0729 0.00288 0.211 
Quercetin-3-O-glucoside 0.856 -0.0607 0.8915 -0.0600 
Kaempferol-3-O-rutinoside NA NA NA  NA 
Betulinic acid 0.738 -0.0465 0.638 -0.0275 
Ursolic acid 0.101 0.0866 0.0438 0.111 
Total quantified phenolics 0.994 -0.0811 0.148 0.0568 
Total quantified terpenes 0.0100 0.206 0.001 0.587 
Total quantified compounds 0.0244 0.163 0.001 0.384 
┼Log transformation 
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Figure 4.1 Sample UPLC chromatogram separaration methods A and B using positive and 
negative ionization methods (table 1) of S. pupurea leave extracts. Numbers represent 
compounds as follow: (+)-catechin (1), morronoside (2), (-)-epicatechin (3) taxifolin-3-
glucoside (4), quercetin-3-galactoside (5), quercetin-3-glucoside (6), betulinic acid (8) and 
ursolic acid (9). 
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Figure 4.2 Concentration means ± SD (mg/g DW) for each quantified marker in S. purpurea leaves from 2006 (n = 40) and 2010 (n 
= 60) harvests. Mean contents, within each year, accompanied by the same letter (a-f) are not significantly different in Tukey's 
multiple-comparison tests. 
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Figure 4.3 Frequency (%) of accessions found within various ranges of phenolics 
concentrations (% calculated from the lowest to highest concentration) expressed as the sum 
of all quantified compounds, phenolics and terpenes for 2006 (n = 40) and B) 2010 (n = 60). 
In 2006, phenolic content ranged from 7.05 – 28.14 mg/g DW (mean = 16.33 mg/g DW), 
terpene content from 12.25 – 48.01 mg/g DW (mean = 28.94 mg/g DW) and the total from 
22.77 – 67.67 mg/g DW (mean = 45.26 mg/g DW). In 2010, phenolic content ranged from 
9.64 – 61.02 mg/g DW (mean = 29.08 mg/g DW), terpene content from 11.16 – 59.98 mg/g 
DW (mean = 33.43 mg/g DW) and the total from 30.21 – 98.18 mg/g DW (mean = 62.51 
mg/g DW). 
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Figure 4.4 Phytochemical variation of morronoside, the most abundant compound, in (A) 
2006 (4 locations) and (B) 2010 (6 locations). Mean concentration ± SD (n = 10) in S. 
purpurea leaf extracts collected from Northern Quebec and Eastern Ontario is shown. 
Different letters (a-d) indicate significant differences between communities in Tukey's 
multiple-comparison tests. 
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Figure 4.5 Phytochemical variation of (A) (-)-epicatechin, (B) quercetin-3-O- galactoside and 
(C) ursolic acid for the 2010 sampling year. Mean concentration ± SD (n = 10) in S. purpurea 
leaf extracts collected from Northern Quebec and Eastern Ontario is shown. Different letters 
(a-d) indicate significant differences between communities in Tukey's multiple-comparison 
tests. 
 98 
Figure 4.6 Phytochemical variation of the sum of all quantified phenolics ((-)-epicatechin, 
taxifolin-3-O-glucoside, quercetin-3-O-galactoside and quercetin-3-O-glucoside), terpenes 
(morronoside, betulinic acid and ursolic acid) and total compounds (phenolics and terpenes) in 
(A) 2006 and (B) 2010. Mean concentration ± SD (n = 10) in S. purpurea leaf extracts 
collected from Northern Quebec and Eastern Ontario is shown. Different letters (a-d) indicate 
significant differences between communities in Tukey's multiple-comparison tests. 
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Figure 4.7 RDA ordination biplots, in type 2 scaling, of concentration variations in the profile 
of bioactive constituents in S. purpurea leaves as a function of community of origin for the 
2010 harvest. Results from the 2006 harvest are not presented here because morronoside was 
the only varying compound. Symbols represent sampling sites from the communities of 
Ottawa (○), Mistissini (▲), Nemaska (●), Waskaganish (▼), Eastmain (■) and Wemindji (®). 
Centroids for these sites are drawn out by ellipses. Markers included in the analysis were those 
which could be quantified for both sampling years and are represented by the following 
numbers: morronoside (2), (-)-epicatechin (3) taxifolin-3-glucoside (4), quercetin-3-
galactoside (5), quercetin-3-glucoside (6), betulinic acid (8) and ursolic acid (9). Arrows for 
all but morronoside (2) and quercetin-3-galactoside (5) appear absent as scores remained close 
to the origin. 
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Adipogenic activity of wild populations of 
Rhododendron groenlandicum, a medicinal shrub of the 
James Bay Cree traditional pharmacopeia. 
 
Michel Rapinski1,2, Lina Musallam1,3, John Thor Arnason1,4, Pierre Haddad1,3* and Alain 
Cuerrier1,2* 
1 CIHR Team in Aboriginal Antidiabetic Medicines, Université de Montréal, Montreal, 
Canada 
2 Institut de recherche en biologie végétale, Jardin botanique de Montréal, Université de 
Montréal, 4101 Sherbrooke Est, Montréal, QC H1X 2B2, Canada. 
3 Natural Health Products and Metabolic Diseases Laboratory, Département de pharmacologie, 
Université de Montréal, Montréal, QC, H3C 3J7, Canada. 
4 Centre for Research in Biotechnology and Biopharmaceuticals, Department of Biology, 
University of Ottawa, Ottawa, ON, K1N 6N5, Canada. 
* Co-corresponding authors 
5.1 Abstract 
The traditional medicinal plant, Labrador tea (Rhododendron groenlandicum; 
Ericaceae), present in the pharmacopoeia of the Cree of Eeyou Istchee, has shown glitazone-
like activity in the 3T3-L1 adipogenesis bioassay. This activity has been attributed to phenolic 
compounds, which have been shown to vary in this plant as a function of insolation 
parameters. The goal of this study was to determine if these changes in phenolic content were 
pharmacologically significant. Leaves were harvested in 2006 throughout the James Bay 
region of Northern Quebec and ethanol extracts were tested in vitro using the 3T3-L1 murine 
cell line adipogenesis bioassay. This traditional medicinal plant was found active in the assay. 
However, there was no detectable spatial pattern in the accumulation of intracellular 
triglycerides, suggesting that such patterns previously observed in the phenolic profile of 
Labrador tea were not pharmacologically significant. Nonetheless, a reduction in the 
adipogenic activity was observed and associated with higher concentrations of quercetin for 
which selected environmental variables did not appropriately explain its variation. 
 
Key words: Phenolic compounds, traditional medicine, type 2 diabetes, adipogenesis, Cree 
Nation of Eeyou Istchee. 
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5.2 Introduction 
In a previous study on the phytochemistry of the North American medicinal plant, 
Rhododendron groenlandicum (Oeder) Kron & Judd (Ericaceae), Labrador tea, we found the 
concentration of biologically active compounds to vary on a latitudinal scale in Northern 
Quebec's Hudson and James Bay region (Rapinski et al., in preparation(a)). Labrador tea is a 
common species in Canada's boreal forest. More importantly, it is a popular medicinal plant 
found in the traditional pharmacopoeia of indigenous populations from the Algonquian, 
Salish, Waskashane, Tsimshianic and Eskimo-Aleut linguistic families (Arnason et al., 1981; 
Zieba, 1990; Siegfried, 1994; Marles et al., 2008; Cuerrier and Elders of Kangiqsualujjuaq, 
2011; Cuerrier and Elders of Kangiqsujuaq, 2011; Cuerrier et al., 2011; Cuerrier and 
Hermanutz, 2012). 
In ethnobotanical studies conducted in six communities of the Cree Nation of Eeyou 
Istchee (CEI), we found R. groenlandicum to be the top-ranked plant species used for the 
treatment of symptoms associated with type 2 diabetes (T2D) (Fraser, 2006; Leduc et al., 
2006; Downing, 2010; Rapinski et al., in preparation(b)). The inherent cultural relevance of 
this species to CEI traditional medicine (CTM) warrants further investigation into its 
antidiabetic potential. 
The CIHR Team on Antidiabetic Aboriginal Medicines (CIHR-TAAM), formed 
through collaborative work between CEI communities, the Cree Board of Health and Social 
Services of James Bay (CBHSSJB) and Canadian academic researchers, has screened many of 
the multiple plants present in the CEI pharmacopoeia (Spoor et al., 2006; Fraser et al., 2007; 
Harbilas et al., 2009; Harris et al., 2011). Of these, R. groenlandicum was shown to possess in 
vitro glitazone-like activity comparable to rosiglitazone in an adipogenic assay measuring the 
lipid accumulation of differentiating 3T3-L1 preadipocytes (Spoor et al., 2006). 
The antidiabetic drug rosiglitazone induces an increase in the sensitivity to insulin, 
acting as a PPARγ receptor agonist (Fang et al., 2008); the expression of this transcription 
factor being particularly implicated in the differentiation of adipocytes (Grimaldi, 2001; 
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MacDougald and Mandrup, 2002; Hansen and Kristiansen, 2006; Rosen and MacDougald, 
2006) and in insulin sensitivity (Fang et al., 2008). Hence, it plays a critical role in the 
pathogenesis of T2D. The action of PPARγ is an improvement in the absorption of fatty acids 
in differentiated adipocytes which store them as triglycerides (TG) (Fang et al., 2008). Hence, 
adipocytes provide storage for fatty substances that would otherwise accumulate in tissues 
such as skeletal muscle and liver, thereby contributing to metabolic disorders such as insulin 
resistance (Rosen and MacDougald, 2006). 
The pharmacological activity of R. groenlandicum has been attributed to phenolic 
compounds (Spoor et al., 2006; Harbilas et al., 2009; Saleem et al., 2010). Bioassay-guided 
fractionation using adipogenesis of 3T3-L1 murine cells confirmed that specific phenolics are 
the most active compounds (Ouchfoun, 2011). In developing culturally appropriate approaches 
to treating T2D in the CEI communities, the variation of these compounds in R. 
groenlandicum has important implications in ensuring the quality control of traditional 
medicinal plants or to develop standardized natural health products (NHPs). 
In this study, we assessed potential variations in the antidiabetic potential of R. 
groenlandicum. Our objective was to determine if the phytochemical variations observed in 
the species' phenolic profile (Rapinski et al., in preparation(a)) are biologically significant. We 
evaluated the in vitro pharmacological activity of crude extracts from various localities using 
the adipogenesis bioassay and hypothesized that high concentrations of phenolic compounds 
would result in a stronger adipogenic activity. 
 
5.3 Materials and Methods 
5.3.1 Sampling 
Mature leaves of R. groenlandicum were sampled during the summer of 2006 around 
the communities of Mistissini, Nemaska, Eastmain, Wemindji and Whapmagoostui, thus 
covering much of the north-south gradient in Eeyou Istchee.  Five accessions, each containing 
leaves from multiple individual plants, were collected within a 50 km radius around each 
community. Samples were air dried and preserved in paper bags at room temperature. 
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5.3.2 Extraction 
The extraction method was previously described in Rapinski et al. (in preparation(a)). 
Plant material was thoroughly dried at 35°C overnight in a commercial food dehydrator 
(Nesco® Professional Food and Jerky Dehydrator). Samples were milled through a Wiley Mill 
with at 40 mesh and extracted overnight in at 25 mL/g of 80 % EtOH by orbital shaking at 
room temperature at 250 RPM. The pellet was extracted overnight in 15 mL 80 % EtOH. The 
pooled supernatants (adjusted to 50.0 mL in a volumetric flask) were centrifuged for 15 min at 
1828 x g at room temperature. An aliquot (1 mL) of the centrifuged extract was prepared for 
High Performance Liquid Chromatography coupled with Diode Array Detector (HPLC-DAD) 
by filtering through a 20 µm PTFE filter. Extracts were kept at -20°C and sonicated before 
analysis. Unfiltered crude extracts were dried using a speedVac. Trace water was removed by 
lyophilization using SuperModulo freeze dryer and stored at -80°C. 
5.3.3 Cell lines, chemicals, biochemicals and standards 
For the identification and quantification of phenolic markers, (+)-Catechin (1), 
chlorogenic acid (2), (-)-epicatechin (3), p-coumaric acid (4), rutin (5), quercetin-3-galactoside 
(6), quercetin-3-glucoside (7), quercetin-3-rhamnoside (12), myricetin (13) and quercetin (14) 
were purchased from Sigma-Aldrich (Oakville, Ontario, Canada) and Extrasynthese (Genay, 
France). HPLC grade water, acetonitrile, and formic acid (99% purity) were purchased from 
Sigma-Aldrich. 
For cell culture and adipogenesis, pre-adipocyte 3T3-L1 cell line was purchased from 
the American Type Culture Collection (ATCC; Manassas, VA). Dexamethasone (DMX), 
bovine pancreatic insulin, 3-isobutyl-1-methylxanthine (IBMX), Dimethyl sulfoxide (DMSO) 
were purchased from Sigma-Aldrich (Oakville, ON). Rosiglitazone from was obtained Alexis 
Biochemicals (Hornby, ON). 
Dubelcco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS) and bovine 
calf serum (NCS) were from Wisent Inc (St-Bruno, QC). AdipoRed reagent was purchased 
from Combrex Bio Science Walkersville Inc (Walkersville, MD). 
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5.3.4 Identification and Quantification 
The method for identifying and quantifying the phenolic compounds in the samples 
presented here have been previously described in Rapinski et al. (in preparation(a)). Briefly, a 
10 µL of each extract was injected through an autosampler and detected by DAD at 290 nm, 
band width 4, reference off. The separations were performed on a Luna C18 column (250 x 
4.6 mm, 5 µM particle size). Peak identification was undertaken by co-chromatographic 
comparison of the spectral data adopted in our in-house metabolomics spectral library (Saleem 
et al., 2010). A standard curve was constructed by injection of serially diluted marker 
compounds in methanol. The quantification was based on peak height and area. The 
quantitation of putatively identified quercetin-glycosides was achieved based on calibration 
curve of quercetin-3-galactoside. Each sample was analyzed in triplicate and averaged to 
account for instrumental variation. 
5.3.5 Cell culture 
3T3-L1 murine pre-adipocyte cells were grown to confluence in 24-well plates in 
DMEM proliferation medium containing 10% FBS. Media was changed every 2 days. At 24 h 
post-confluence (day 0), cells were induced to differentiate with a short-term differentiation 
medium of DMEM supplemented with 10 % FBS, 1 µM DMX, 250 µM IBMX and 500 nM 
insulin. After 48 h, the media was replaced with DMEM containing 10 % FBS and 500 nM 
insulin for long-term differentiation. Cells were differentiated for a total of 5 days with media 
change every 2 days. Rhododendron groenlandicum extracts (75 µg/mL) and rosiglitazone (10 
µM; positive control) were dissolved in DMSO and added to the cells as of day 0 of 
differentiation. The final concentration of DMSO was kept at 0.1 % throughout the 
differentiation period. 
5.3.6 Adipogenesis 
We measured intracellular TG content at day 5 of differentiation using the AdipoRed 
reagent according to the manufacturer’s instructions. Methods have been previously described 
in Spoor et al. (2006) and Harbilas et al. (2009). In short, wells were washed twice with 
phosphate-buffered saline (PBS) before 1 mL of PBS containing 30 µl of AdipoRed reagent 
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was added to each well and incubated for 15 minutes at room temperature. AdipoRed becomes 
fluorescent when partitioned in a hydrophobic compartment. The fluorescence of each well 
was measured with a Wallac Victor2 fluorimeter (Perkin-Elmer, St-Laurent, QC) at an 
excitation wavelength of 485 nm and an emission wavelength of 572 nm. The results were 
reported as percentage of the vehicle control, 0.1 %DMSO. 
5.3.7 Environmental data 
Estimates for insolation variables were provided by the Canadian Forest Services of 
Natural Resources Canada. Values were generated by spatially continuous climatic models 
adjusted by ANUSPLIN, a non-parametric multivariate technique for the noise-reduction of 
multiple variable data. Interpolation of surfaces is calculated by smoothing algorithms and 
taking into consideration the effect of altitude. These surfaces are generated from a 30 years 
data span collected by meteorological stations across the country. Using each sample's 
geographical coordinates at a resolution of 4 decimal-degrees, estimates were obtained for 
each collection site. Monthly estimates for solar radiation (Mjoules) were obtained from data 
of the 1961-1990 period. Details of the protocols generating these estimates are described by 
McKenney et al. (2007a,b). 
5.3.8 Statistical analysis 
To reduce interassay variation, TG content was normalized relative to each assay’s 
vehicle control, 0.1% DMSO, set at 100%. Rhododendron groenlandicum and rosiglitazone 
always induced significant increases in activity as verified by the fact that the 95% confidence 
interval of the mean activity (quadruplicate determinations) did not include the 100%  
adipogenic activity reference (p<0.05). Differences between communities were analyzed by 
one-way analysis of variance. The relationships between TG content and compounds were 
analyzed by multiple and simple linear regressions. To represent the adipogenic activity of R. 
groenlandicum and the quantified compounds, principal components analysis (PCA) was 
performed on the matrix of these compounds using the correlation matrix. Individual samples 
were scored onto the PCA axes and represented with the vectors for each compounds. TG 
content was subsequently projected onto the principal components in order to interpret the 
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dimensions of variability. Finally, we partitioned the variation in the adipogenic activity of R. 
groenlandicum between the two sets of variables: compounds and insolation factors. This was 
done using a partial-redundancy analysis (partial-RDA) approach (Borcard and Legendre, 
1992; Meot et al., 1998). All analyses were performed using R statistical language (R 
Development Core Team, 2012). Results are reported as means ± SD and statistical 
significance set at α = 0.05. 
 
5.4 Results and Discussion 
The phytochemistry of the same R. groenlandicum accessions has already been 
described and discussed in greater length in Rapinski et al. (in preparation(a)). Here, we 
present the results of a sub-sample of 2006 accessions in the adipogenesis bioassay. 
The glitazone-like activity of R. groenlandicum to increase the accumulation of 
intracellular TG in 3T3-L1 adipocytes was measured at day 5 of differentiation. Extracts 
increased adipogenesis, with an average content of TG of 159.0 % that of DMSO (fig. 5.1) 
with a 95% confidence interval of 138.8 – 179.1% of DMSO. The adipogenic activity of R. 
groenlandicum was half of the positive control, rosiglitazone. This is lower than what has 
previously been reported for this species. Spoor et al. (2006) reported the stimulation of 
adipogenesis to be comparable to rosiglitazone, while later determinations measured an 
activity representing two-thirds that of the antidiabetic drug (Ouchfoun, 2011). With the 
exception of a few samples, which inhibited adipogenesis (fig. 5.2), our results nonetheless 
confirm the antidiabetic potential of this species. It is important to consider the fact that 
previous determinations of activity were carried out using extracts prepared from large 
quantities of source material (large number of individual plants) collected a few years prior to 
the material used in the present studies. Hence, inter-individual variations were absent and 
different climatic conditions may have prevailed. This can explain, at least in part, the 
differences in adipogenic potential observed between the studies. 
There were no statistically distinct spatial patterns detected in the pharmacological 
activity of R. groenlandicum. None of the communities sampled possessed accessions which 
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significantly increased intracellular TG more than the others (p = 0.348, fig. 5.3). We have 
previously found that biologically active phenolics were greater in collections made around 
the communities of Nemaska, Eastmain and Wemindji and that this variation followed a 
quadratic latitudinal trend (Rapinski et al., in preparation(a)). The adipogenic activity of R. 
groenlandicum followed a similar trend, as can be observed in figure 5.3, albeit statistical 
significance of a polynomial relationship was not achieved (p = 0.170), possibly due to high 
variability. This suggests that variations in the phytochemical profiles, observed in Rapinski et 
al. (in preparation(a)), may be pharmacologically relevant, but further studies will be 
necessary to confirm this point. 
Indeed, we found that quantified compounds explained considerable variability 
obtained in this species' pharmacological activity (p = 0.0279, R2adj = 0.491). The 
phytochemical profile and distribution of R. groenlandicum could be reconstructed into three 
principal components explaining 69.92% of the variation, whereby some major markers were 
shown to be highly correlated (fig. 5.4). When projecting intracellular TG onto this plot, it did 
not appear well correlated with the bulk of these markers. The only marker for which a 
significant relationship with TG appears to exist is quercetin (fig. 5.4b and 5.4c). Figure 5.5 
further illustrates the linear correlation (p = 0.0458, R2 = 0.162) whereby the adipogenic 
activity of R. groenlandicum decreases as the concentration of quercetin in the sample 
increases. This is consistent with observations from our own group (Ouchfoun, 2011) where 
pure quercetin was found to inhibit adipogenesis in a dose-dependent manner. The activity of 
quercetin is well studied and has also been consistently shown by others to be a potent 
inhibitor of adipocyte differentiation and adipogenesis (Iwashita et al., 2001; Hsu and Yen, 
2007; Fang et al., 2008; Yang et al., 2008). 
Our results suggest that while the geographical location does not appear to have a 
statistically significant impact on the adipogenic activity of crude extracts of localized R. 
groenlandicum samples, variations in active compounds do explain a significant proportion of 
variability in pharmacological activity. We have shown that insolation parameters, such as 
solar radiation, could significantly explain some of the variation in the species' phenolic 
compounds (Rapinski et al., in preparation(a)). When the variation in TG content was 
partitioned, a significant proportion of the variation was explained by these environmental 
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variables and this converged with the variation explained by the phenolic compounds (table 
5.1, fig 5.6). Indeed, while the relationship with compounds was statistically significant, the 
unique contribution of phenolics were no longer evident when the effect of environmental 
variables were taken into account. 
This confirms the caveat that environmental variables play an underlying role in 
affecting the content of biologically active compounds. Conversely, quercetin, the only 
significant compound related to changes in the adipogenic activity of R. groenlandicum, was 
not found to be strongly associated with environmental variables (Rapinski et al., in 
preparation(a)). This may have contributed to reduce the relationship of variability between 
adipogenic activity and phenolic content when environmental factors were taken into account. 
On the other hand, our results provide support for the hypothesis that synergistic 
interactions may occur between compounds. For instance, the inhibitory action of Hibiscus 
sabdariffa (Malvaceae) was greater than the sum of its parts when polyphenols had been 
fractionated, isolated and tested individually (Herranz-López et al., 2012). More importantly, 
in bioassay-guided fractionation experiments, the activity of crude Labrador tea extracts was 
higher than that of each active compound tested individually (Ouchfoun, 2011). Finally, 
quercetin and resveratrol, together, decreased lipid accumulation considerably more than each 
of these used separately at the same dose (Yang et al., 2008). 
Many of the compounds quantified in this paper have shown adipogenic activity in 
some form or another. Quercetin-3-glucoside has been found toxic to adipocytes at relatively 
low concentration (50 µM) but was not found to affect adipogenic activity (Hsu and Yen, 
2007). Quercetin-3-rhamnoside has been found inactive at low concentrations, but was found 
to inhibit at high concentrations and chlorogenic acid has been found to inhibit intracellular 
triglycerides accumulation (Hsu and Yen, 2007). Content variations of some of these, 
particularly (+)-catechin and (-)-epicatechin, have been explained by environmental variables 
(Rapinski et al., in preparation(a)). Although the individual effect of these compounds were 
not detected in our study, it does not undermine the role they may play when found in a 
cocktail of substances. 
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5.5 Conclusion 
We have previously shown that latitude acted as a marker for the impact of 
environmental variables on phytochemical concentrations (Rapinski et al., in preparation(a)). 
Therefore, a trend could possibly exist between abiotic factors and concentration of targeted 
secondary metabolites, but a larger sample size might be needed to detect it. There may also 
be other environmental, climatic and even biotic factors that were not taken into account, 
which explain the changes in quercetin content. These may better explain the ecophysiological 
processes affecting the antidiabetic potential of R. groenlandicum. Increase in the adipogenic 
potential of this traditional medicine was associated primarily with lower concentrations of 
quercetin, but the cause for its variation will require further investigation. Nonetheless, our 
results do not provide enough evidence to justify the idea that specific accessions of Labrador 
tea may have reproducibly better adipogenic potential than others along a latitudinal gradient. 
Conversely, our study implies that random harvesting of R. groenlandicum in the Eeyouch 
territory of Northern Quebec should not have a major impact on the quality of traditional 
preparations or NHPs made from this plant.  
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5.7 Tables and Figures 
 
Table 5.1 Variation partitioning of the adipogenic activity of R. 
groenlandicum leaf extracts explained by the content in 
biologicaly active compounds and the effect of insolation 
parameters. The variation of each fractions are represented in 
figure 5.6. Asterix (*) indicate significant fractions at α = 0.05. 
Fractions R2adj p 
[a+b] = Compounds  0.491 0.0272 * 
[b+c] = Insolation 0.145 0.0700 
[a+b+c] = Compounds + Insolation 0.476 0.0555 
[a] = Compounds|Insolation 0.331 0.0948 
[b] 0.160 Not testable 
[c] = Insolation|Compounds -0.0156 0.473 
[d] = Unexplained 0.524 Not testable 
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Figure 5.1 Effect of R. groenlandicum crude leaf extracts from Northern Quebec on lipid 
accumulation. Intracellular triglyceride content was measured by AdipoRed fluorescence, in 
live 3T3-L1 murine adipocytes incubated with plant extracts for 5 days post-differentiation. 
Means ± SD (n = 4 for rosiglitazone, n=100 for R. groenlandicum) are normalized to the 
vehicle control (0.1% DMSO). Asterix (*) indicate significant differences with respect to the 
DMSO control at α = 0.05. 
 
Figure 5.2 Frequency distribution of the adipogenic activity from 25 samples of R. 
groenlandicum leaves collected throughout Northern Quebec. Intracellular triglyceride content 
was measured by AdipoRed fluorescence, in live 3T3-L1 murine adipocytes incubated with 
plant extracts for 5 days post-differentiation. Triglyceride content was normalized to the 
vehicle control (0.1% DMSO). Samples with content levels below 100% (in white) were 
considered inhibitory and decreased lipid accumulation. 
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Figure 5.3 Effect of R. groenlandicum crude leaf extracts prepared from accessions collected 
around five communities in Northern Quebec on lipid accumulation. Intracellular triglyceride 
content was measured by AdipoRed fluorescence, in live 3T3-L1 murine adipocytes incubated 
with plant extracts for 5 days post-differentiation. Means ± SD (n = 5) are normalized to the 
vehicle control (0.1% DMSO). There were no significant differences between communities (p 
= 0.348). 
Figure 5.4 Principal component analysis biplot of 11 phenolic compounds in R. 
groenlandicum leaves. Solid lines represent relative loadings of these variables on axes 1, 2 
and 3. TG content (bold arrow) was selected as a supplementary variable and plotted onto 
principal components generated from the phytochemical markers. Scores for individual 
samples are represented by symbols for the communities of Mistissini (▲), Nemaska (●), 
Eastmain (■), Wemindji (®) and Whapmagoostui (▼). 
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Figure 5.5 Intracellular triglycerides content of 3T3-L1 murine adipocytes exposed to 75 
µg/ml of R. groenlandicum leaf extracts collected from various locations. Quercetin 
concentrations in crude extract were significantly and negatively associated with the species' 
adipogenic activity (p = 0.0458). Triglyceride contents are normalized to the vehicle control 
(0.1% DMSO). 
 
Figure 5.6 Percentages of variation in the adipogenic activity of R. groenlandicum leaf 
extracts explained by the content in biologicaly active compounds and the effect of insolation 
parameters. a = compounds, b = compounds + insolation, d = undetermined. Fraction c = 
insolation is not shown as the percentage of variation explained was not significant (see table 
5.1). Asterix (*) indicate significant fractions at α = 0.05. 
  
115 
Chapitre 6 - Conclusion 
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De façon générale, nous pouvons dire que nous avons rencontré les objectifs que nous 
nous étions fixés, soit 1) identifier les plantes à potentiel antidiabétique provenant de la 
pharmacopée traditionnelle de Wemindji et d’Oujé-Bougoumou et de les comparer à la 
pharmacopée des autres communautés CEI, 2) déterminer si des variations spatiales 
(latitudinales) peuvent être observées parmi les composantes biologiquement actives de deux 
plantes médicinales CEI, et 3) déterminer si ces variations phytochimiques sont 
pharmacologiquement significatives. 
L’intégration des communautés de Wemindji et Oujé-Bougoumou à l’équipe CIHR-
TAAM a été réalisée avec succès suite aux interviews menés auprès de leurs Aînés et 
Guérisseurs. À l’aide d’entretiens semi-dirigés basés sur les symptômes et complications 
associés au T2D, 16 et 25 plantes ont été respectivement mentionnées dans les communautés 
de Wemindji et d’Oujé-Bougoumou. Ces études, conforment à celles menées dans les 
communautés de Mistissini, Nemaska, Waskaganish et Whapmagoostui dans le cadre du 
projet de l’équipe CIHR-TAAM, sont les premières investigations de ce genre pour ces 
communautés. En plus d’ajouter sept nouvelles espèces et un champignon à la liste des 
espèces à potentiel antidiabétique, plusieurs des plantes médicinales traditionnelles 
importantes à Wemindji et Oujé-Bougoumou sont couramment utilisées à travers le territoire 
Eeyouch. Les espèces qui ressortent selon leurs valeurs de SIV globales représentent des 
plantes médicinales culturellement importantes aux CEI. Cela en fait des plantes candidates 
appropriées pour le développement d’approches thérapeutiques culturellement adaptées. Le 
thé du Labrador, Rhododendron groenlandicum, se classe en première position suite à la 
classification par SIV pour le traitement du T2D. Cela témoigne de son importance culturelle 
et vient justifier la nécessité d’évaluer sa diversité phytochimique aux fins éventuelles de 
production de produits de santé naturels normalisés et de contrôle de qualité des préparations 
traditionnelles. 
Effectivement, la teneur en composantes biologiquement actives trouvée dans les 
feuilles du R. groenlandicum varie spatialement en fonction de la latitude. Étant donné la 
nature antioxydante des composés phénoliques ainsi identifiés, l’hypothèse que ces derniers 
varient positivement en fonction de paramètres d’insolation, telles la radiation solaire ou la 
photopériode a été vérifiée en utilisant des techniques analytiques et statistiques avancées et 
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innovatrices. Ces résultats, reproduits sur deux années de collecte et montrés pour la première 
fois sur un tel gradient, sont significatifs en ce qu’ils viennent appuyer davantage le rôle 
physiologique que jouent les composés phénoliques dans la protection contre la 
photoinhibition et le photodommage chez les plantes. 
Les études sur R. groenlandicum font aussi le lien entre les facteurs environnementaux, 
qui influencent la production de composantes biologiquement actives dans les plantes, et leur 
effet pharmacologique. Toutefois, l’analyse phytochimique de la sarracénie pourpre, 
Sarracenia purpurea, une autre plante importante de la pharmacopée CEI, montre que ses 
composantes ne sont pas affectées par les mêmes facteurs. Cela témoigne des relations 
complexes qui existent entre les espèces végétales et leur environnement. Quoique des études 
approfondies nous permettent de faire des prédictions touchant le développement de produits 
de santé naturels, elles ne peuvent être généralisées à tous les cas. 
Afin de voir si la variation phytochimique du R. groenlandicum est biologiquement 
significative, les échantillons du R. groenlandicum ont été évalués par bioessai in vitro; en 
l’occurrence, l’adipogenèse. Quoique le thé du Labrador stimule généralement l’entreposage 
intracellulaire des triglycérides, son profil d’activité adipogénique ne reflète pas en général les 
tendances observées dans les variations de son profil phénolique. Cependant, des échantillons 
en haute teneur de quercétine ont malgré tout une activité biologique réduite suggérant que des 
facteurs, abiotiques ou biotiques, menant à ces variations peuvent tout de même avoir un 
impact significatif sur l’action pharmacologique de la plante. Cela n’appuie pas l’hypothèse 
voulant que l’activité pharmacologique de R. groenlandicum soit plus élevée suite à un 
contenu plus élevé en composés phénoliques. De toute évidence, l’on doit aussi considérer le 
rôle complexe des relations synergistiques et antagonistiques qui peuvent exister entre les 
diverses composantes d’un extrait brut. Il faudra attendre des études plus fines visant des 
molécules précises afin de mieux cerner le rôle de certains phénols en lien avec 
l’environnement tant abiotique que biotique. Ces études devront être couplées à des analyses 
pharmacologiques. 
Les études présentées dans ce mémoire représentent les premières investigations 
approfondies et si étendues sur la phytochimie et la pharmacologie de plantes médicinales 
canadiennes. À l’exception des populations de R. groenlandicum provenant de 
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Whapmagoostui, où il semble y avoir une différentiation du profil phytochimique, l’absence 
de chémotypes indique que la phytochimie du R. groenlandicum et S. purpurea est assez 
constante. En conséquence, ces espèces peuvent être utilisées comme produit de santé naturel 
sans crainte sur tout le territoire Eeyouch. Malgré tout, les variations observées peuvent 
justifier le recours éventuel à la normalisation, surtout si l’usage thérapeutique de la plante 
chez les diabétiques cris prend beaucoup d’ampleur. 
Les résultats de l’analyse phytochimique du R. groenlandicum appuient l’hypothèse 
que son contenu phénolique sera plus élevé dans les populations exposées à de plus hauts 
niveaux de stress associés à l’ensoleillement, comme la radiation solaire ou la photopériode. 
Les résultats du S. purpurea, quant à eux, ne viennent pas la supporter. Cela pourrait 
s’expliquer par les effets de l’environnement aquatique de cette plante. Par ailleurs, la 
production de ses composantes pourrait être induite par des facteurs qui n’ont pas été mesurés 
dans cette étude. Il semble, par exemple, que le niveau d’eau dans les tourbières soit crucial 
pour cette espèce (Tendland, 2011). 
Table 6.1 Description des modèles animaux in vivo et des bioessais in vitro utilisés 
pour évaluer le potentiel antidiabétique des plantes médicinales de la pharmacopée 
CEI. L’ordre de présentation des modèles réflète le plan de priorisation des espèces en 
fonction de leur activité antidiabétique selon Haddad et al. (2012). 
ID Modèle Description 
1 in vivo Souris DIO C57BL/6 (activité hypoglycémiante et anti-obésité) 
2 in vivo Rats STZ (activité hypoglycémiante; diabète type 1) 
3 in vivo Souris KK-Ay (activité hypoglycémiante; diabète type 2)	  
4 in vivo Rats pré-diabétiques résistants à l’insuline (sensibilisation à l’insuline)	  
5 in vivo Rats normaux	  
6 in vitro Sécrétion d’insuline dans les cellules β pancréatiques β TC-tet	  
7 in vitro Prolifération des cellules β pancréatiques β TC-tet	  
8 in vitro Absorption du glucose par les myotubes C2C12	  
9 in vitro Absorption du glucose par les adipocytes 3T3-L1	  
10 in vitro Production du glucose dans les cellules hépatiques H4IIE	  
11 in vitro Adipogenèse des adipocytes 3T3-L1 
12 in vitro Absorption intestinale du glucose dans les cellules Caco-2 
13 in vitro Produits terminaux de glycation avancée 
14 in vitro Toxicité glycémique des pré-neurones sympathiques PC12-AC 
15 in vitro Carence glycémique des pré-neurones sympathiques PC12-AC	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Table 6.2 Activité antidiabétique des plantes médicinales de la pharmacopée CEI évaluée par expériences in vitro et in vivo 
décrites dans le tableau 6.1. Voir les références pour plus de détails sur la méthodologie et les résultats. 
Rang Espèce Activité ID Références 
1 R. groenlandicum Hypoglycémiante  1, 8, 9 Ouchfoun, 2011; Spoor et al., 2006 
 Adipogénique 11 Ouchfoun, 2011; Spoor et al., 2006 
 Antiglycation 13 Harris et al., 2011 
 Anti-obésité 1 Ouchfoun, 2011 
     
2 L. laricina Hypoglycémiante 1, 8 Harbilas, et al., 2012a; Spoor et 2al., 2006 
 Insulino-sensibilisatrice 1 Harbilas et al., 2012a 
 Anti-obésité 1 Harbilas et al., 2012a 
 Adipogénique 11 Shang et al., 2012; Spoor et al., 2006 
     
3 R. tomentosum Hypoglycémiante 5, 9, 12 Harbilas et al., 2009; Nistor Baldea et al., 2010 
 Adipogénique 11 Harbilas et al., 2009 
 Cytoprotective 14, 15 Harbilas et al., 2009 
 Antiglycation 13 Harris et al., 2011 
     
4 P. mariana Hypoglycémiante 5, 9, 12 Nistor Baldea et al., 2010; Spoor et al., 2006 
 Adipogénique 11 Spoor et al., 2006 
 Cytoprotective 14 Downing, 2010; Spoor et al., 2006 
 Antiglycation 13 Harris et al., 2011 
     
5 P. glauca Hypoglycémiante 12 Nistor Baldea et al., 2010 
 Cytoprotective 14, 15 Harbilas et al., 2009; Harris et al., 2008 
 Antiglycation 13 Harris et al., 2011 
     
6 K. angustifolia Adipogénique 11 Harbilas et al., 2009 
 Antiglycation 13 Harris et al., 2011 
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7 S. decora Hypoglycémiante 2, 3, 4, 8, 
12 
Guerrero-Analco et al., 2010; Nistor Baldea et al., 
2010; Spoor et al., 2006; Vianna et al., 2011 
 Insulino-sensibilisatrice 4 Vianna et al., 2011 
 Cytoprotective 14 Spoor et al., 2006 
     
8 A. balsamea Hypoglycémiante  8, 9 Spoor et al., 2006 
 Anti-glycation 13 Harris et al., 2011 
     
9 A. incana subsp. rugosa Anti-obésité 11 Martineau, Hervé, et al., 2010; Martineau, 
Muhammad, et al., 2010 
 Hypoglycémiante 8, 9, 12 Nistor Baldea et al., 2010; Spoor et al., 2006 
 Cytoprotective 15 Spoor et al., 2006 
     
10 J. communis Hypoglycémiante 12 Nistor Baldea et al., 2010 
 Anti-glycation 13 Harris et al., 2011 
     
11 P. banksiana Hypoglycémiante 9, 12 Nistor Baldea et al., 2010; Spoor et al., 2006 
 Adipogénique 11 Spoor et al., 2006 
 Cytoprotective 15 Spoor et al., 2006 
 Anti-glycation 13 Harris et al., 2011 
     
12 S. planifolia Hypoglycémiante 9, 12 Harbilas et al., 2009; Nistor Baldea et al., 2010 
 Cytoprotective 15 Harbilas et al., 2009 
 Anti-glycation 13 Harris et al., 2011 
     
14 V. vitis-idaea Hypoglycémiante 8, 9, 12 Eid et al., 2010; Harbilas et al., 2009; Nistor Baldea 
et al., 2010 
 Adipogénique 11 Harbilas et al., 2009 
 Anti-glycation 13 Beaulieu et al., 2010; Harris et al., 2011 
     
15 S. purpurea Cytoprotective 14, 15 Harris et al., 2012; Spoor et al., 2006 
 Hypoglycémiante 8, 9, 10, Muhammad et al., 2012; Nistor Baldea et al., 2010; 
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12 Spoor et al., 2006 
 Anti-glycation 13 Harris et al., 2011 
     
16 P. balsamifera Anti-obésité 1, 11 Harbilas et al., 2012b; Martineau, Hervé, et al., 2010; 
Martineau, Muhammad, et al., 2010 
 Hypoglycémiante 1, 12 Harbilas et al., 2012b; Nistor Baldea et al., 2010 
 Insulino-sensibilisatrice 1 Harbilas et al., 2012b 
 Cytoprotective 14 Harbilas et al., 2009 
 Anti-glycation 13 Harris et al., 2011 
     
17 G. hispidula Hypoglycémiante 9, 12 Harbilas et al., 2009; Nistor Baldea et al., 2010 
 Cytoprotective 14, 15 Harbilas et al., 2009 
 Anti-glycation 13 Harris et al., 2011 
     
20 L. clavatum Hypoglycémiante 12 Nistor Baldea et al., 2010 
 Adipogénique 11 Harbilas et al., 2009 
 Cytoprotective 14 Harbilas et al., 2009 
     
21 V. angustifolium Hypoglycémiante 8, 9 Martineau et al., 2006 
 Adipogénique 11 Martineau et al., 2006 
 Cytoprotective 14 Martineau et al., 2006 
 Insulinotrope 6 Martineau et al., 2006 
 Proliférative 7 Martineau et al., 2006 
 Anti-glycation 13 McIntyre et al., 2008 
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Outre leur activité antioxydante évaluée dans maints modèles expérimentaux (Spoor et 
al., 2006; Fraser et al., 2007; Harbilas et al., 2009; Harris et al., 2011), plusieurs des plantes 
médicinales citées dans les communautés de Wemindji et Oujé-Bougoumou ont déjà été 
testées à l’aide d’une plateforme étendue de bioessais in vitro et de modèles animaux in vivo 
(tableau 6.1). Le résultat de ces expériences témoigne du potentiel antidiabétique que 
possèdent les plantes de la médecine traditionnelle crie (tableau 6.2) et, conséquemment, de la 
possibilité de les intégrer dans des approches culturellement adaptées pour aider à gérer le 
DT2. 
L’usage sécuritaire et efficace de ces plantes dans des régimes de médecine 
traditionnelle dépend toutefois de plusieurs facteurs. Il faut, d’une part, s’assurer d’une mise 
en place qui tienne compte des différents intervenants du milieu de la santé cri (projet en 
cours) et, d’autre part, du développement durable de cette ressource. Ainsi, Tendland et al. 
(2012) décrivent expérimentalement les seuils de surexploitation du R. groenlandicum et 
modélisent ainsi le temps de réhabilitation chez les populations sauvages afin d’assurer le 
renouvèlement de la ressource. Les études sur la variabilité phytochimique, quant à elles, 
permettent de développer des produits de santé naturels de qualité, efficaces et normalisés. 
La variabilité géographique des composantes phytochimiques est bien documentée, tel 
qu’est le cas chez Abies balsamea (Zavarin and Snajberk, 1972; Lester, 1974). Il existe 
également quelques études cherchant à élucider les tendances et les gradients qui les 
soutendent (tableau 6.3). Cependant, les gradients géographiques sont souvent variés et 
contradictoires, comme on le remarque dans ce mémoire en comparant les résultats pour R. 
groenlandicum et S. purpurea. De plus, les liens de causalité avec les facteurs biotiques et 
abiotiques soupçonnés d’être impliqués sont rarement mesurés ni testés efficacement et 
relèvent généralement de la spéculation. 
Deux hypothèses s’opposent pour expliquer de manière générale les variations 
géographiques qui existent chez les métabolites secondaires (Zidorn, 2009). Premièrement, 
plus le climat est extrême, moins la pression sélective par l’herbivorie est prononcée. Ainsi, la 
quantité et diversité de composantes bioactives devraient diminuer de l’équateur vers les 
pôles. Deuxièmement, les extrêmes climatiques par rapport à la radiation solaire et à la 
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température, par exemple, sont des facteurs de stress sur les plantes. On observerait donc 
l’effet opposé; les plantes ayant recours aux composantes bioactives pour se protéger. 
Ces hypothèses ne peuvent cependant pas être généralisées à toutes les composantes, 
car elles ne possèdent pas toutes les mêmes fonctions physiologiques. Cela étant dit, les 
structures spatiales sont plutôt des marqueurs expliquant des relations biotiques ou abiotiques. 
Les études qui s’y rattachent doivent donc être réalisées et interprétées cas par cas en prenant 
en considération les groupes de composantes ciblés, l’impact de la variabilité génétique, les 
interactions avec les autres métabolites présents ainsi que leur rôle dans les voies 
biosynthétiques. 
Finalement, un suivi des résultats obtenus de l’analyse phytochimique du S. purpurea 
est tout indiqué pour mieux les comprendre dans un contexte de pharmacologie. Comme il a 
été fait pour R. groenlandicum, l’analyse pharmacologique par bioessai in vitro, soit une étude 
tenant compte de l’absorption du glucose en présence de la sarracénie (Spoor et al., 2006; 
Muhammad et al., 2012), éluciderait le rôle pharmacologique des variations phytochimiques 
observées. Quant au R. groenlandicum, des études contrôlées en serre sont nécessaires afin 
d’élucider davantage le rôle de la radiation solaire et de la photopériode sur la production de 
composantes biologiquement actives. 
De plus, la compilation des données ethnobotaniques révèle des espèces végétales 
possédant une importance culturelle élevée par rapport à la médicine traditionnelle des CEI. 
Plusieurs de ces plantes ont démontré un potentiel antidiabétique (tableau 6.2) et 
bénéficieront d’études plus poussées comme les études cliniques. Malgré leur faible 
classement, une attention particulière devrait tout de même être portée aux fruits sauvages, tels 
Vaccinium uliginosum, Empetrum nigrum et Prunus pensylvanica, pour lesquels les bienfaits 
ont déjà été explorés scientifiquement. Puisque ces fruits sont principalement perçus et 
appréciés comme aliments, ils peuvent être utilisés pour remplacer d’autres sources 
alimentaires de glucides raffinés, tels les sucreries et les boissons gazeuses. Leur intégration 
dans des approches culturellement adaptées pour traiter le DT2 pourrait donc être facilitée. 
Des études ethnobotaniques ayant pour objectif d’identifier les fruits sauvages couramment 
consommés et recherchés permettraient de mieux cerner cette approche. 
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Table 6.3 Liste des études portant sur les gradients géographiques et la phytochimie de diverses espèces végétales. Les variables 
spatiales associées à ces tendances sont indiquées suivi des facteurs abiotiques ou biotiques déduits ou testés pour expliquer ces 
corrélations. 
Espèce Famille Métabolite Corrélation1 Facteur abiotique/biotique Référence 
Cinchona spp. Rubiaceae Alcaloïdes Altitude (+) Température Camp, 1949 
Lupinus sericeus Fabaceae Flavonoles Latitude (-)  Nicholls and Bohm, 1982, 1983 
Satureja douglasii Lamiaceae Monoterpènes Latitude Luminosité et herbivorie 
Lincoln and Langenheim, 1976, 
1979 
Sanguinaria canadensis Papaveraceae Alcaloïdes Altitude (-) Herbivorie et pathogénie Salmore and Hunter, 2001 
Pteridium caudatum Dennstaedtiaceae Polyphénoles Altitude (+) Radiation solaire Alonso-Amelot et al., 2004 
Pteridium arachnoideum Dennstaedtiaceae Polyphénoles Altitude (+) Radiation solaire Alonso-Amelot et al., 2004, 2007 
Juniperus communis Cupressaceae 
Alkanes Altitude (x2) Température et aridité Dodd and Poveda, 2003 
Polyphénoles Latitude (+)  Martz et al., 2009 
Terpènes Altitude (+)  Martz et al., 2009 
Vaccinium myrtillus Ericaceae Polyphénoles 
Latitude (+) Luminosité, 
température et qualité 
du sol 
Martz et al., 2010 Altitude (+) 
Jungermannia exsertifolia 
subsp. cordifolia Jungermanniaceae Polyphénoles Altitude (+) Radiation solaire Arróniz-Crespo et al., 2006 
Betula pubescens Betulaceae Flavonoïdes Latitude (+/-)2 Température et [P] Stark et al., 2008 
Scorzoneroides helvetica Asteraceae Flavonoles Altitude (-)  Zidorn, 2009 
1(+) = relation positive, (-) = relation négative, (x2) = relation quadratique 
2Gradients de quercétine et ses dérivées sont opposés à ceux d’apigénine et de naringénine 
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Annexe I – Certificat d’éthique 
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Annexe II – Spécimens d’herbier : ethnobotanique de 
Wemindji et Oujé-Bougoumou 
Spécimen # de récolte Herbier* 
      
Wemindji     
Abies balsamea MTR-2011-080 MT; OTT; a; b 
Alnus incana subsp. rugosa MTR-2011-079 MT; OTT; a; b 
Betula papyrifera MTR-2011-087 MT; OTT; a; b 
Gaultheria hispidula MTR-2011-077 MT; OTT; a; b 
Juniperus communis MTR-2011-031 MT; b 
Juniperus communis MTR-2011-030 MT; OTT; a 
Kalmia angustifolia MTR-2011-086 MT; OTT; a; b 
Larix laricina MTR-2011-071 MT; OTT; a; b 
Picea glauca MTR-2011-033 MT; OTT; a; b 
Picea mariana MTR-2011-074 MT; b 
Picea mariana MTR-2011-055 MT; OTT, a 
Populus balsamifera MTR-2011-062 MT; OTT; a; b 
Populus tremuloides MTR-2011-061 MT; OTT; a; b 
Rhododendron groenlandicum MTR-2011-054 MT; OTT; a; b 
Sphagnum fuscum MTR-2011-035-D MT 
Typha latifolia MTR-2011-085 MT; OTT; a; b 
Vaccinium angustifolium MTR-2011-056 MT; OTT; a; b 
Vaccinium uliginosum MTR-2011-042 MT; OTT; a; b 
Vaccinium vitis-idaea MTR-2011-068 MT; OTT; a; b 
Espèces mentionées par le participant inuit ou métis: 
Andromeda polifolia MTR-2011-036 MT; OTT; a 
Chamerion angustifolium MTR-2011-073 MT; OTT; a; b 
Honckenya peploides MTR-2011-046 MT; OTT 
Empetrum nigrum MTR-2011-059 MT; OTT; a; b 
Rhododendron tomentosum Non trouvé  
Salix arctophila  MTR-2011-043 MT; OTT; a 
Sorbus decora MTR-2011-065 MT; OTT; a; b 
      
Ouje-Bougoumou     
Abies balsamea MTR-2011-128 MT; OTT; a; c 
Alnus incana subsp. rugosa MTR-2011-107 MT; OTT; a; c 
Andromeda polifolia1 MTR-2011-036 MT; OTT; a; c 
Betula papyrifera MTR-2011-104 MT; OTT; a; c 
 
 
iii 
 
 
 
 
 
Cornus stolonifera MTR-2011-143 MT; OTT; a; c 
Gaultheria hispidula MTR-2011-109 MT; a 
Gaultheria hispidula MTR-2011-110 MT; OTT; a; c 
Kalmia angustifolia MTR-2011-126 MT; OTT; a; c 
Larix laricina MTR-2011-089 MT; OTT; a; c 
Lycopodium annotinum MTR-2011-146 MT; OTT; a; c 
Lycopodium clavatum Non trouvé  
Picea glauca MTR-2011-129 MT; OTT; a; c 
Picea mariana MTR-2011-088 MT; OTT; a; c 
Pinus banksiana MTR-2011-127 MT; OTT; a; c 
Plantago major MTR-2011-114 MT; OTT; a; c 
Populus balsamifera MTR-2011-139 MT; OTT; a; c 
Populus tremuloides MTR-2011-120 MT; OTT; a; c 
Prunus pensylvanica MTR-2011-144 MT; OTT; a; c 
Rhododendron groenlandicum MTR-2011-103 MT; OTT; a; c 
Ribes lacustre MTR-2011-145 MT; OTT; a; c 
Rubus pubescens MTR-2011-111 MT; OTT; a; c 
Salix humilis var. humilis MTR-2011-132 MT; OTT; a; c 
Sarracenia purpurea MTR-2011-100 MT; OTT; a; c 
Sorbus americana MTR-2011-142 MT; OTT; a; c 
Sorbus decora1 MTR-2011-065 MT; OTT; a; b 
Thuja occidentalis MTR-2011-121 MT; OTT; a; c 
Vaccinium angustifolium MTR-2011-141 MT; OTT; a; c 
Vaccinium myrtilloides MTR-2011-140 MT; OTT; a; c 
Vaccinium vitis-idaea Non trouvé   
* Les spécimens d'herbier sont déponsés dans l'herbier Marie-Victorin du Jardin Botanique de 
Montréal (MT), l'herbier de l'Université d'Ottawa (OTT), le Centre de Culture Crie 
Aanischaaukamikw (a), l'école Maquatua de Wemindji (b) et Waapihtiiwewan de Oujé-Bougoumou 
(c). 
1Spécimen récolté à Wemindji 
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Annexe III – Spécimens d’herbier : phytochimie de 
Rhododendron groenlandicum et Sarracenia purpurea 
 
 
 
 
 
 
 
 
 
 
 
 
 
# de récolte Lieux Herbier 
 
Rhododendron groenlandicum 
MTR-2010-001 Ottawa OTT 
MTR-2010-025 Mistissini MT; OTT 
MTR-2010-003 Nemaska MT; OTT 
MTR-2010-017 Waskaganish MT; OTT 
MTR-2010-018 Eastmain MT; OTT 
MTR-2010-021 Wemindji MT; OTT 
MTR-2010-008 Whapmagoostui MT; OTT 
   
Sarracenia purpurea 
MTR-2010-002 Ottawa OTT 
MTR-2010-023 Mistissini MT; OTT 
MTR-2010-006 Waskaganish MT; OTT 
MTR-2010-022 Wemindji MT; OTT 
MTR-2010-020 Eastmain MT; OTT 
MTR-2010-004 Nemaska MT; OTT 
* Les spécimens d'herbier sont déponsés dans l'herbier Marie-Victorin du 
Jardin Botanique de Montréal (MT) et l'herbier de l'Université d'Ottawa 
(OTT). 
 
 
v 
Annexe IV – Liste des espèces avec autorité et famille 
Espèce Famille 
Plantae  
Abies balsamea (L.) Mill. Pinaceae 
Alnus incana subsp. rugosa (Du Roi) R. T. Clausen Betulaceae 
Alnus viridis subsp. crispa (Ait.) Turrill Salicaceae 
Andromeda polifolia L. Ericaceae 
Betula papyrifera Marsh. Betulaceae 
Chamerion angustifolium (L.) Holub  Onagraceae 
Cornus stolonifera Michx. Cornaceae 
Empetrum nigrum L. Ericaceae 
Gaultheria hispidula (L.) Muhl. Ericaceae 
Heracleum maximum W. Bartram  Apiaceae 
Honckenya peploides (L.) Ehrh. Caryophyllaceae 
Juniperus communis L. Cupressaceae 
Kalmia angustifolia L. Ericaceae 
Larix laricina (Du Roi) K. Koch Pinaceae 
Leymus mollis (Trin.) Pilg. Poaceae 
Lycopodium annotinum L. Lycopodiaceae 
Lycopodium clavatum L. Lycopodiaceae 
Picea glauca (Moench) Voss Pinaceae 
Picea mariana (Mill.) BSP Pinaceae 
Pinus banksiana Lamb. Pinaceae 
Plantago major L. Plantaginaceae 
Populus balsamifera L. Salicaceae 
Populus tremuloides Michx. Salicaceae 
Prunus pensylvanica L. f. Rosaceae 
Rhododendron groenlandicum (Oeder) Kron & Judd Ericaceae 
Rhododendron tomentosum Harmaja Ericaceae 
Ribes lacustre (Pers.) Poir. Grossulariaceae 
Rubus pubescens Raf. Rosaceae 
Salix humilis Marsh. var. humilis Salicaceae 
Sarracenia purpurea L. Sarraceniaceae 
Sorbus americana Marsh. Rosaceae 
Sorbus decora C. K. Schneid. Rosaceae 
Sphagnum fuscum  (Schimp.) Klinggr Sphagnaceae 
Thuja occidentalis L. Cupressaceae 
Typha latifolia L. Typhaceae 
Vaccinium angustifolium Ait. Ericaceae 
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 Vaccinium boreale I.V. Hall & Aalders Ericaceae 
Vaccinium myrtilloides Michx. Ericaceae 
Vaccinium uliginosum L. Ericaceae 
Vaccinium vitis – idaea L. Ericaceae 
